DATE ADDED TO CATALOG	PUBMEDID	FIRST AUTHOR	DATE	JOURNAL	LINK	STUDY	DISEASE/TRAIT	INITIAL SAMPLE SIZE	REPLICATION SAMPLE SIZE	REGION	CHR_ID	CHR_POS	REPORTED GENE(S)	MAPPED_GENE	UPSTREAM_GENE_ID	DOWNSTREAM_GENE_ID	SNP_GENE_IDS	UPSTREAM_GENE_DISTANCE	DOWNSTREAM_GENE_DISTANCE	STRONGEST SNP-RISK ALLELE	SNPS	MERGED	SNP_ID_CURRENT	CONTEXT	INTERGENIC	RISK ALLELE FREQUENCY	P-VALUE	PVALUE_MLOG	P-VALUE (TEXT)	OR or BETA	95% CI (TEXT)	PLATFORM [SNPS PASSING QC]	CNV	MAPPED_TRAIT	MAPPED_TRAIT_URI	STUDY ACCESSION	GENOTYPING TECHNOLOGY
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	16q22.1	16	70741552	VAC14	VAC14			ENSG00000103043			rs875858-?	rs875858	0	875858	intron_variant	0	NR	2E-8	7.698970004336019		3.6	[2.21-5.84]	Illumina [498081]	N	peripheral neuropathy, response to docetaxel, metastatic prostate cancer	http://www.ebi.ac.uk/efo/EFO_0003100, http://purl.obolibrary.org/obo/GO_1902519, http://www.ebi.ac.uk/efo/EFO_0000196	GCST003672	Genome-wide genotyping array
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	10q26.3	10	130032376	Intergenic	C10orf143			ENSG00000237489			rs11017056-?	rs11017056	0	11017056	intron_variant	0	NR	4E-7	6.3979400086720375		2.61	[1.77-3.84]	Illumina [498081]	N	peripheral neuropathy, response to docetaxel, metastatic prostate cancer	http://www.ebi.ac.uk/efo/EFO_0003100, http://purl.obolibrary.org/obo/GO_1902519, http://www.ebi.ac.uk/efo/EFO_0000196	GCST003672	Genome-wide genotyping array
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	13q12.13	13	25800908	ATP8A2	ATP8A2			ENSG00000132932			rs1326116-?	rs1326116	0	1326116	intron_variant	0	NR	2E-6	5.698970004336019		2.77	[1.79-4.27]	Illumina [498081]	N	peripheral neuropathy, response to docetaxel, metastatic prostate cancer	http://www.ebi.ac.uk/efo/EFO_0003100, http://purl.obolibrary.org/obo/GO_1902519, http://www.ebi.ac.uk/efo/EFO_0000196	GCST003672	Genome-wide genotyping array
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	18p11.31	18	4772808	Intergenic	AP005403.1 - AP005203.1	ENSG00000265545	ENSG00000266268		313350	2246	rs8089250-?	rs8089250	0	8089250	intergenic_variant	1	NR	2E-6	5.698970004336019		2.72	[1.78-4.17]	Illumina [498081]	N	peripheral neuropathy, response to docetaxel, metastatic prostate cancer	http://www.ebi.ac.uk/efo/EFO_0003100, http://purl.obolibrary.org/obo/GO_1902519, http://www.ebi.ac.uk/efo/EFO_0000196	GCST003672	Genome-wide genotyping array
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	2q36.3	2	225488082	KIAA1486	NYAP2			ENSG00000144460			rs6436559-?	rs6436559	0	6436559	intron_variant	0	NR	3E-6	5.522878745280337		3.34	[1.95-5.71]	Illumina [498081]	N	peripheral neuropathy, response to docetaxel, metastatic prostate cancer	http://www.ebi.ac.uk/efo/EFO_0003100, http://purl.obolibrary.org/obo/GO_1902519, http://www.ebi.ac.uk/efo/EFO_0000196	GCST003672	Genome-wide genotyping array
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	5p15.33	5	3727065	Intergenic	IRX1 - AC025773.1	ENSG00000170549	ENSG00000248962		125662	285643	rs1566691-?	rs1566691	0	1566691	intergenic_variant	1	NR	4E-6	5.3979400086720375		3.64	[2.03-6.52]	Illumina [498081]	N	peripheral neuropathy, response to docetaxel, metastatic prostate cancer	http://www.ebi.ac.uk/efo/EFO_0003100, http://purl.obolibrary.org/obo/GO_1902519, http://www.ebi.ac.uk/efo/EFO_0000196	GCST003672	Genome-wide genotyping array
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	11q25	11	132887775	OPCML	OPCML			ENSG00000183715			rs1027796-?	rs1027796	0	1027796	intron_variant	0	NR	4E-6	5.3979400086720375		2.38	[1.62-3.48]	Illumina [498081]	N	peripheral neuropathy, response to docetaxel, metastatic prostate cancer	http://www.ebi.ac.uk/efo/EFO_0003100, http://purl.obolibrary.org/obo/GO_1902519, http://www.ebi.ac.uk/efo/EFO_0000196	GCST003672	Genome-wide genotyping array
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	9q33.1	9	115509305	Intergenic	AL691420.1			ENSG00000228714			rs2213920-?	rs2213920	0	2213920	intron_variant	0	NR	5E-6	5.301029995663981		2.63	[1.70-4.06]	Illumina [498081]	N	peripheral neuropathy, response to docetaxel, metastatic prostate cancer	http://www.ebi.ac.uk/efo/EFO_0003100, http://purl.obolibrary.org/obo/GO_1902519, http://www.ebi.ac.uk/efo/EFO_0000196	GCST003672	Genome-wide genotyping array
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	2q36.3	2	228150003	SPHKAP	SPHKAP			ENSG00000153820			rs4438470-?	rs4438470	0	4438470	intron_variant	0	NR	5E-6	5.301029995663981		2.71	[1.73-4.25]	Illumina [498081]	N	peripheral neuropathy, response to docetaxel, metastatic prostate cancer	http://www.ebi.ac.uk/efo/EFO_0003100, http://purl.obolibrary.org/obo/GO_1902519, http://www.ebi.ac.uk/efo/EFO_0000196	GCST003672	Genome-wide genotyping array
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	2p25.2	2	6637697	Intergenic	MIR7515HG			ENSG00000236172			rs17815605-?	rs17815605	0	17815605	non_coding_transcript_exon_variant	0	NR	6E-6	5.221848749616356		2.886	[NR]	Illumina [498081]	N	peripheral neuropathy, response to docetaxel, metastatic prostate cancer	http://www.ebi.ac.uk/efo/EFO_0003100, http://purl.obolibrary.org/obo/GO_1902519, http://www.ebi.ac.uk/efo/EFO_0000196	GCST003672	Genome-wide genotyping array
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	5q31.1	5	136245971	TRPC7	TRPC7			ENSG00000069018			rs11740657-?	rs11740657	0	11740657	intron_variant	0	NR	9E-6	5.045757490560675		2.776	[NR]	Illumina [498081]	N	peripheral neuropathy, response to docetaxel, metastatic prostate cancer	http://www.ebi.ac.uk/efo/EFO_0003100, http://purl.obolibrary.org/obo/GO_1902519, http://www.ebi.ac.uk/efo/EFO_0000196	GCST003672	Genome-wide genotyping array
2017-02-24	27143689	Hertz DL	2016-05-03	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27143689	Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.	Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer	50 European ancestry cases with neuropathy, 573 European ancestry cases without neuropathy	NA	10q21.3	10	66659088	CTNNA3	CTNNA3			ENSG00000183230			rs10997287-?	rs10997287	0	10997287	intron_variant	0	NR	9E-6	5.045757490560675		4.0816326	[NR]	Illumina [498081]	N	peripheral neuropathy, response to docetaxel, metastatic prostate cancer	http://www.ebi.ac.uk/efo/EFO_0003100, http://purl.obolibrary.org/obo/GO_1902519, http://www.ebi.ac.uk/efo/EFO_0000196	GCST003672	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	7q21.3 x 10q26.13	7 x 10	98391899 x 125008303	BAIAP2L1 x CTBP2	BAIAP2L1 x CTBP2						rs9649213-? x rs4962416-?	rs9649213 x rs4962416	0		intron_variant x intron_variant		NR	1E-6	6.0		1.28	[1.16-1.42]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	14q11.2 x 11q13.3	14 x 11	20556460 x 69167951	RNASE9 x MYEOV	RNASE9 x AP003071.2						rs1243647-? x rs12418451-?	rs1243647 x rs12418451	0		missense_variant x intron_variant		NR	1E-6	6.0		1.3333	[1.19-1.49]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	9q22.2 x 4q24	9 x 4	90793457 x 105140377	SYK x TET2	OR7E108P - SYK x AC004069.1						rs290258-? x rs7679673-?	rs290258 x rs7679673	0		intergenic_variant x intron_variant		NR	1E-6	6.0		1.3333	[1.19-1.49]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	9p24.1 x 8q24.21	9 x 8	8012418 x 127472793	C9orf123 x NR	AL135923.2 - PTPRD x CASC8						rs12682851-? x rs1447295-?	rs12682851 x rs1447295	0		intergenic_variant x intron_variant		NR	2E-6	5.698970004336019		1.3889	[1.22-1.59]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	6q22.31 x 17q12	6 x 17	122961796 x 37714971	CLVS2 x HNF1B	ATP5MGP2 - AL591428.1 x HNF1B						rs13192613-? x rs11649743-?	rs13192613 x rs11649743	0		intergenic_variant x intron_variant		NR	3E-6	5.522878745280337		1.37	[1.20-1.56]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	2q31.3 x 17q24.3	2 x 17	180176559 x 71112612	CWC22 x NR	CWC22 - AC012669.1 x CASC17						rs16867225-? x rs1859962-?	rs16867225 x rs1859962	0		intergenic_variant x intron_variant		NR	3E-6	5.522878745280337		1.5625	[1.3-1.89]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	20q13.33 x 19q13.33	20 x 19	63037684 x 50861367	LOC63930 x KLK3	LINC01749 x KLK3 - KLK2						rs6089829-? x rs2735839-?	rs6089829 x rs2735839	0		intron_variant x intergenic_variant		NR	3E-6	5.522878745280337		1.3514	[1.19-1.54]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	7p14.1 x 8q24.21	7 x 8	40925528 x 127472793	INHBA x NR	SUGCT - LINC01450 x CASC8						rs7789197-? x rs1447295-?	rs7789197 x rs1447295	0		intergenic_variant x intron_variant		NR	3E-6	5.522878745280337		1.5152	[1.27-1.79]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	5q13.1 x 3p12.1	5 x 3	67537429 x 87061524	CD180 x NR	AC112206.2 x PPATP1 - LINC00506						rs7717572-? x rs2660753-?	rs7717572 x rs2660753	0		intron_variant x intergenic_variant		NR	3E-6	5.522878745280337		1.94	[1.47-2.56]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	5p15.2 x 19q13.2	5 x 19	13505322 x 41479716	DNAH5 x PPP1R14A	RPS23P5 - NENFP3 x PCAT19						rs4463179-? x rs887391-?	rs4463179 x rs887391	0		intergenic_variant x intron_variant		NR	2E-6	5.698970004336019		1.5625	[1.3-1.89]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	14q32.31 x 3q21.3	14 x 3	101260770 x 128319530	MIR656 x EEFSEC	AL359682.1 x EEFSEC						rs2400997-? x rs10934853-?	rs2400997 x rs10934853	0		intron_variant x intron_variant		NR	3E-6	5.522878745280337		1.25	[1.14-1.38]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	3p26.3 x 7q21.3	3 x 7	108303 x 98187015	CHL1 x LMTK2	AC066595.1 - CHL1-AS2 x LMTK2						rs12485321-? x rs6465657-?	rs12485321 x rs6465657	0		intergenic_variant x intron_variant		NR	3E-6	5.522878745280337		1.2346	[1.14-1.35]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	22q13.1 x 11p15.5	22 x 11	40258272 x 2212344	TNRC6B x IGF2, IGF2AS, INS, TH	TNRC6B x MIR4686 - ASCL2						rs12628051-? x rs7127900-?	rs12628051 x rs7127900	0		intron_variant x intergenic_variant		NR	3E-6	5.522878745280337		1.3	[1.17-1.46]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	8q21.13 x 9q33.2	8 x 9	82161594 x 121665094	SNX16 x DAB2IC	AC027701.1 - HNRNPA1P4 x DAB2IP						rs13264970-? x rs1571801-?	rs13264970 x rs1571801	0		intergenic_variant x intron_variant		NR	4E-6	5.3979400086720375		1.2987	[1.16-1.45]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	8q24.13 x 11p15.5	8 x 11	123702482 x 2212344	ANXA13 x IGF2, IGF2AS, INS, TH	ANXA13 x MIR4686 - ASCL2						rs13258681-? x rs7127900-?	rs13258681 x rs7127900	0		intron_variant x intergenic_variant		NR	4E-6	5.3979400086720375		1.32	[1.17-1.48]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	6p22.1 x 8p21.2	6 x 8	29734733 x 23668950	LOC285830 x NKX3.1	HLA-F, HLA-F-AS1 x SINHCAFP3 - NKX3-1						rs2523395-? x rs1512268-?	rs2523395 x rs1512268	0		intron_variant x TF_binding_site_variant		NR	2E-6	5.698970004336019		1.24	[1.14-1.35]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	4q25 x 8q24.21	4 x 8	113079800 x 126999692	ANK2 x NR	ANK2 x PCAT1						rs7694725-? x rs10086908-?	rs7694725 x rs10086908	0		intron_variant x intron_variant		NR	2E-6	5.698970004336019		1.36	[1.20-1.55]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	15q26.2 x 8q24.21	15 x 8	96459423 x 127472793	NR2F2 x NR	AC087477.4 - RN7SKP254 x CASC8						rs11637980-? x rs1447295-?	rs11637980 x rs1447295	0		intergenic_variant x intron_variant		NR	2E-6	5.698970004336019		1.4706	[1.27-1.72]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	3p25.2 x 10q11.22	3 x 10	12510308 x 46046326	TSEN2 x MSMB	TSEN2 x MSMB - RPL23AP61						rs6766510-? x rs10993994-?	rs6766510 x rs10993994	0		intron_variant x intergenic_variant		NR	2E-6	5.698970004336019		1.58	[1.31-1.91]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	4p16.2 x 19q13.2	4 x 19	5757142 x 41479716	EVC x PPP1R14A	EVC, CRMP1 x PCAT19						rs735172-? x rs887391-?	rs735172 x rs887391	0		intron_variant x intron_variant		NR	2E-6	5.698970004336019		1.31	[1.17-1.46]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	12q13.11 x 22q13.2	12 x 22	46978487 x 43104206	AMIGO2 x TTLL1, BIK, MCAT, PACSIN2	AC079906.1 - AMIGO2 x AL022237.1 - BIK						rs2711721-? x rs5759167-?	rs2711721 x rs5759167	0		intergenic_variant x TF_binding_site_variant		NR	2E-6	5.698970004336019		1.28	[1.16-1.42]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	3q13.2 x 2q31.1	3 x 2	112779033 x 172446825	CD200R1L x ITAGA6	LINC02042 - CD200R1L-AS1 x ITGA6						rs1002979-? x rs12621278-?	rs1002979 x rs12621278	0		intergenic_variant x intron_variant		NR	3E-6	5.522878745280337		1.5873	[1.32-1.92]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	13q31.3 x 8p21.2	13 x 8	90213292 x 23668950	MIR622 x NKX3.1	FAR1P1 - KRT18P27 x SINHCAFP3 - NKX3-1						rs16944141-? x rs1512268-?	rs16944141 x rs1512268	0		intergenic_variant x TF_binding_site_variant		NR	3E-6	5.522878745280337		1.5385	[1.28-1.85]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	15q21.1 x 11q13.3	15 x 11	48747600 x 69167951	CEP152 x MYEOV	CEP152 x AP003071.2						rs784411-? x rs12418451-?	rs784411 x rs12418451	0		intron_variant x intron_variant		NR	1E-7	7.0		1.42	[1.25-1.61]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	18q12.3 x 3q21.3	18 x 3	45145697 x 128319530	MIR4319 x EEFSEC	AC090376.1 x EEFSEC						rs998124-? x rs10934853-?	rs998124 x rs10934853	0		intron_variant x intron_variant		NR	5E-6	5.301029995663981		1.33	[1.18-1.51]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	2q33.1 x 11q13.3	2 x 11	198304372 x 69227200	PLCL1 x MYEOV	PLCL1, LINC01923 x AP003071.2 - MYEOV						rs13398206-? x rs10896449-?	rs13398206 x rs10896449	0		intron_variant x intergenic_variant		NR	4E-6	5.3979400086720375		1.24	[1.13-1.36]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	10q25.3 x 8q24.21	10 x 8	114567791 x 127472793	ABLIM1 x NR	ABLIM1 x CASC8						rs10885582-? x rs1447295-?	rs10885582 x rs1447295	0		intron_variant x intron_variant		NR	4E-6	5.3979400086720375		1.3699	[1.20-1.59]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	12q21.31 x 8q24.21	12 x 8	82770777 x 127112671	TMTC2 x NR	TMTC2 x CASC19, PCAT1						rs12317459-? x rs16901979-?	rs12317459 x rs16901979	0		intron_variant x intron_variant		NR	4E-6	5.3979400086720375		2.06	[1.52-2.80]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	5q11.2 x 10q26.13	5 x 10	57834991 x 125008303	ACTBL2 x CTBP2	AC106822.1 - LINC02225 x CTBP2						rs10940579-? x rs4962416-?	rs10940579 x rs4962416	0		regulatory_region_variant x intron_variant		NR	4E-6	5.3979400086720375		1.32	[1.18-1.49]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	7q31.1 x 17q24.3	7 x 17	109363517 x 71112612	C7orf66 x NR	AC002386.1 - AC073071.1 x CASC17						rs10277209-? x rs1859962-?	rs10277209 x rs1859962	0		intergenic_variant x intron_variant		NR	4E-6	5.3979400086720375		1.36	[1.19-1.55]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	9q33.1 x 3q21.3	9 x 3	115068533 x 128319530	TNC x EEFSEC	DEC1, TNC x EEFSEC						rs7847271-? x rs10934853-?	rs7847271 x rs10934853	0		intron_variant x intron_variant		NR	4E-6	5.3979400086720375		1.4925	[1.27-1.79]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	3p26.3 x 22q13.1	3 x 22	1470903 x 40056115	CNTN6 x TNRC6B	CNTN6 - RPL23AP38 x TNRC6B						rs6763848-? x rs9623117-?	rs6763848 x rs9623117	0		intergenic_variant x intron_variant		NR	4E-6	5.3979400086720375		1.3	[1.16-1.45]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	13q14.11 x 2p21	13 x 2	44063269 x 43326810	NCRNA00284 x THADA	LINC00284 - LINC00390 x THADA						rs9567349-? x rs1465618-?	rs9567349 x rs1465618	0		intergenic_variant x intron_variant		NR	4E-6	5.3979400086720375		1.6393	[1.33-2.04]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	15q14 x 8q24.21	15 x 8	34776108 x 127401060	ACTC1 x NR	AC087457.1 x CCAT2, POU5F1B, CASC8, PCAT1						rs543686-? x rs6983267-?	rs543686 x rs6983267	0		intron_variant x non_coding_transcript_exon_variant		NR	4E-6	5.3979400086720375		1.24	[1.13-1.35]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	22q12.1 x 8q24.21	22 x 8	27456222 x 127310936	MN1 x NR	AL049536.1 - AL050402.1 x CASC8, PCAT1						rs6005451-? x rs445114-?	rs6005451 x rs445114	0		intergenic_variant x intron_variant		NR	4E-6	5.3979400086720375		1.42	[1.22-1.65]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	22q11.22 x 4q24	22 x 4	22490916 x 105140377	ZNF280B x TET2	ZNF280B x AC004069.1						rs5751168-? x rs7679673-?	rs5751168 x rs7679673	0		intron_variant x intron_variant		NR	4E-6	5.3979400086720375		1.44	[1.23-1.67]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	18q12.1 x Xp11.22	18 x X	33347811 x 51498820	C18orf34 x NUDT10	CCDC178 x NUDT11 - LINC01496						rs6507016-? x rs5945619-?	rs6507016 x rs5945619	0		intron_variant x intergenic_variant		NR	4E-6	5.3979400086720375		1.2821	[1.15-1.41]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	22q13.1 x 11p15.5	22 x 11	40279087 x 2212344	TNRC6B x IGF2, IGF2AS, INS, TH	TNRC6B x MIR4686 - ASCL2						rs4821941-? x rs7127900-?	rs4821941 x rs7127900	0		intron_variant x intergenic_variant		NR	4E-6	5.3979400086720375		1.3	[1.16-1.46]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	2q13 x 11p15.5	2 x 11	111039954 x 2212344	ACOXL x IGF2, IGF2AS, INS, TH	ACOXL, MIR4435-2HG x MIR4686 - ASCL2						rs3789080-? x rs7127900-?	rs3789080 x rs7127900	0		intron_variant x intergenic_variant		NR	4E-6	5.3979400086720375		1.4085	[1.22-1.64]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	11p15.2 x 4q24	11 x 4	15333700 x 105140377	INSC x TET2	INSC - RF00324 x AC004069.1						rs11605083-? x rs7679673-?	rs11605083 x rs7679673	0		intergenic_variant x intron_variant		NR	4E-6	5.3979400086720375		1.28	[1.15-1.43]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	1p34.3 x 17q12	1 x 17	37731169 x 37738049	EPHA10 x HNF1B	EPHA10 x HNF1B						rs731174-? x rs4430796-?	rs731174 x rs4430796	0		intron_variant x intron_variant		NR	5E-6	5.301029995663981		1.27	[1.15-1.40]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	16q12.1 x 7q21.3	16 x 7	49360365 x 98187015	C16orf78 x LMTK2	AC007614.1 - C16orf78 x LMTK2						rs8057939-? x rs6465657-?	rs8057939 x rs6465657	0		intergenic_variant x intron_variant		NR	5E-6	5.301029995663981		1.37	[1.20-1.57]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	3p12.1 x 4q22.3	3 x 4	86845328 x 94641726	VGLL3 x PDLIM5	AC108706.1 - VGLL3 x PDLIM5						rs9757252-? x rs17021918-?	rs9757252 x rs17021918	0		regulatory_region_variant x intron_variant		NR	5E-6	5.301029995663981		1.25	[1.13-1.37]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	6p22.3 x 8q24.21	6 x 8	17813594 x 126999692	KIF13A x NR	KIF13A x PCAT1						rs10456809-? x rs10086908-?	rs10456809 x rs10086908	0		intron_variant x intron_variant		NR	5E-6	5.301029995663981		1.25	[1.14-1.38]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	3q26.31 x 7p15.1	3 x 7	173125487 x 27936944	SPATA16 x JAZF1	SPATA16 x JAZF1						rs11720607-? x rs10486567-?	rs11720607 x rs10486567	0		intron_variant x intron_variant		NR	5E-6	5.301029995663981		1.3699	[1.20-1.59]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	6q12 x 6q25.3	6 x 6	68584593 x 160412632	BAI3 x NR	LINC02549 - AL606923.1 x SLC22A3						rs9351730-? x rs9364554-?	rs9351730 x rs9364554	0		intergenic_variant x intron_variant		NR	5E-6	5.301029995663981		1.25	[1.13-1.37]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	1p35.3 x 19q13.2	1 x 19	29712815 x 38244973	PTPRU x NR	AC092265.1 - AL645944.2 x SPINT2						rs1866967-? x rs8102476-?	rs1866967 x rs8102476	0		intergenic_variant x intron_variant		NR	5E-6	5.301029995663981		1.2195	[1.12-1.33]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	8q21.13 x 9q33.2	8 x 9	78044423 x 121665094	PKIA x DAB2IC	AC062004.1 - AC084706.1 x DAB2IP						rs2219968-? x rs1571801-?	rs2219968 x rs1571801	0		intergenic_variant x intron_variant		NR	6E-7	6.221848749616356		1.3	[1.17-1.43]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	10p14 x 19q13.2	10 x 19	12009817 x 38244973	UPF2 x NR	UPF2 x SPINT2						rs10795917-? x rs8102476-?	rs10795917 x rs8102476	0		intron_variant x intron_variant		NR	7E-7	6.154901959985743		1.24	[1.14-1.36]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	12q13.11 x 17q12	12 x 17	48417317 x 37738049	ANP32D x HNF1B	OR8S21P, AC090115.1 x HNF1B						rs4489787-? x rs4430796-?	rs4489787 x rs4430796	0		non_coding_transcript_exon_variant x intron_variant		NR	1E-6	6.0		1.47	[1.25-1.72]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2012-03-31	22219177	Tao S	2012-01-04	Carcinogenesis	www.ncbi.nlm.nih.gov/pubmed/22219177	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	Prostate cancer (SNP x SNP interaction)	4,723 European ancestry cases, 4,792 European ancestry controls	NA	3p14.3 x 11q13.3	3 x 11	57409039 x 69167951	DNAH12 x MYEOV	DNAH12 x AP003071.2						rs1916284-? x rs12418451-?	rs1916284 x rs12418451	0		intron_variant x intron_variant		NR	1E-6	6.0		1.2658	[1.15-1.41]	Affymetrix, Illumina [1117531] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001370	Genome-wide genotyping array
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	8q24.21	8	127401060	NR	CCAT2, POU5F1B, PCAT1, CASC8			ENSG00000280997, ENSG00000212993, ENSG00000253438, ENSG00000246228			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	NR	1E-8	8.0		1.36	[NR]	Illumina [2639562] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002413	Genome-wide genotyping array
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	10q11.22	10	46046326	MSMB	MSMB - RPL23AP61	ENSG00000263639	ENSG00000280012		57	16924	rs10993994-T	rs10993994	0	10993994	intergenic_variant	1	0.42	2E-7	6.698970004336019		1.32	[1.21-1.43]	Illumina [2639562] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002413	Genome-wide genotyping array
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	11p15.5	11	2212344	NR	MIR4686 - ASCL2	ENSG00000265258	ENSG00000183734		39206	56151	rs7127900-A	rs7127900	0	7127900	intergenic_variant	1	NR	1E-7	7.0		1.4	[NR]	Illumina [2639562] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002413	Genome-wide genotyping array
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	11q13.3	11	69227030	NR	AP003071.2 - MYEOV	ENSG00000261070	ENSG00000172927		55466	67108	rs7931342-G	rs7931342	0	7931342	intergenic_variant	1	NR	1E-6	6.0		1.3	[NR]	Illumina [2639562] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002413	Genome-wide genotyping array
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	17q12	17	37736310	TCF2	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs2005705-G	rs2005705	0	2005705	intron_variant	0	0.56	1E-6	6.0		1.35	[1.23-1.47]	Illumina [2639562] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002413	Genome-wide genotyping array
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	8q24.21	8	127395198	MYC	PCAT1, POU5F1B, CASC8			ENSG00000253438, ENSG00000212993, ENSG00000246228			rs10505477-A	rs10505477	0	10505477	intron_variant	0	0.49	9E-9	8.045757490560675		1.39	[1.28-1.50]	Illumina [2639562] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002413	Genome-wide genotyping array
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	11q13.3	11	69241647	MYEOV	AP003071.2 - MYEOV	ENSG00000261070	ENSG00000172927		70083	52491	rs11228583-T	rs11228583	0	11228583	regulatory_region_variant	1	0.52	2E-7	6.698970004336019		1.33	[1.22-1.44]	Illumina [2639562] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002413	Genome-wide genotyping array
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	19q13.33	19	50858501	KLK3	KLK3			ENSG00000142515			rs17632542-T	rs17632542	0	17632542	missense_variant	0	0.92	1E-7	7.0		1.85	[1.61-2.09]	Illumina [2639562] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002413	Genome-wide genotyping array
2014-11-09	24740154	Lange EM	2014-04-16	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24740154	Genome-wide association scan for variants associated with early-onset prostate cancer.	Prostate cancer (early onset)	931 European ancestry cases, 4,120 European ancestry controls	2,571 European ancestry cases, 921 European ancestry controls	11p15.5	11	2207722	TH	MIR4686 - ASCL2	ENSG00000265258	ENSG00000183734		34584	60773	rs7126629-C	rs7126629	0	7126629	intergenic_variant	1	0.21	2E-8	7.698970004336019		1.44	[1.31-1.57]	Illumina [2639562] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002413	Genome-wide genotyping array
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	2p24.1	2	20688505	C2orf43	LDAH			ENSG00000118961			rs13385191-G	rs13385191	0	13385191	intron_variant	0	0.44	8E-8	7.096910013008056		1.15	[1.10-1.21]	Illumina [510687]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000750	Genome-wide genotyping array
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	5p15.33	5	1895715	intergenic	CTD-2194D22.4						rs12653946-T	rs12653946	0	12653946	intron_variant	0	0.44	4E-18	17.397940008672037		1.26	[1.20-1.33]	Illumina [510687]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000750	Genome-wide genotyping array
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	6p21.1	6	41568689	FOXP4	FOXP4			ENSG00000137166			rs1983891-T	rs1983891	0	1983891	intron_variant	0	0.41	8E-8	7.096910013008056		1.15	[1.09-1.21]	Illumina [510687]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000750	Genome-wide genotyping array
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	6q22.1	6	116888889	GPRC6A, RFX6	RFX6			ENSG00000185002			rs339331-T	rs339331	0	339331	intron_variant	0	0.37	2E-12	11.698970004336019		1.22	[1.15-1.28]	Illumina [510687]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000750	Genome-wide genotyping array
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	13q22.1	13	73154002	intergenic	RNU6-66P - RNU4-10P	ENSG00000200267	ENSG00000201253		40984	37526	rs9600079-T	rs9600079	0	9600079	intergenic_variant	1	0.38	3E-9	8.522878745280337		1.18	[1.12-1.24]	Illumina [510687]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000750	Genome-wide genotyping array
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	8q24.21	8	127527115	intergenic	CASC8 - CASC11	ENSG00000246228	ENSG00000249375		44976	159228	rs7837688-?	rs7837688	0	7837688	intergenic_variant	1	NR	1E-25	25.0				Illumina [510687]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000750	Genome-wide genotyping array
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	8q24.21	8	127091692	intergenic	CASC19, PCAT1, PRNCR1			ENSG00000254166, ENSG00000253438, ENSG00000282961			rs1456315-?	rs1456315	0	1456315	non_coding_transcript_exon_variant	0	NR	2E-29	28.69897000433602				Illumina [510687]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000750	Genome-wide genotyping array
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	3p11.2	3	87103019	intergenic	LINC00506			ENSG00000281392			rs9284813-?	rs9284813	0	9284813	intron_variant	0	NR	5E-9	8.301029995663981				Illumina [510687]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000750	Genome-wide genotyping array
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	8p21.2	8	23668950	NKX3.1	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		33443	9743	rs1512268-?	rs1512268	0	1512268	TF_binding_site_variant	1	NR	4E-11	10.397940008672037				Illumina [510687]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000750	Genome-wide genotyping array
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	10q11.22	10	46046326	MSMB	MSMB - RPL23AP61	ENSG00000263639	ENSG00000280012		57	16924	rs10993994-?	rs10993994	0	10993994	intergenic_variant	1	NR	3E-8	7.522878745280337				Illumina [510687]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000750	Genome-wide genotyping array
2010-09-11	20676098	Takata R	2010-08-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20676098	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	Prostate cancer	1,583 Japanese ancestry cases, 3,386 Japanese ancestry controls	3,001 Japanese ancestry cases, 5,415 Japanese ancestry controls	17q12	17	37741165	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7501939-?	rs7501939	0	7501939	intron_variant	0	NR	1E-12	12.0				Illumina [510687]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000750	Genome-wide genotyping array
2008-09-17	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Prostate cancer	59 cases, 558 controls	NA	3p22.2	3	37954986	CTDSPL	CTDSPL			ENSG00000144677			rs9311171-?	rs9311171	0	9311171	splice_region_variant	0	NR	2E-6	5.698970004336019				Affymetrix [70897]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000095	Genome-wide genotyping array
2008-09-17	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Prostate cancer	59 cases, 558 controls	NA	13q33.1	13	103275657	intergenic	SLC10A2 - AL162717.1	ENSG00000125255	ENSG00000285789		208811	68003	rs1529276-?	rs1529276	0	1529276	intergenic_variant	1	NR	2E-6	5.698970004336019				Affymetrix [70897]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000095	Genome-wide genotyping array
2008-09-17	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Prostate cancer	59 cases, 558 controls	NA	6p12.2	6	51801833	PKHD1	PKHD1			ENSG00000170927			rs10498792-?	rs10498792	0	10498792	intron_variant	0	NR	3E-6	5.522878745280337				Affymetrix [70897]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000095	Genome-wide genotyping array
2008-09-17	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Prostate cancer	59 cases, 558 controls	NA	5q14.3	5	83689920	HAPLN1	HAPLN1			ENSG00000145681			rs4466137-?	rs4466137	0	4466137	intron_variant	0	NR	3E-6	5.522878745280337				Affymetrix [70897]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000095	Genome-wide genotyping array
2008-09-17	17903305	Murabito JM	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903305	A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.	Prostate cancer	59 cases, 558 controls	NA	3q24	3	145456001	intergenic	AC011592.1 - LARP7P4	ENSG00000280397	ENSG00000244024		1010157	67537	rs345013-?	rs345013	0	345013	intergenic_variant	1	NR	5E-6	5.301029995663981				Affymetrix [70897]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000095	Genome-wide genotyping array
2017-11-24	29117387	Conti DV	2017-08-01	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/29117387	Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry.	Prostate cancer	5,454 African American cases, 474 West African cases, 4,274 African American and African ancestry cases, 6,328 African American controls, 458 West African controls, 4,024 African American and African ancestry controls	NA	13q34	13	109708437	IRS2	AL163541.1			ENSG00000285534			rs75823044-T	rs75823044	0	75823044	intron_variant	0	0.02	6E-12	11.221848749616356		1.55	[1.37-1.76]	Affymetrix, Illumina [17013228] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST004982	Genome-wide genotyping array
2017-11-24	29117387	Conti DV	2017-08-01	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/29117387	Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry.	Prostate cancer	5,454 African American cases, 474 West African cases, 4,274 African American and African ancestry cases, 6,328 African American controls, 458 West African controls, 4,024 African American and African ancestry controls	NA	22q12.1	22	27978955	CHEK2	TTC28-AS1, TTC28			ENSG00000235954, ENSG00000100154			rs78554043-C	rs78554043	0	78554043	3_prime_UTR_variant	0	0.013	8E-10	9.096910013008056		1.62	[1.39-1.89]	Affymetrix, Illumina [17013228] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST004982	Genome-wide genotyping array
2014-11-07	24753544	Knipe DW	2014-04-21	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24753544	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	Prostate cancer	1,146 European ancestry cases, 1,804 European ancestry controls	1,854 European ancestry cases, 1,437 European ancestry controls	8q24.21	8	127094539	SRRM1P1, POU5F1B	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs12682344-G	rs12682344	0	12682344	intron_variant	0		5E-12	11.301029995663981		0.67	[0.48-0.86] unit increase	Illumina [514432] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002421	Genome-wide genotyping array
2014-12-17	24974847	Fachal L	2014-06-29	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/24974847	A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.	Response to radiotherapy in prostate cancer (toxicity)	Up to 652 European ancestry cases	849 European ancestry cases	2q24.2	2	159042977	TANC1, BTF3L4P2, GSTM3P2	TANC1			ENSG00000115183			rs7582141-T	rs7582141	0	7582141	intron_variant	0	0.04	5E-11	10.301029995663981	(late toxicity)	0.37	[NR] unit increase	Affymetrix [552597]	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST002511	Genome-wide genotyping array
2014-11-07	24753544	Knipe DW	2014-04-21	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24753544	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	Prostate cancer	1,146 European ancestry cases, 1,804 European ancestry controls	1,854 European ancestry cases, 1,437 European ancestry controls	8q24.21	8	127401060	SRRM1P1, POU5F1B	CCAT2, POU5F1B, PCAT1, CASC8			ENSG00000280997, ENSG00000212993, ENSG00000253438, ENSG00000246228			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0		4E-15	14.397940008672037		0.29	[0.22-0.36] unit increase	Illumina [514432] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002421	Genome-wide genotyping array
2014-11-07	24753544	Knipe DW	2014-04-21	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24753544	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	Prostate cancer	1,146 European ancestry cases, 1,804 European ancestry controls	1,854 European ancestry cases, 1,437 European ancestry controls	8q24.21	8	127472793	MYC	CASC8			ENSG00000246228			rs1447295-A	rs1447295	0	1447295	intron_variant	0		6E-18	17.221848749616356		0.51	[0.40-0.63] unit increase	Illumina [514432] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002421	Genome-wide genotyping array
2014-11-07	24753544	Knipe DW	2014-04-21	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24753544	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	Prostate cancer	1,146 European ancestry cases, 1,804 European ancestry controls	1,854 European ancestry cases, 1,437 European ancestry controls	10q11.22	10	46046326	MSMB	MSMB - RPL23AP61	ENSG00000263639	ENSG00000280012		57	16924	rs10993994-T	rs10993994	0	10993994	intergenic_variant	1		3E-26	25.522878745280337		0.4	[0.33-0.47] unit increase	Illumina [514432] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002421	Genome-wide genotyping array
2014-11-07	24753544	Knipe DW	2014-04-21	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24753544	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	Prostate cancer	1,146 European ancestry cases, 1,804 European ancestry controls	1,854 European ancestry cases, 1,437 European ancestry controls	17q24.3	17	71122495	SOX9, CALM2P1	CASC17			ENSG00000260785			rs4793529-T	rs4793529	0	4793529	intron_variant	0		2E-13	12.698970004336019		0.28	[0.20-0.35] unit increase	Illumina [514432] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002421	Genome-wide genotyping array
2014-11-07	24753544	Knipe DW	2014-04-21	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/24753544	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	Prostate cancer	1,146 European ancestry cases, 1,804 European ancestry controls	1,854 European ancestry cases, 1,437 European ancestry controls	19q13.33	19	50858501	KLK3	KLK3			ENSG00000142515			rs17632542-T	rs17632542	0	17632542	missense_variant	0		2E-28	27.69897000433602		0.73	[0.60-0.86] unit increase	Illumina [514432] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002421	Genome-wide genotyping array
2009-02-26	19117981	Sun J	2009-01-01	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/19117981	Sequence variants at 22q13 are associated with prostate cancer risk.	Prostate cancer	1,235 European ancestry aggressive cases, 1,599 European ancestry controls	1,215 European ancestry aggressive cases, 2,213 European ancestry non-aggressive cases, 1,208 European ancestry controls, 1,034 aggressive cases, 921 non-aggressive cases, 2,231 controls	22q13.1	22	40056115	TNRC6B	TNRC6B			ENSG00000100354			rs9623117-C	rs9623117	0	9623117	intron_variant	0	0.21	5E-7	6.301029995663981		1.18	[1.11-1.26]	Affymetrix, Illumina [~ 2000000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000307	Genome-wide genotyping array
2013-05-09	23376709	Kerns SL	2013-01-31	J Urol	www.ncbi.nlm.nih.gov/pubmed/23376709	A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer.	Urinary symptoms in response to radiotherapy in prostate cancer	346 European, African, Hispanic and Asian ancestry individuals	377 European, African, Hispanic and Asian ancestry individuals	9p21.2	9	27488094	IFNK, MOB3B	MOB3B			ENSG00000120162			rs17779457-?	rs17779457	0	17779457	intron_variant	0	0.25	7E-7	6.154901959985743	(at 2-3 yrs)	2.4	[1.1-3.6] unit increase	Affymetrix [613496]	N	response to radiation, lower urinary tract symptom, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0008008, http://www.ebi.ac.uk/efo/EFO_0001663	GCST001847	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	13q13.3	13	36861531	NR	SMAD9			ENSG00000120693			rs140971918-G	rs140971918	0	140971918	intron_variant	0	0.63	4E-6	5.3979400086720375		1.68	[1.34-2.09]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	13q34	13	112620498	NR	AL139384.2 - ATP11AUN	ENSG00000277159	ENSG00000197595		14081	26546	rs7325069-G	rs7325069	0	7325069	intergenic_variant	1	0.62	3E-6	5.522878745280337		1.63	[1.33-1.99]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	14q32.2	14	97356528	NR	AL158800.1 - LINC02325	ENSG00000285584	ENSG00000246084		138750	102288	rs234439-G	rs234439	0	234439	intergenic_variant	1	0.79	3E-6	5.522878745280337		1.78	[1.39-2.26]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	16p13.3	16	7552979	NR	RBFOX1			ENSG00000078328			rs112896149-G	rs112896149	0	112896149	intron_variant	0	0.8	5E-6	5.301029995663981		1.87	[1.43-2.45]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	18q21.1	18	49679976	NR	SMUG1P1 - AC090227.2	ENSG00000267444	ENSG00000267674		28816	59847	rs8093567-T	rs8093567	0	8093567	intergenic_variant	1	0.84	2E-6	5.698970004336019		2.01	[1.51-2.69]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	19q13.31	19	44371829	NR	AC245748.1			ENSG00000267173			rs2571082-G	rs2571082	0	2571082	intron_variant	0	0.72	7E-6	5.154901959985743		1.76	[1.38-2.25]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	19q13.43	19	56687205	NR	AC006115.1 - OR5AH1P	ENSG00000268352	ENSG00000268067		2552	3481	rs7258285-G	rs7258285	0	7258285	intergenic_variant	1	0.7	3E-6	5.522878745280337		1.66	[1.34-2.06]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	1p31.1	1	79987113	NR	AC099671.1			ENSG00000285409			rs1340678-T	rs1340678	0	1340678	intron_variant	0	0.51	4E-6	5.3979400086720375		1.56	[1.29-1.89]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	1p22.2	1	89431556	NR	GBP1P1 - LRRC8B	ENSG00000225492	ENSG00000197147		5313	93280	rs12095604-C	rs12095604	0	12095604	intergenic_variant	1	0.1	5E-6	5.301029995663981		2.1	[1.53-2.88]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	1q42.11	1	224217786	NR	AC092809.2 - AC092809.4	ENSG00000232628	ENSG00000237101		4507	1827	rs61005944-CT	rs61005944	0	61005944	regulatory_region_variant	1	0.22	1E-6	6.0		1.77	[1.41-2.23]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	2p22.1	2	41094221	NR	LINC01794 - HNRNPA1P57	ENSG00000233128	ENSG00000237442		326769	49559	rs148184576-A	rs148184576	0	148184576	intergenic_variant	1	0.94	3E-6	5.522878745280337		3.59	[2.09-6.16]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	2q11.2	2	97135631	NR	ANKRD36			ENSG00000135976			rs58488929-C	rs58488929	1	2443902	intron_variant	0	0.07	6E-6	5.221848749616356		2.28	[1.59-3.25]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	2q14.3	2	127104557	NR	BIN1			ENSG00000136717			rs6431219-C	rs6431219	0	6431219	intron_variant	0	0.51	8E-6	5.096910013008056		1.55	[1.28-1.88]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	3q27.1	3	184083406	NR	HTR3C2P			ENSG00000233576			rs5855014-GC	rs5855014	0	5855014	intron_variant	0	0.85	3E-6	5.522878745280337		2.12	[1.55-2.91]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA				NR							chr4:181412356-T	chr4:181412356	0			1	0.93	5E-6	5.301029995663981		3.04	[1.88-4.91]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	5q23.1	5	116942357	NR	AC010267.1 - AC093534.1	ENSG00000249150	ENSG00000250650		112170	77191	rs76861935-C	rs76861935	0	76861935	intergenic_variant	1	0.86	9E-6	5.045757490560675		2.02	[1.48-2.75]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	5q34	5	162565392	NR	AC113414.1			ENSG00000254186			rs17060512-T	rs17060512	0	17060512	intron_variant	0	0.89	7E-6	5.154901959985743		2.32	[1.61-3.35]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	6p25.1	6	4905041	NR	CDYL			ENSG00000153046			rs79774606-G	rs79774606	0	79774606	intron_variant	0	0.81	9E-6	5.045757490560675		1.93	[1.44-2.57]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	7p14.3	7	29103463	NR	CPVL			ENSG00000106066			rs6979813-C	rs6979813	0	6979813	intron_variant	0	0.72	6E-6	5.221848749616356		1.7	[1.35-2.14]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	8q24.21	8	127062570	NR	PCAT1			ENSG00000253438			rs72725854-T	rs72725854	0	72725854	intron_variant	0	0.06	2E-11	10.698970004336019		3.37	[2.36-4.82]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	8q24.21	8	127164718	NR	PCAT1, CASC19			ENSG00000253438, ENSG00000254166			rs76784613-G	rs76784613	0	76784613	intron_variant	0	0.04	1E-6	6.0		2.86	[1.87-4.37]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	9p23	9	11130398	NR	AKAP8P1 - AL451129.1	ENSG00000234146	ENSG00000230365		117302	144916	rs2151715-G	rs2151715	0	2151715	intergenic_variant	1	0.7	3E-6	5.522878745280337		1.74	[1.38-2.18]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	9p23	9	12079333	NR	AL353595.1 - AL589678.1	ENSG00000285784	ENSG00000224935		21106	19327	rs4741206-G	rs4741206	0	4741206	intergenic_variant	1	0.78	9E-6	5.045757490560675		1.78	[1.38-2.30]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	9p23	9	12184024	NR	AL589678.1 - JKAMPP1	ENSG00000224935	ENSG00000231491		24877	103296	rs73408421-A	rs73408421	0	73408421	intergenic_variant	1	0.76	1E-6	6.0		1.81	[1.42-2.30]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2018-07-03	29356057	Du Z	2018-01-21	Prostate	www.ncbi.nlm.nih.gov/pubmed/29356057	Genetic risk of prostate cancer in Ugandan men.	Prostate cancer	560 Ugandan ancestry cases, 480 Ugandan ancestry controls	NA	10q21.1	10	53578095	NR	RNA5SP318 - AL365496.1	ENSG00000252161	ENSG00000233805		119807	188305	rs11003686-A	rs11003686	0	11003686	intergenic_variant	1	0.1	9E-6	5.045757490560675		2.06	[1.50-2.84]	Illumina [17125421] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST005786	Genome-wide genotyping array
2012-01-11	22130093	Nam RK	2011-12-01	Cancer Biol Ther	www.ncbi.nlm.nih.gov/pubmed/22130093	New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort.	Prostate cancer	316 cases, 229 controls	55 Asian ancestry cases, 134 Asian ancestry controls, 1,382 European ancestry cases, 1,428 European ancestry controls, 184 Black cases, 127 Black controls, 42 cases, 87 controls	10q26.12	10	121273005	intergenic	LINC01153 - RN7SKP167	ENSG00000227143	ENSG00000222979		87039	137911	rs11199874-?	rs11199874	0	11199874	intergenic_variant	1	NR	3E-10	9.522878745280337				Affymetrix [443816]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001338	Genome-wide genotyping array
2012-01-11	22130093	Nam RK	2011-12-01	Cancer Biol Ther	www.ncbi.nlm.nih.gov/pubmed/22130093	New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort.	Prostate cancer	316 cases, 229 controls	55 Asian ancestry cases, 134 Asian ancestry controls, 1,382 European ancestry cases, 1,428 European ancestry controls, 184 Black cases, 127 Black controls, 42 cases, 87 controls	15q21.1	15	46347610	intergenic	MTND5P40 - RF01182	ENSG00000259593	ENSG00000238819		6011	4052	rs4775302-?	rs4775302	0	4775302	intergenic_variant	1	NR	4E-8	7.3979400086720375				Affymetrix [443816]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001338	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	2p16.3	2	48974189	FSHR	FSHR, AC009975.1			ENSG00000170820, ENSG00000282890			rs2268363-?	rs2268363	0	2268363	intron_variant	0	0.18	5E-8	7.301029995663981		7.03	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	2p21	2	47012873	TTC7A	TTC7A			ENSG00000068724			rs10194115-?	rs10194115	0	10194115	intron_variant	0	0.07	5E-7	6.301029995663981		9.0	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	1p13.1	1	116927159	PTGFRN	PTGFRN			ENSG00000134247			rs2806864-?	rs2806864	0	2806864	intron_variant	0	0.15	6E-7	6.221848749616356		6.42	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	Xq11.2	X	65147139	KIAA1166	ZC4H2 - AL445523.1	ENSG00000126970	ENSG00000237971		112426	37879	rs7064929-?	rs7064929	0	7064929	intergenic_variant	1	0.17	7E-7	6.154901959985743		13.65	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	12q23.3	12	108373556	CMKLR1	CMKLR1 - LINC01498	ENSG00000174600	ENSG00000247213		34215	60574	rs10861905-?	rs10861905	0	10861905	regulatory_region_variant	1	0.01	8E-7	6.096910013008056		33.95	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	2q14.3	2	122533446	TSN	LINC01823 - AC062020.1	ENSG00000224655	ENSG00000237856		736744	531875	rs1527243-?	rs1527243	0	1527243	intergenic_variant	1	0.43	1E-6	6.0		6.67	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	9p13.3	9	33283584	CHMP5	CHMP5 - NFX1	ENSG00000086065	ENSG00000086102		1515	6927	rs12336160-?	rs12336160	0	12336160	intergenic_variant	1	0.09	1E-6	6.0		7.26	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	2p22.1	2	39720581	TMEM178	TMEM178A - THUMPD2	ENSG00000152154	ENSG00000138050		2618	15479	rs2716734-?	rs2716734	0	2716734	intergenic_variant	1	0.14	2E-6	5.698970004336019		5.97	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	2q22.1	2	141038051	LRP1B	LRP1B			ENSG00000168702			rs10210358-?	rs10210358	0	10210358	intron_variant	0	0.31	2E-6	5.698970004336019		5.34	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	1p36.13	1	17967993	IGSF21	ACTL8 - AL357509.1	ENSG00000117148	ENSG00000284653		140930	47719	rs16861326-?	rs16861326	0	16861326	intergenic_variant	1	0.02	2E-6	5.698970004336019		17.85	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	Xp22.11	X	22873960	DDX53	PTCHD1-AS			ENSG00000233067			rs5925696-?	rs5925696	0	5925696	intron_variant	0	0.26	3E-6	5.522878745280337		12.52	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	2p22.2	2	38050689	FAM82A1	RMDN2-AS1, RMDN2			ENSG00000235848, ENSG00000115841			rs6741148-?	rs6741148	0	6741148	intron_variant	0	0.33	4E-6	5.3979400086720375		5.2	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	9q22.32	9	94978992	C9orf3	C9orf3			ENSG00000148120			rs3802458-?	rs3802458	0	3802458	intron_variant	0	0.04	4E-6	5.3979400086720375		10.53	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	5q23.2	5	125030274	ZNF608	LINC02240			ENSG00000260192			rs6862844-?	rs6862844	0	6862844	intron_variant	0	0.09	4E-6	5.3979400086720375		6.72	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	1p36.21	1	15465931	ELA2A	CELA2B, CELA2A			ENSG00000215704, ENSG00000142615			rs2901964-?	rs2901964	0	2901964	non_coding_transcript_exon_variant	0	0.37	5E-6	5.301029995663981		5.26	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	2q14.2	2	120943713	GLI2	GLI2			ENSG00000074047			rs11122834-?	rs11122834	0	11122834	intron_variant	0	0.29	5E-6	5.301029995663981		4.93	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	2q11.2	2	96835063	CNNM3	ANKRD23			ENSG00000163126			rs9948-?	rs9948	0	9948	intron_variant	0	0.31	6E-6	5.221848749616356		4.9	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	Xq12	X	66386851	HEPH	AL157698.1 - AL592049.1	ENSG00000231356	ENSG00000226820		25075	50494	rs5965182-?	rs5965182	0	5965182	intergenic_variant	1	0.12	6E-6	5.221848749616356		11.73	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	Xp21.3	X	25835497	MAGEB18	AC097263.1 - AC121342.1	ENSG00000228519	ENSG00000233403		189170	42842	rs5944185-?	rs5944185	0	5944185	intergenic_variant	1	0.16	7E-6	5.154901959985743		10.5	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	2p24.1	2	21354871	APOB	AC018742.1, AC011752.1			ENSG00000233005, ENSG00000231204			rs219553-?	rs219553	0	219553	intron_variant	0	0.42	7E-6	5.154901959985743		5.56	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	20p11.21	20	24077771	GGTLC1	POM121L3P - AL110503.1	ENSG00000167390	ENSG00000236151		87317	64819	rs6049375-?	rs6049375	0	6049375	intergenic_variant	1	0.28	8E-6	5.096910013008056		4.84	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	Xp21.3	X	28214936	WDR42B	DCAF8L1 - MIR6134	ENSG00000226372	ENSG00000277569		233487	280619	rs5971305-?	rs5971305	0	5971305	intergenic_variant	1	0.02	8E-6	5.096910013008056		33.69	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2010-11-15	20932654	Kerns SL	2010-10-05	Int J Radiat Oncol Biol Phys	www.ncbi.nlm.nih.gov/pubmed/20932654	Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.	Erectile dysfunction and prostate cancer treatment	27 African American cases, 52 African American controls	NA	Xp11.4	X	37995474	SYTL5	AF241726.2			ENSG00000250349			rs872690-?	rs872690	0	872690	intron_variant	0	0.03	9E-6	5.045757490560675		11.78	[NR]	Affymetrix [512497]	N	response to radiation, prostate carcinoma, erectile dysfunction	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0004234	GCST000824	Genome-wide genotyping array
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	10p14	10	9602837	intergenic	LINC00709 - HSP90AB7P	ENSG00000230014	ENSG00000235838		315780	119126	rs4749884-C	rs4749884	0	4749884	intergenic_variant	1	0.533	7E-6	5.154901959985743		1.12	[NR]	Illumina [4550396] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003148	Genome-wide genotyping array
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	11p15.4	11	7535346	PPFIBP2	PPFIBP2			ENSG00000166387			rs12791447-C	rs12791447	0	12791447	intron_variant	0	0.136	4E-8	7.3979400086720375		1.23	[NR]	Illumina [4550396] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003148	Genome-wide genotyping array
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	12q23.1	12	97483128	RMST	RMST			ENSG00000255794			rs75718479-C	rs75718479	0	75718479	intron_variant	0	0.877	1E-6	6.0		1.22	[NR]	Illumina [4550396] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003148	Genome-wide genotyping array
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	14q23.2	14	64227194	ESR2	ESR2			ENSG00000140009			rs58262369-T	rs58262369	0	58262369	3_prime_UTR_variant	0	0.072	6E-10	9.221848749616356		1.28	[NR]	Illumina [4550396] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003148	Genome-wide genotyping array
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	2p24.1	2	20688505	C2orf43	LDAH			ENSG00000118961			rs13385191-G	rs13385191	0	13385191	intron_variant	0	NR	5E-6	5.301029995663981		1.17	[NR]	Illumina [4550396] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003148	Genome-wide genotyping array
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	3p12.1	3	87061524	VGLL3	PPATP1 - LINC00506	ENSG00000241293	ENSG00000281392		8786	27605	rs2660753-T	rs2660753	0	2660753	intergenic_variant	1	NR	6E-6	5.221848749616356		1.1904762	[NR]	Illumina [4550396] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003148	Genome-wide genotyping array
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	5p15.33	5	1895715	IRX4	CTD-2194D22.4						rs12653946-A	rs12653946	0	12653946	intron_variant	0	NR	2E-12	11.698970004336019		1.2820514	[NR]	Illumina [4550396] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003148	Genome-wide genotyping array
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	6q22.1	6	116888889	RFX6	RFX6			ENSG00000185002			rs339331-T	rs339331	0	339331	intron_variant	0	NR	4E-11	10.397940008672037		1.2820514	[NR]	Illumina [4550396] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003148	Genome-wide genotyping array
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	8p21.2	8	23668950	NKX3-1	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		33443	9743	rs1512268-T	rs1512268	0	1512268	TF_binding_site_variant	1	NR	1E-13	13.0		1.3157895	[NR]	Illumina [4550396] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003148	Genome-wide genotyping array
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	8q24.21	8	127112671	POU5F1B	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs16901979-A	rs16901979	0	16901979	intron_variant	0	NR	1E-16	16.0		1.3888888	[NR]	Illumina [4550396] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003148	Genome-wide genotyping array
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	8q24.21	8	127472793	LOC727677, POU5F1B	CASC8			ENSG00000246228			rs1447295-A	rs1447295	0	1447295	intron_variant	0	NR	4E-23	22.397940008672037		1.5384616	[NR]	Illumina [4550396] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003148	Genome-wide genotyping array
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	10q11.22	10	46046326	MSMB	MSMB - RPL23AP61	ENSG00000263639	ENSG00000280012		57	16924	rs10993994-T	rs10993994	0	10993994	intergenic_variant	1	NR	4E-8	7.3979400086720375		1.2048193	[NR]	Illumina [4550396] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003148	Genome-wide genotyping array
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	13q22.1	13	73154002	KLF5	RNU6-66P - RNU4-10P	ENSG00000200267	ENSG00000201253		40984	37526	rs9600079-T	rs9600079	0	9600079	intergenic_variant	1	NR	1E-6	6.0		1.1904762	[NR]	Illumina [4550396] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003148	Genome-wide genotyping array
2016-06-13	26443449	Wang M	2015-10-07	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/26443449	Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer.	Prostate cancer	3,000 East Asian ancestry cases, 4,394 East Asian ancestry controls	3,605 East Asian ancestry cases, 3,919 East Asian ancestry controls	17q12	17	37738049	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs4430796-A	rs4430796	0	4430796	intron_variant	0	NR	6E-8	7.221848749616356		1.2345679	[NR]	Illumina [4550396] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003148	Genome-wide genotyping array
2019-04-03	30410027	Gudmundsson J	2018-11-08	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/30410027	Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA.	Prostate cancer	11,708 European ancestry cases, 284,184 European ancestry controls	NA	17q12	17	37742390	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651052-G	rs11651052	0	11651052	intron_variant	0	0.53	2E-40	39.69897000433602		1.22	[1.19-1.27]	Affymetrix, Illumina [42907111] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST007506	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	5q31.2	5	138428109	FAM53C, CDC25C, KDM3B	KDM3B			ENSG00000120733			rs17599026-T	rs17599026	0	17599026	intron_variant	0	0.08	4E-8	7.3979400086720375		3.12	[2.08-4.69]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003582	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	12q13.13	12	53200654	intergenic	ITGB7			ENSG00000139626			rs11574532-T	rs11574532	0	11574532	intron_variant	0	0.07	2E-7	6.698970004336019		3.25	[2.08-5.07]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003582	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	4q22.1	4	87150076	intergenic	AFF1 - KLHL8	ENSG00000172493	ENSG00000145332		9022	10027	rs342442-?	rs342442	0	342442	regulatory_region_variant	1	0.62	4E-7	6.3979400086720375		1.9607843	[1.52-2.56]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003582	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	12p13.31	12	8514205	intergenic	CLEC4D			ENSG00000166527			rs4534636-A	rs4534636	0	4534636	intron_variant	0	0.20	2E-6	5.698970004336019		1.96	[1.49-2.59]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003582	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	18q21.1	18	45971047	intergenic	EPG5 - PSTPIP2	ENSG00000152223	ENSG00000152229		3708	12489	rs8098701-T	rs8098701	0	8098701	intergenic_variant	1	0.07	2E-6	5.698970004336019		2.41	[1.68-3.47]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003582	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	1q41	1	214606084	intergenic	CENPF, ABHD17AP3			ENSG00000117724, ENSG00000250536			rs7366282-C	rs7366282	0	7366282	splice_region_variant	0	0.06	2E-6	5.698970004336019		3.2	[1.98-5.16]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003582	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	2q36.1	2	221684477	intergenic	AC068489.1 - AC009302.1	ENSG00000234446	ENSG00000233868		42664	259746	rs10209697-A	rs10209697	0	10209697	intergenic_variant	1	0.07	2E-6	5.698970004336019		2.66	[1.77-3.99]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003582	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	6q14.1	6	82698067	intergenic	TPBG - UBE3D	ENSG00000146242	ENSG00000118420		327239	194331	rs4997823-?	rs4997823	0	4997823	regulatory_region_variant	1	0.65	2E-6	5.698970004336019		2.0408163	[1.52-2.78]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003582	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	6p24.1	6	12217189	intergenic	HIVEP1 - EDN1	ENSG00000095951	ENSG00000078401		52190	73174	rs7356945-T	rs7356945	0	7356945	regulatory_region_variant	1	0.33	4E-6	5.3979400086720375		1.74	[1.38-2.21]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003582	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	22q11.23	22	23942638	intergenic	AP000350.1			ENSG00000206090			rs6003982-?	rs6003982	0	6003982	non_coding_transcript_exon_variant	0	0.56	4E-6	5.3979400086720375		1.9607843	[1.47-2.63]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003582	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, urinary frequency)	1,409 European ancestry individuals	NA	8q24.3	8	141800605	intergenic	MIR1302-7 - AC104417.1	ENSG00000221768	ENSG00000254183		14292	167486	rs10101158-A	rs10101158	0	10101158	regulatory_region_variant	1	0.44	4E-6	5.3979400086720375		1.8	[1.40-2.31]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003582	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, decreased urine stream)	1,245 European ancestry individuals	NA	5p15.2	5	13858219	DNAH5	DNAH5			ENSG00000039139			rs7720298-G	rs7720298	0	7720298	intron_variant	0	0.24	3E-8	7.522878745280337		2.71	[1.90-3.86]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003581	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, decreased urine stream)	1,245 European ancestry individuals	NA	8p23.2	8	5689302	intergenic	AC084768.1 - AC084768.2	ENSG00000254007	ENSG00000275461		19225	27282	rs17362923-G	rs17362923	0	17362923	intergenic_variant	1	0.18	7E-7	6.154901959985743		2.7	[1.83-4.00]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003581	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, decreased urine stream)	1,245 European ancestry individuals	NA	1q32.1	1	198705436	intergenic	PTPRC, PTPRC			ENSG00000262418, ENSG00000081237			rs76273496-C	rs76273496	0	76273496	intron_variant	0	0.07	3E-6	5.522878745280337		3.68	[2.13-6.33]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003581	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, decreased urine stream)	1,245 European ancestry individuals	NA	Xq21.1	X	80753384	intergenic	BRWD3			ENSG00000165288			rs2203205-C	rs2203205	0	2203205	intron_variant	0	0.29	3E-6	5.522878745280337		1.74	[1.38-2.20]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003581	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, decreased urine stream)	1,245 European ancestry individuals	NA	3q28	3	190286521	intergenic	NMNAT1P3 - CLDN1	ENSG00000238077	ENSG00000163347		118870	19180	rs144596911-A	rs144596911	0	144596911	intergenic_variant	1	0.09	3E-6	5.522878745280337		3.6	[2.11-6.17]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003581	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, decreased urine stream)	1,245 European ancestry individuals	NA	18p11.32	18	514471	intergenic	LINC01925			ENSG00000264265			rs62091368-A	rs62091368	0	62091368	intron_variant	0	0.07	4E-6	5.3979400086720375		4.36	[2.33-8.14]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003581	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, decreased urine stream)	1,245 European ancestry individuals	NA	5q23.3	5	128745323	intergenic	SLC27A6			ENSG00000113396			rs141342719-T	rs141342719	0	141342719	intron_variant	0	0.12	4E-6	5.3979400086720375		3.5	[2.05-5.95]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003581	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, decreased urine stream)	1,245 European ancestry individuals	NA	18p11.32	18	2825420	intergenic	AP001011.1			ENSG00000266049			rs673783-G	rs673783	0	673783	intron_variant	0	0.31	4E-6	5.3979400086720375		2.49	[1.69-3.67]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003581	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	1,487 European ancestry individuals	NA	3p12.3	3	76667643	intergenic	ROBO2			ENSG00000185008			rs12497518-?	rs12497518	0	12497518	intron_variant	0	0.53	1E-6	6.0		1.6666665	[1.35-2.08]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003584	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	1,487 European ancestry individuals	NA	Xq23	X	115688155	intergenic	ASS1P5 - EEF1GP5	ENSG00000227881	ENSG00000234785		22022	14656	rs141044160-C	rs141044160	0	141044160	intergenic_variant	1	0.05	2E-6	5.698970004336019		2.68	[1.78-4.04]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003584	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	1,487 European ancestry individuals	NA	3q26.1	3	162481716	intergenic	AC131211.1 - TOMM22P6	ENSG00000240354	ENSG00000241874		659808	4825	rs7432328-A	rs7432328	0	7432328	intergenic_variant	1	0.06	3E-6	5.522878745280337		3.36	[2.05-5.59]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003584	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	1,487 European ancestry individuals	NA	8q21.13	8	79779234	intergenic	LINC01607, AC036214.1			ENSG00000272138, ENSG00000249328			rs6999859-G	rs6999859	0	6999859	intron_variant	0	0.28	3E-6	5.522878745280337		1.73	[1.37-2.17]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003584	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	1,487 European ancestry individuals	NA	19p13.2	19	10457843	intergenic	PDE4A						rs4804134-?	rs4804134	0	4804134	intron_variant	0	0.69	3E-6	5.522878745280337		1.6666665	[1.35-2.08]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003584	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)	1,487 European ancestry individuals	NA	1q42.12	1	225904035	intergenic	LEFTY1, AL117348.2			ENSG00000243709, ENSG00000255835			rs360071-T	rs360071	0	360071	intron_variant	0	0.49	4E-6	5.3979400086720375		1.61	[1.32-1.97]	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003584	Genome-wide genotyping array
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	16q22.2	16	71997071	PKD1L3	PKD1L3			ENSG00000277481			rs12597458-G	rs12597458	0	12597458	intron_variant	0	0.56	1E-7	7.0		1.11	[1.06‐1.15]	Illumina [1531807] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002890	Genome-wide genotyping array
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	6p22.3	6	21330062	CDKAL1	CDKAL1 - AL031767.1	ENSG00000145996	ENSG00000227089		97658	24349	rs12198220-T	rs12198220	0	12198220	intergenic_variant	1	0.74	2E-7	6.698970004336019		1.12	[1.07‐1.17]	Illumina [1531807] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002890	Genome-wide genotyping array
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	8q24.21	8	127505328	LOC727677, CASC8	CASC8 - CASC11	ENSG00000246228	ENSG00000249375		23189	181015	rs4242382-A	rs4242382	0	4242382	regulatory_region_variant	1	0.1	1E-34	34.0		1.45	[1.35-1.54]	Illumina [1531807] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002890	Genome-wide genotyping array
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	17q12	17	37741595	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs8064454-C	rs8064454	0	8064454	intron_variant	0	0.52	8E-29	28.096910013008056		1.24	[1.19‐1.29]	Illumina [1531807] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002890	Genome-wide genotyping array
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	17q24.3	17	71110733	BC039327, CASC17	CASC17			ENSG00000260785			rs17765344-A	rs17765344	0	17765344	intron_variant	0	0.48	4E-21	20.397940008672037		1.19	[1.15-1.23]	Illumina [1531807] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002890	Genome-wide genotyping array
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	22q13.2	22	43104206	BIK	AL022237.1 - BIK	ENSG00000234735	ENSG00000100290		11682	6542	rs5759167-G	rs5759167	0	5759167	TF_binding_site_variant	1	0.5	1E-16	16.0		1.18	[1.12-1.22]	Illumina [1531807] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002890	Genome-wide genotyping array
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	10q11.22	10	46046326	PARG, TIMM23, MSMB	MSMB - RPL23AP61	ENSG00000263639	ENSG00000280012		57	16924	rs10993994-T	rs10993994	0	10993994	intergenic_variant	1	0.39	1E-15	15.0		1.16	[1.12-1.20]	Illumina [1531807] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002890	Genome-wide genotyping array
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	3q26.2	3	170281428	PRKCI	PRKCI			ENSG00000163558			rs71277158-T	rs71277158	0	71277158	non_coding_transcript_exon_variant	0	0.82	8E-14	13.096910013008056		1.22	[1.15-1.28]	Illumina [1531807] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002890	Genome-wide genotyping array
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	11q13.3	11	69218116	LOC338694, MYEOV	AP003071.2 - MYEOV	ENSG00000261070	ENSG00000172927		46552	76022	rs7929962-T	rs7929962	0	7929962	regulatory_region_variant	1	0.51	2E-13	12.698970004336019		1.15	[1.11‐1.19]	Illumina [1531807] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002890	Genome-wide genotyping array
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	6q25.3	6	160419220	SLC22A3	SLC22A3			ENSG00000146477			rs7758229-T	rs7758229	0	7758229	intron_variant	0	0.31	4E-12	11.397940008672037		1.15	[1.10‐1.20]	Illumina [1531807] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002890	Genome-wide genotyping array
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	2p15	2	62950976	EHBP1	EHBP1			ENSG00000115504			rs2430386-T	rs2430386	0	2430386	intron_variant	0	0.5	9E-12	11.045757490560675		1.14	[1.10‐1.18]	Illumina [1531807] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002890	Genome-wide genotyping array
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	3p12.1	3	87085650	LINC00506, BC050344	PPATP1 - LINC00506	ENSG00000241293	ENSG00000281392		32912	3479	rs17023900-G	rs17023900	0	17023900	intergenic_variant	1	0.07	1E-11	11.0		1.26	[1.18‐1.34]	Illumina [1531807] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002890	Genome-wide genotyping array
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	5p15.33	5	1282299	TERT, hTERT	TERT			ENSG00000164362			rs7725218-G	rs7725218	0	7725218	intron_variant	0	0.64	3E-11	10.522878745280337		1.15	[1.10-1.19]	Illumina [1531807] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002890	Genome-wide genotyping array
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	12q24.21	12	114228397	TBX5	AC010183.2 - LINC02459	ENSG00000257997	ENSG00000257476		114908	10573	rs10774740-G	rs10774740	0	10774740	intergenic_variant	1	0.6	3E-10	9.522878745280337		1.14	[1.09-1.18]	Illumina [1531807] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002890	Genome-wide genotyping array
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	4q24	4	105140377	TET2	AC004069.1			ENSG00000251259			rs7679673-C	rs7679673	0	7679673	intron_variant	0	0.58	4E-9	8.397940008672037		1.12	[1.08-1.16]	Illumina [1531807] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002890	Genome-wide genotyping array
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	Xp11.22	X	52867918	NR	XAGE3			ENSG00000171402			rs2807031-C	rs2807031	0	2807031	intron_variant	0	0.161	4E-6	5.3979400086720375		1.15	[1.09-1.22]	Illumina [1531807] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002890	Genome-wide genotyping array
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	8q24.21	8	127401060	NR	CCAT2, POU5F1B, PCAT1, CASC8			ENSG00000280997, ENSG00000212993, ENSG00000253438, ENSG00000246228			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	0.499	4E-10	9.397940008672037		1.23	[1.15-1.32]	Illumina [1531807] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002890	Genome-wide genotyping array
2016-02-12	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer	4,600 European ancestry cases, 2,941 European ancestry controls	7,779 European ancestry cases, 7,623 European ancestry controls	8q24.21	8	127112671	NR	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs16901979-A	rs16901979	0	16901979	intron_variant	0	0.029	5E-9	8.301029995663981		1.65	[1.39-1.95]	Illumina [1531807] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002890	Genome-wide genotyping array
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	5p15.33	5	1895715	NR	CTD-2194D22.4						rs12653946-T	rs12653946	0	12653946	intron_variant	0	0.43	3E-7	6.522878745280337	(Japanese)	1.39	[1.22-1.57]	Illumina [528023]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001646	Genome-wide genotyping array
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	8p21.2	8	23668950	NR	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		33443	9743	rs1512268-T	rs1512268	0	1512268	TF_binding_site_variant	1	0.36	5E-6	5.301029995663981	(Japanese)	1.35	[1.19-1.53]	Illumina [528023]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001646	Genome-wide genotyping array
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	8q24.21	8	127094635	NR	PCAT1, CASC19			ENSG00000253438, ENSG00000254166			rs6983561-C	rs6983561	0	6983561	intron_variant	0	0.18	4E-13	12.397940008672037	(Japanese)	1.87	[1.58-2.22]	Illumina [528023]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001646	Genome-wide genotyping array
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	8q24.21	8	127519892	NR	CASC8 - CASC11	ENSG00000246228	ENSG00000249375		37753	166451	rs10090154-T	rs10090154	0	10090154	intergenic_variant	1	0.08	3E-6	5.522878745280337	(Latin American)	1.68	[1.35-2.09]	Illumina [528023]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001646	Genome-wide genotyping array
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	8q24.21	8	127112950	NR	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs10505483-T	rs10505483	0	10505483	intron_variant	0	NR	7E-15	14.154901959985743	(Japanese and Latin American)	1.73	NR	Illumina [528023]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001646	Genome-wide genotyping array
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	3p12.1	3	87085650	NR	PPATP1 - LINC00506	ENSG00000241293	ENSG00000281392		32912	3479	rs17023900-G	rs17023900	0	17023900	intergenic_variant	1	NR	6E-8	7.221848749616356	(Japanese and Latin American)	1.41	NR	Illumina [528023]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001646	Genome-wide genotyping array
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	8p21.2	8	23676505	NR	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		40998	2188	rs10503733-T	rs10503733	0	10503733	regulatory_region_variant	1	NR	8E-8	7.096910013008056	(Japanese and Latin American)	1.29	NR	Illumina [528023]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001646	Genome-wide genotyping array
2012-10-23	22923026	Cheng I	2012-08-24	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/22923026	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	Prostate cancer	1,033 Japanese ancestry cases, 1,042 Japanese ancestry controls, 1,043 Latino cases, 1,057 Latino controls	1,583 Japanese ancestry cases, 3,386 Japanese ancestry  controls, 1,854 European ancestry cases, 3,748 European ancestry controls	8q24.21	8	127092098	NR	PRNCR1, PCAT1, CASC19			ENSG00000282961, ENSG00000253438, ENSG00000254166			rs13254738-C	rs13254738	0	13254738	non_coding_transcript_exon_variant	0	0.54	4E-10	9.397940008672037	(Japanese)	1.59	[1.38-1.84]	Illumina [528023]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001646	Genome-wide genotyping array
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	10p12.31	10	21147293	C10orf113	NEBL			ENSG00000078114			rs12243039-?	rs12243039	0	12243039	intron_variant	0	0.01	6E-6	5.221848749616356	(All samples, overall toxicity, multivariable analysis)	3.39		Illumina [2417493] (imputed)	N	response to radiation, prostate carcinoma, breast carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_0000305	GCST002431	Genome-wide genotyping array
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	1p13.2	1	111873741	KCND3	KCND3			ENSG00000171385			rs2788612-?	rs2788612	0	2788612	intron_variant	0	0.05	6E-16	15.221848749616356	(Prostate cancer, rectal incontinence, univariable analysis)	0.18	[NR] unit increase	Illumina [2417493] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST002431	Genome-wide genotyping array
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	10q24.31	10	100170652	ERLIN1	ERLIN1			ENSG00000107566			rs11595238-?	rs11595238	0	11595238	intron_variant	0	0.04	2E-6	5.698970004336019	(Prostate cancer, rectal incontinence, multivariable analysis)	6.61		Illumina [2417493] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST002431	Genome-wide genotyping array
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	3p24.1	3	29287529	RBMS3	RBMS3-AS3, RBMS3, AC098650.1			ENSG00000235904, ENSG00000144642, ENSG00000283563			rs9832625-?	rs9832625	0	9832625	intron_variant	0	0.08	3E-6	5.522878745280337	(Prostate cancer, rectal incontinence, univariable analysis)	0.07	[NR] unit increase	Illumina [2417493] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST002431	Genome-wide genotyping array
2014-11-12	24785509	Barnett GC	2014-04-28	Radiother Oncol	www.ncbi.nlm.nih.gov/pubmed/24785509	A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.	Response to radiotherapy in cancer (late toxicity)	579 European ancestry prostate cancer cases, 1,194 European ancestry breast cancer cases	516 European ancestry prostate cancer cases, 862 prostate cancer cases, 355 breast cancer cases	21q21.1	21	16396204	CNTNAP2	MIR99AHG			ENSG00000215386			rs2823779-?	rs2823779	0	2823779	intron_variant	0	0.09	7E-6	5.154901959985743	(Prostate cancer, urine incontinence, univariable analysis)	0.1	[NR] unit increase	Illumina [2417493] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST002431	Genome-wide genotyping array
2015-05-15	23104005	Gudmundsson J	2012-10-28	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23104005	A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer.	Prostate cancer	5,141 European ancestry cases, 54,444 European ancestry controls	Up to 5,470 European ancestry cases, up to 7,583 European ancestry controls	8q24.21	8	127179427	HOXB13	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs188140481-A	rs188140481	0	188140481	non_coding_transcript_exon_variant	0	0.054	6E-34	33.221848749616356		2.9	[2.44-3.44]	Illumina [~ 32500000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001719	Genome-wide genotyping array
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	3q21.3	3	128319530	intergenic	EEFSEC			ENSG00000132394			rs10934853-A	rs10934853	0	10934853	intron_variant	0	0.28	3E-10	9.522878745280337		1.12	[1.08-1.16]	Illumina [310520]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000489	Genome-wide genotyping array
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	8q24.21	8	127310936	intergenic	PCAT1, CASC8			ENSG00000253438, ENSG00000246228			rs445114-T	rs445114	0	445114	intron_variant	0	0.64	5E-10	9.301029995663981		1.14	[1.10-1.19]	Illumina [310520]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000489	Genome-wide genotyping array
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	19q13.2	19	38244973	intergenic	SPINT2			ENSG00000167642			rs8102476-C	rs8102476	0	8102476	intron_variant	0	0.54	2E-11	10.698970004336019		1.12	[1.08-1.15]	Illumina [310520]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000489	Genome-wide genotyping array
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	11q13.3	11	69211113	intergenic	AP003071.2 - MYEOV	ENSG00000261070	ENSG00000172927		39549	83025	rs11228565-A	rs11228565	0	11228565	regulatory_region_variant	1	0.20	7E-12	11.154901959985743		1.23	[1.16-1.31]	Illumina [310520]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000489	Genome-wide genotyping array
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	8q24.21	8	127112671	intergenic	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs16901979-A	rs16901979	0	16901979	intron_variant	0	0.04	3E-14	13.522878745280337		1.8	[1.55-2.09]	Illumina [310520]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000489	Genome-wide genotyping array
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	17q12	17	37738049	intergenic	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs4430796-A	rs4430796	0	4430796	intron_variant	0	0.52	8E-6	5.096910013008056		1.19	[1.10-1.28]	Illumina [310520]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000489	Genome-wide genotyping array
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	8q24.21	8	127308101	intergenic	PCAT1, CASC8			ENSG00000253438, ENSG00000246228			rs16902094-G	rs16902094	0	16902094	intron_variant	0	0.15	6E-15	14.221848749616356		1.21	[1.15-1.26]	Illumina [310520]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000489	Genome-wide genotyping array
2009-10-05	19767754	Gudmundsson J	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767754	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	Prostate cancer	Up to 1,968 European ancestry cases, 35,382 European ancestry controls	Up to 11,806 European ancestry cases, 12,387 European ancestry controls	8q24.21	8	127472793	intergenic	CASC8			ENSG00000246228			rs1447295-A	rs1447295	0	1447295	intron_variant	0	0.11	2E-19	18.69897000433602		1.58	[1.43-1.74]	Illumina [310520]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000489	Genome-wide genotyping array
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls	NA				NR							kgp1923988-C	kgp1923988	0			1	0.192	3E-8	7.522878745280337		1.41	[1.25-1.59]	Illumina [~ 9400000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003586	Genome-wide genotyping array
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls	NA	6q25.3	6	160421505	SLC22A3	SLC22A3			ENSG00000146477			rs3123636-C	rs3123636	0	3123636	intron_variant	0	0.356	3E-9	8.522878745280337		1.37	[1.23-1.51]	Illumina [~ 9400000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003586	Genome-wide genotyping array
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls	NA				NR							kgp9645322-A	kgp9645322	0			1	0.044	8E-10	9.096910013008056		2.39	[1.81-3.16]	Illumina [~ 9400000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003586	Genome-wide genotyping array
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls	NA	10q11.22	10	46057653	TIMM23	MSMB - RPL23AP61	ENSG00000263639	ENSG00000280012		11384	5597	rs10763567-A	rs10763567	0	10763567	intergenic_variant	1	0.489	6E-10	9.221848749616356		1.31	[1.19-1.44]	Illumina [~ 9400000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003586	Genome-wide genotyping array
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls	NA	11q13.3	11	69244777	MYEOV	AP003071.2 - MYEOV	ENSG00000261070	ENSG00000172927		73213	49361	rs12270641-T	rs12270641	0	12270641	intergenic_variant	1	0.45	1E-11	11.0		1.4	[1.27-1.55]	Illumina [~ 9400000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003586	Genome-wide genotyping array
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls	NA	17q12	17	37742390	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11651052-A	rs11651052	0	11651052	intron_variant	0	0.435	3E-10	9.522878745280337		1.37	[1.24-1.51]	Illumina [~ 9400000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003586	Genome-wide genotyping array
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls	NA	8q24.21	8	127101181	PRNCR1	PCAT1, CASC19			ENSG00000253438, ENSG00000254166			rs56005245-T	rs56005245	0	56005245	intron_variant	0	0.225	1E-8	8.0		1.41	[1.25-1.59]	Illumina [~ 9400000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003586	Genome-wide genotyping array
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls	NA	8q24.21	8	127196124	CASC19	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs138042437-G	rs138042437	0	138042437	intron_variant	0	0.015	2E-8	7.698970004336019		13.25	[5.37-32.69]	Illumina [~ 9400000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003586	Genome-wide genotyping array
2017-02-03	27262462	Teerlink CC	2016-06-04	Hum Genet	www.ncbi.nlm.nih.gov/pubmed/27262462	Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.	Prostate cancer	2,511 European ancestry cases, 1,382 European ancestry controls	NA	8q24.21	8	127311646	CASC8, CASC21	CASC8, PCAT1			ENSG00000246228, ENSG00000253438			rs4506170-C	rs4506170	0	4506170	non_coding_transcript_exon_variant	0	0.166	2E-9	8.698970004336019		1.51	[1.32-1.73]	Illumina [~ 9400000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST003586	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	11q12.2	11	60441351	Intergenic	MS4A5			ENSG00000166930			rs11230328-G	rs11230328	0	11230328	intron_variant	0	0.27	6E-10	9.221848749616356		0.31	[0.21-0.41] unit increase	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003583	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	10p14	10	10074911	Intergenic	AL138775.1 - ELOCP3	ENSG00000224788	ENSG00000229919		11409	99319	rs147596965-T	rs147596965	0	147596965	intergenic_variant	1	0.07	6E-8	7.221848749616356		0.67	[0.43-0.91] unit increase	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003583	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	2q31.1	2	174729547	Intergenic	AC010894.3			ENSG00000236449			rs77530448-G	rs77530448	0	77530448	intron_variant	0	0.09	7E-8	7.154901959985743		0.36	[0.23-0.49] unit increase	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003583	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	15q12	15	25730061	Intergenic	ATP10A			ENSG00000206190			rs4906759-T	rs4906759	0	4906759	intron_variant	0	0.06	2E-7	6.698970004336019		0.55	[0.34-0.75] unit increase	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003583	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	4p15.2	4	26002024	Intergenic	SMIM20 - LINC02357	ENSG00000250317	ENSG00000283314		72150	68730	rs71610881-A	rs71610881	0	71610881	regulatory_region_variant	1	0.06	5E-7	6.301029995663981		0.6	[0.36-0.83] unit increase	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003583	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	19q13.2	19	40682173	Intergenic	NUMBL			ENSG00000105245			rs141799618-G	rs141799618	0	141799618	intron_variant	0	0.06	1E-6	6.0		0.44	[0.26-0.62] unit increase	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003583	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	10q26.2	10	126642144	Intergenic	C10orf90			ENSG00000154493			rs2842169-C	rs2842169	0	2842169	intron_variant	0	0.1	1E-6	6.0		0.28	[0.17-0.40] unit increase	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003583	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	11q24.1	11	123204711	Intergenic	AP001970.1			ENSG00000254710			rs11219068-A	rs11219068	0	11219068	intron_variant	0	0.15	2E-6	5.698970004336019		0.28	[0.17-0.40] unit increase	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003583	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	17p13.2	17	6384826	Intergenic	AC055872.2 - AIPL1	ENSG00000285593	ENSG00000129221		9746	8867	rs8075565-T	rs8075565	0	8075565	intergenic_variant	1	0.13	2E-6	5.698970004336019		0.28	[0.16-0.39] unit increase	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003583	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	4q28.3	4	134616564	Intergenic	LINC02462 - AC093722.1	ENSG00000251291	ENSG00000249000		158712	142835	rs6535028-T	rs6535028	0	6535028	intergenic_variant	1	0.1	3E-6	5.522878745280337		0.29	[0.17-0.40] unit increase	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003583	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	15q21.1	15	46564730	Intergenic	AC091074.1 - RNU6-1014P	ENSG00000285934	ENSG00000238456		183687	95928	rs4775602-C	rs4775602	0	4775602	intergenic_variant	1	0.16	3E-6	5.522878745280337		0.23	[0.13-0.32] unit increase	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003583	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	1p13.3	1	109165601	Intergenic	KIAA1324			ENSG00000116299			rs60481745-A	rs60481745	0	60481745	intron_variant	0	0.1	4E-6	5.3979400086720375		0.37	[0.22-0.53] unit increase	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003583	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	8p23.2	8	3289837	Intergenic	CSMD1			ENSG00000183117			rs7829759-A	rs7829759	0	7829759	intron_variant	0	0.11	4E-6	5.3979400086720375		0.33	[0.19-0.47] unit increase	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003583	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	15q24.2	15	75637650	Intergenic	AC105020.2			ENSG00000260206			rs79604958-C	rs79604958	0	79604958	intron_variant	0	0.07	4E-6	5.3979400086720375		0.47	[0.27-0.68] unit increase	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003583	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	12p13.31	12	8552873	Intergenic	AC092746.1			ENSG00000255801			rs10770857-A	rs10770857	0	10770857	intron_variant	0	0.37	5E-6	5.301029995663981		0.17	[0.10-0.25] unit increase	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003583	Genome-wide genotyping array
2017-02-02	27515689	Kerns SL	2016-07-20	EBioMedicine	www.ncbi.nlm.nih.gov/pubmed/27515689	Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.	Response to radiotherapy in prostate cancer (overall toxicity)	1,346 European ancestry individuals	NA	15q25.1	15	79696844	Intergenic	AC023968.1 - AC026826.3	ENSG00000259208	ENSG00000260674		28028	46467	rs12591436-G	rs12591436	0	12591436	intergenic_variant	1	0.34	6E-6	5.221848749616356		0.18	[0.10-0.26] unit increase	NR [~ 38000000] (imputed)	N	response to radiation, prostate carcinoma	http://purl.obolibrary.org/obo/GO_0009314, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003583	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	19q13.33	19	50851341	KLK3	AC011523.1 - KLK3	ENSG00000267968	ENSG00000142515		252	3574	rs2659124-T	rs2659124	0	2659124	intergenic_variant	1	0.854	1E-13	13.0		1.18	[1.13-1.24]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127119564	NR	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs116041037-A	rs116041037	0	116041037	intron_variant	0	1.0E-4	6E-10	9.221848749616356	(African American)	2.67	[1.96-3.64]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127064901	NR	PCAT1			ENSG00000253438			rs77541621-A	rs77541621	0	77541621	non_coding_transcript_exon_variant	0	0.022	2E-26	25.69897000433602	(conditioned, EA)	2.0408163	[1.79-2.33]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127091724	NR	CASC19, PCAT1, PRNCR1			ENSG00000254166, ENSG00000253438, ENSG00000282961			rs72725879-T	rs72725879	0	72725879	non_coding_transcript_exon_variant	0	0.667	3E-8	7.522878745280337	(conditioned, East Asian)	1.92	[1.54-2.44]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127519444	NR	CASC8 - CASC11	ENSG00000246228	ENSG00000249375		37305	166899	rs11986220-A	rs11986220	0	11986220	intergenic_variant	1	0.14	9E-7	6.045757490560675	(East Asian)	1.83	[1.44-2.33]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	6q22.1	6	116888889	NR	RFX6			ENSG00000185002			rs339331-T	rs339331	0	339331	intron_variant	0	0.71	1E-6	6.0	(European)	1.13	[1.07-1.18]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	12q13.12	12	49282227	NR	TUBA1C - AC125611.4	ENSG00000167553	ENSG00000258334		7624	10404	rs10875943-C	rs10875943	0	10875943	regulatory_region_variant	1	0.29	2E-6	5.698970004336019	(European)	1.12	[1.07-1.18]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	19q13.33	19	50861367	NR	KLK3 - KLK2	ENSG00000142515	ENSG00000167751		603	201	rs2735839-G	rs2735839	0	2735839	intergenic_variant	1	0.85	2E-8	7.698970004336019	(European)	1.2	[1.13-1.28]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	1q21.3	1	150685811	NR	GOLPH3L			ENSG00000143457			rs17599629-G	rs17599629	0	17599629	intron_variant	0	0.21	1E-6	6.0	(European)	1.14	[1.08-1.20]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	2p11.2	2	85567174	NR	VAMP8			ENSG00000118640			rs10187424-A	rs10187424	0	10187424	intron_variant	0	0.58	5E-6	5.301029995663981	(European)	1.11	[1.06-1.16]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	7p15.1	7	27936944	NR	JAZF1			ENSG00000153814			rs10486567-G	rs10486567	0	10486567	intron_variant	0	0.77	3E-9	8.522878745280337	(European)	1.17	[1.11-1.23]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8p21.2	8	23668950	NR	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		33443	9743	rs1512268-A	rs1512268	0	1512268	TF_binding_site_variant	1	0.43	2E-12	11.698970004336019	(European)	1.17	[1.12-1.22]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	126999692	NR	PCAT1			ENSG00000253438			rs10086908-T	rs10086908	0	10086908	intron_variant	0	0.71	2E-10	9.698970004336019	(European)	1.17	[1.12-1.23]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127081052	NR	PCAT1, CASC19, PRNCR1			ENSG00000253438, ENSG00000254166, ENSG00000282961			rs1016343-T	rs1016343	0	1016343	non_coding_transcript_exon_variant	0	0.21	5E-21	20.30102999566398	(European)	1.28	[1.21-1.34]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127094635	NR	PCAT1, CASC19			ENSG00000253438, ENSG00000254166			rs6983561-C	rs6983561	0	6983561	intron_variant	0	0.035	5E-19	18.30102999566398	(European)	1.61	[1.45-1.78]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127328663	NR	CASC8, PCAT1, POU5F1B			ENSG00000246228, ENSG00000253438, ENSG00000212993			rs16902104-T	rs16902104	0	16902104	intron_variant	0	0.14	5E-10	9.301029995663981	(European)	1.21	[1.14-1.28]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127401060	NR	CCAT2, POU5F1B, PCAT1, CASC8			ENSG00000280997, ENSG00000212993, ENSG00000253438, ENSG00000246228			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	0.51	3E-24	23.522878745280337	(European)	1.25	[1.20-1.31]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127519444	NR	CASC8 - CASC11	ENSG00000246228	ENSG00000249375		37305	166899	rs11986220-A	rs11986220	0	11986220	intergenic_variant	1	0.099	2E-40	39.69897000433602	(European)	1.56	[1.46-1.67]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	11q13.3	11	69227200	NR	AP003071.2 - MYEOV	ENSG00000261070	ENSG00000172927		55636	66938	rs10896449-G	rs10896449	0	10896449	intergenic_variant	1	0.52	8E-18	17.096910013008056	(European)	1.21	[1.16-1.26]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	12q13.13	12	52880120	NR	KRT78 - RPL7P41	ENSG00000170423	ENSG00000241146		31028	5309	rs902774-A	rs902774	0	902774	TF_binding_site_variant	1	0.15	1E-7	7.0	(European)	1.17	[1.11-1.24]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q12	17	37741165	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7501939-C	rs7501939	0	7501939	intron_variant	0	0.6	1E-14	14.0	(European)	1.19	[1.14-1.24]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q24.3	17	71112612	NR	CASC17			ENSG00000260785			rs1859962-G	rs1859962	0	1859962	intron_variant	0	0.48	8E-9	8.096910013008056	(European)	1.13	[1.09-1.18]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	22q13.2	22	43104206	NR	AL022237.1 - BIK	ENSG00000234735	ENSG00000100290		11682	6542	rs5759167-G	rs5759167	0	5759167	TF_binding_site_variant	1	0.51	5E-9	8.301029995663981	(European)	1.14	[1.09-1.19]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	10q11.22	10	46046326	NR	MSMB - RPL23AP61	ENSG00000263639	ENSG00000280012		57	16924	rs10993994-T	rs10993994	0	10993994	intergenic_variant	1	0.4	3E-18	17.522878745280337	(European)	1.21	[1.16-1.26]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q12	17	37714971	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11649743-G	rs11649743	0	11649743	intron_variant	0	0.81	1E-6	6.0	(European)	1.15	[1.09-1.22]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	2p11.2	2	85578945	NR	VAMP8			ENSG00000118640			rs3731827-T	rs3731827	0	3731827	intron_variant	0	0.584	1E-9	9.0		1.13	[1.09-1.18]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	7p15.1	7	27937744	NR	JAZF1			ENSG00000153814			rs7808935-T	rs7808935	0	7808935	intron_variant	0	0.766	3E-11	10.522878745280337		1.17	[1.12-1.22]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8p21.2	8	23649749	NR	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		14242	28944	rs142463603-A	rs142463603	1	13279749	intergenic_variant	1	0.417	4E-16	15.397940008672037		1.18	[1.13-1.22]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127519444	NR	CASC8 - CASC11	ENSG00000246228	ENSG00000249375		37305	166899	rs11986220-A	rs11986220	0	11986220	intergenic_variant	1	0.099	4E-45	44.39794000867204		1.54	[1.45-1.63]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	10q11.22	10	46046326	NR	MSMB - RPL23AP61	ENSG00000263639	ENSG00000280012		57	16924	rs10993994-T	rs10993994	0	10993994	intergenic_variant	1	0.401	7E-21	20.154901959985743		1.21	[1.16-1.25]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	11q13.3	11	69244226	NR	AP003071.2 - MYEOV	ENSG00000261070	ENSG00000172927		72662	49912	rs376592364-T	rs376592364	0	376592364	intergenic_variant	1	0.52	6E-20	19.221848749616356		1.2	[1.16-1.25]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls				NR							12:49672714-G	12:49672714	0			1	0.254	8E-9	8.096910013008056		1.14	[1.09-1.19]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls				NR							12:53309584-A	12:53309584	0			1	0.122	2E-14	13.698970004336019		1.25	[1.18-1.33]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q12	17	37743574	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11263763-A	rs11263763	0	11263763	intron_variant	0	0.519	5E-24	23.30102999566398		1.22	[1.18-1.28]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q24.3	17	71111532	NR	CASC17			ENSG00000260785			rs8071558-C	rs8071558	0	8071558	intron_variant	0	0.483	7E-11	10.154901959985743		1.14	[1.09-1.18]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	22q13.2	22	43104206	NR	AL022237.1 - BIK	ENSG00000234735	ENSG00000100290		11682	6542	rs5759167-G	rs5759167	0	5759167	TF_binding_site_variant	1	0.505	2E-9	8.698970004336019		1.13	[1.09-1.18]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	11q13.3	11	69227200	NR	AP003071.2 - MYEOV	ENSG00000261070	ENSG00000172927		55636	66938	rs10896449-G	rs10896449	0	10896449	intergenic_variant	1	0.52	5E-19	18.30102999566398		1.2	[1.15-1.24]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	12q13.13	12	52880120	NR	KRT78 - RPL7P41	ENSG00000170423	ENSG00000241146		31028	5309	rs902774-A	rs902774	0	902774	TF_binding_site_variant	1	0.15	9E-8	7.045757490560675		1.16	[1.10-1.23]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q12	17	37741165	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7501939-C	rs7501939	0	7501939	intron_variant	0	0.6	4E-15	14.397940008672037		1.17	[1.13-1.22]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q24.3	17	71112612	NR	CASC17			ENSG00000260785			rs1859962-G	rs1859962	0	1859962	intron_variant	0	0.48	2E-9	8.698970004336019		1.13	[1.08-1.17]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	6q22.1	6	116888889	NR	RFX6			ENSG00000185002			rs339331-T	rs339331	0	339331	intron_variant	0	0.71	6E-7	6.221848749616356		1.12	[1.07-1.17]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	7p15.1	7	27936944	NR	JAZF1			ENSG00000153814			rs10486567-G	rs10486567	0	10486567	intron_variant	0	0.77	3E-11	10.522878745280337		1.17	[1.12-1.22]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8p21.2	8	23668950	NR	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		33443	9743	rs1512268-A	rs1512268	0	1512268	TF_binding_site_variant	1	0.43	4E-15	14.397940008672037		1.17	[1.12-1.22]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127328663	NR	CASC8, PCAT1, POU5F1B			ENSG00000246228, ENSG00000253438, ENSG00000212993			rs16902104-T	rs16902104	0	16902104	intron_variant	0	0.14	1E-9	9.0		1.18	[1.12-1.25]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	1q21.3	1	150685811	NR	GOLPH3L			ENSG00000143457			rs17599629-G	rs17599629	0	17599629	intron_variant	0	0.21	9E-6	5.045757490560675		1.12	[1.06-1.17]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	2p11.2	2	85567174	NR	VAMP8			ENSG00000118640			rs10187424-A	rs10187424	0	10187424	intron_variant	0	0.58	3E-9	8.522878745280337		1.13	[1.08-1.17]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	4q24	4	105140377	NR	AC004069.1			ENSG00000251259			rs7679673-C	rs7679673	0	7679673	intron_variant	0	0.59	5E-8	7.301029995663981		1.12	[1.07-1.16]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	126999692	NR	PCAT1			ENSG00000253438			rs10086908-T	rs10086908	0	10086908	intron_variant	0	0.71	2E-12	11.698970004336019		1.17	[1.12-1.22]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127081052	NR	PCAT1, CASC19, PRNCR1			ENSG00000253438, ENSG00000254166, ENSG00000282961			rs1016343-T	rs1016343	0	1016343	non_coding_transcript_exon_variant	0	0.21	6E-21	20.221848749616356		1.25	[1.19-1.30]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127082911	NR	PCAT1, PRNCR1, CASC19			ENSG00000253438, ENSG00000282961, ENSG00000254166			rs13252298-A	rs13252298	0	13252298	non_coding_transcript_exon_variant	0	0.71	2E-6	5.698970004336019		1.11	[1.06-1.16]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127094635	NR	PCAT1, CASC19			ENSG00000253438, ENSG00000254166			rs6983561-C	rs6983561	0	6983561	intron_variant	0	0.035	6E-22	21.221848749616356		1.45	[1.34-1.56]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	8q24.21	8	127401060	NR	CCAT2, POU5F1B, PCAT1, CASC8			ENSG00000280997, ENSG00000212993, ENSG00000253438, ENSG00000246228			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	0.51	3E-27	26.522878745280337		1.25	[1.20-1.30]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	12q13.12	12	49282227	NR	TUBA1C - AC125611.4	ENSG00000167553	ENSG00000258334		7624	10404	rs10875943-C	rs10875943	0	10875943	regulatory_region_variant	1	0.29	7E-8	7.154901959985743		1.12	[1.08-1.17]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	17q12	17	37714971	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs11649743-G	rs11649743	0	11649743	intron_variant	0	0.81	6E-7	6.221848749616356		1.14	[1.08-1.20]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	19q13.33	19	50861367	NR	KLK3 - KLK2	ENSG00000142515	ENSG00000167751		603	201	rs2735839-G	rs2735839	0	2735839	intergenic_variant	1	0.85	6E-9	8.221848749616356		1.17	[1.11-1.24]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	6q25.3	6	160160512	SLC22A2, SLC22A1	SLC22A1 - AL645733.1	ENSG00000175003	ENSG00000216516		1794	3027	rs4646284-TG	rs4646284	0	4646284	regulatory_region_variant	1	0.298	1E-19	19.0		1.18	[1.14-1.22]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2016-07-15	26034056	Hoffmann TJ	2015-06-01	Cancer Discov	www.ncbi.nlm.nih.gov/pubmed/26034056	A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.	Prostate cancer	6,406 European ancestry cases, 601 African American cases, 288 East Asian ancestry cases, 488 Latino cases30,866 European ancestry controls, 1,650 African American controls, 2,938 East Asian ancestry controls, 3,141 Latino controls	4,599 European ancestry cases, 2,265 African American cases, 2,940 European ancestry controls, 2,414 African American controls	6q25.3	6	160412632	SLC22A3	SLC22A3			ENSG00000146477			rs9364554-T	rs9364554	0	9364554	intron_variant	0	0.279	6E-12	11.221848749616356		1.14	[1.10-1.18]	Affymetrix [up to 19977088] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002944	Genome-wide genotyping array
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	6q25.3	6	160412632	SLC22A3	SLC22A3			ENSG00000146477			rs9364554-T	rs9364554	0	9364554	intron_variant	0	0.29	6E-10	9.221848749616356		1.17	[1.08-1.26]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000152	Genome-wide genotyping array
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	7q21.3	7	98187015	LMTK2	LMTK2			ENSG00000164715			rs6465657-C	rs6465657	0	6465657	intron_variant	0	0.46	1E-9	9.0		1.12	[1.05-1.20]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000152	Genome-wide genotyping array
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	10q11.22	10	46046326	MSMB	MSMB - RPL23AP61	ENSG00000263639	ENSG00000280012		57	16924	rs10993994-T	rs10993994	0	10993994	intergenic_variant	1	0.40	7E-13	12.154901959985743		1.16	[1.04-1.29]	Illumina [527869]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000154	Genome-wide genotyping array
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	10q26.13	10	125008303	CTBP2	CTBP2			ENSG00000175029			rs4962416-C	rs4962416	0	4962416	intron_variant	0	0.27	2E-7	6.698970004336019		1.17	[1.05-1.30]	Illumina [527869]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000154	Genome-wide genotyping array
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	11q13.3	11	69227200	intergenic	AP003071.2 - MYEOV	ENSG00000261070	ENSG00000172927		55636	66938	rs10896449-G	rs10896449	0	10896449	intergenic_variant	1	0.52	2E-9	8.698970004336019		1.1	[0.98-1.23]	Illumina [527869]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000154	Genome-wide genotyping array
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	7p15.1	7	27936944	JAZF1	JAZF1			ENSG00000153814			rs10486567-G	rs10486567	0	10486567	intron_variant	0	0.77	2E-6	5.698970004336019		1.12	[1.02-1.25]	Illumina [527869]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000154	Genome-wide genotyping array
2008-06-16	17401366	Gudmundsson J	2007-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17401366	Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.	Prostate cancer	1,453 European ancestry cases, 3,064 European ancestry controls	1,210 European ancestry cases, 2,445 European ancestry controls, 373 African American cases, 372 African American controls	8q24.21	8	127112671	intergenic	CASC19, PCAT1			ENSG00000254166, ENSG00000253438			rs16901979-A	rs16901979	0	16901979	intron_variant	0	0.03	1E-12	12.0	(EA)	1.79	[1.53-2.11]	Illumina [316515]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000019	Genome-wide genotyping array
2008-06-16	17401363	Yeager M	2007-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17401363	Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,124 European ancestry cases, 3,142 European ancestry controls	8q24.21	8	127401060	intergenic	CCAT2, POU5F1B, PCAT1, CASC8			ENSG00000280997, ENSG00000212993, ENSG00000253438, ENSG00000246228			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	0.50	9E-13	12.045757490560675		1.26	[1.13-1.41]	Illumina [538548]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000017	Genome-wide genotyping array
2008-06-16	17401363	Yeager M	2007-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17401363	Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,124 European ancestry cases, 3,142 European ancestry controls	8q24.21	8	127472793	intergenic	CASC8			ENSG00000246228			rs1447295-A	rs1447295	0	1447295	intron_variant	0	0.11	2E-14	13.698970004336019		1.43	[1.29-1.59]	Illumina [538548]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000017	Genome-wide genotyping array
2008-06-16	17401366	Gudmundsson J	2007-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17401366	Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.	Prostate cancer	1,453 European ancestry cases, 3,064 European ancestry controls	1,210 European ancestry cases, 2,445 European ancestry controls, 373 African American cases, 372 African American controls	8q24.21	8	127472793	intergenic	CASC8			ENSG00000246228			rs1447295-A	rs1447295	0	1447295	intron_variant	0	0.09	6E-18	17.221848749616356		1.6	[1.43-1.77]	Illumina [316515]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000019	Genome-wide genotyping array
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	17q24.3	17	71112612	intergenic	CASC17			ENSG00000260785			rs1859962-G	rs1859962	0	1859962	intron_variant	0	0.46	1E-6	6.0		1.26	[NR]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000152	Genome-wide genotyping array
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	8q24.21	8	127401060	intergenic	CCAT2, POU5F1B, PCAT1, CASC8			ENSG00000280997, ENSG00000212993, ENSG00000253438, ENSG00000246228			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	0.53	7E-12	11.154901959985743		1.28	[1.15-1.45]	Illumina [527869]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000154	Genome-wide genotyping array
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	8q24.21	8	127505328	intergenic	CASC8 - CASC11	ENSG00000246228	ENSG00000249375		23189	181015	rs4242382-A	rs4242382	0	4242382	regulatory_region_variant	1	0.12	3E-19	18.522878745280337		1.66	[1.47-1.87]	Illumina [527869]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000154	Genome-wide genotyping array
2008-06-16	18264096	Thomas G	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264096	Multiple loci identified in a genome-wide association study of prostate cancer.	Prostate cancer	1,172 European ancestry cases, 1,157 European ancestry controls	3,941 European ancestry cases, 3,964 European ancestry controls	17q12	17	37738049	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs4430796-A	rs4430796	0	4430796	intron_variant	0	0.54	1E-9	9.0		1.18	[1.04-1.32]	Illumina [527869]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000154	Genome-wide genotyping array
2016-02-13	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer aggressiveness	4,545 European ancestry cases	7,973 European ancestry cases	5q14.3	5	87315172	RASA1, CCNH	RASA1			ENSG00000145715			rs35148638-C	rs35148638	0	35148638	intron_variant	0	0.255	6E-9	8.221848749616356		0.088	[0.059-0.117] unit increase	Illumina [1531807] (imputed)	N	cancer aggressiveness measurement, Gleason score measurement, prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0006999, http://www.ebi.ac.uk/efo/EFO_0007000, http://www.ebi.ac.uk/efo/EFO_0001663	GCST002886	Genome-wide genotyping array
2016-02-13	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer aggressiveness	4,545 European ancestry cases	7,973 European ancestry cases	3q26.31	3	175534948	NAALADL2	NAALADL2			ENSG00000177694			rs78943174-C	rs78943174	0	78943174	intron_variant	0	0.987	4E-8	7.3979400086720375		0.289	[0.19-0.39] unit increase	Illumina [1531807] (imputed)	N	cancer aggressiveness measurement, Gleason score measurement, prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0006999, http://www.ebi.ac.uk/efo/EFO_0007000, http://www.ebi.ac.uk/efo/EFO_0001663	GCST002886	Genome-wide genotyping array
2016-02-13	25939597	Berndt SI	2015-05-05	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25939597	Two susceptibility loci identified for prostate cancer aggressiveness.	Prostate cancer aggressiveness	4,545 European ancestry cases	7,973 European ancestry cases	19q13.33	19	50857584	KLK3	KLK3			ENSG00000142515			rs62113212-T	rs62113212	0	62113212	non_coding_transcript_exon_variant	0	0.061	6E-9	8.221848749616356		0.138	[0.091-0.185] unit increase	Illumina [1531807] (imputed)	N	cancer aggressiveness measurement, Gleason score measurement, prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0006999, http://www.ebi.ac.uk/efo/EFO_0007000, http://www.ebi.ac.uk/efo/EFO_0001663	GCST002886	Genome-wide genotyping array
2016-08-22	26307654	Szulkin R	2015-08-25	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/26307654	Genome-wide association study of prostate cancer-specific survival.	Prostate cancer (survival)	7,322 cases	18,197 European ancestry cases	2p23.1	2	30399958	NR	LINC01936 - AC073255.1	ENSG00000235997	ENSG00000280154		47527	8212	rs114997855-A	rs114997855	0	114997855	intergenic_variant	1	0.02	1E-7	7.0		1.67	[1.38-2.03]	Affymetrix, Illumina [up to 9536409] (imputed)	N	survival time, prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003100	Genome-wide genotyping array
2016-08-22	26307654	Szulkin R	2015-08-25	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/26307654	Genome-wide association study of prostate cancer-specific survival.	Prostate cancer (survival)	7,322 cases	18,197 European ancestry cases	3p14.1	3	67392218	NR	SUCLG2			ENSG00000172340			rs76010824-A	rs76010824	0	76010824	intron_variant	0	0.07	1E-7	7.0		1.26	[1.16-1.38]	Affymetrix, Illumina [up to 9536409] (imputed)	N	survival time, prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003100	Genome-wide genotyping array
2016-08-22	26307654	Szulkin R	2015-08-25	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/26307654	Genome-wide association study of prostate cancer-specific survival.	Prostate cancer (survival)	7,322 cases	18,197 European ancestry cases	Xp11.22	X	50451939	NR	DGKK			ENSG00000274588			rs140659849-A	rs140659849	0	140659849	intron_variant	0	0.01	1E-7	7.0		2.61	[1.83-3.73]	Affymetrix, Illumina [up to 9536409] (imputed)	N	survival time, prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003100	Genome-wide genotyping array
2016-08-22	26307654	Szulkin R	2015-08-25	Cancer Epidemiol Biomarkers Prev	www.ncbi.nlm.nih.gov/pubmed/26307654	Genome-wide association study of prostate cancer-specific survival.	Prostate cancer (survival)	7,322 cases	18,197 European ancestry cases	Xq25	X	127519376	NR	Z82209.2 - AL662814.1	ENSG00000280275	ENSG00000274631		124605	104034	rs723557-G	rs723557	0	723557	intergenic_variant	1	0.08	6E-7	6.221848749616356		1.15	[1.09-1.22]	Affymetrix, Illumina [up to 9536409] (imputed)	N	survival time, prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0000714, http://www.ebi.ac.uk/efo/EFO_0001663	GCST003100	Genome-wide genotyping array
2012-12-11	23023329	Xu J	2012-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23023329	Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.	Prostate cancer	1,417 Han Chinese ancestry cases, 1,008 Han Chinese ancestry controls	3,067 Han Chinese ancestry cases, 7,926 Han Chinese ancestry controls	9q31.2	9	107394019	KLF4, RAD23B	RAD23B - LINC01509	ENSG00000119318	ENSG00000226825		61825	26265	rs817826-C	rs817826	0	817826	intergenic_variant	1	0.084	5E-14	13.301029995663981		1.41	[1.29-1.54]	Illumina [587294]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001702	Genome-wide genotyping array
2012-12-11	23023329	Xu J	2012-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23023329	Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.	Prostate cancer	1,417 Han Chinese ancestry cases, 1,008 Han Chinese ancestry controls	3,067 Han Chinese ancestry cases, 7,926 Han Chinese ancestry controls	19q13.42	19	54293995	LILRA3	MIR4752 - AC245884.5	ENSG00000264703	ENSG00000240197		11815	54	rs103294-C	rs103294	0	103294	3_prime_UTR_variant	1	0.238	5E-16	15.301029995663981		1.28	[1.21-1.36]	Illumina [587294]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001702	Genome-wide genotyping array
2012-12-11	23023329	Xu J	2012-09-30	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23023329	Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.	Prostate cancer	1,417 Han Chinese ancestry cases, 1,008 Han Chinese ancestry controls	3,067 Han Chinese ancestry cases, 7,926 Han Chinese ancestry controls	8q24.21	8	127091692	intergenic	CASC19, PCAT1, PRNCR1			ENSG00000254166, ENSG00000253438, ENSG00000282961			rs1456315-?	rs1456315	0	1456315	non_coding_transcript_exon_variant	0	NR	1E-12	12.0				Illumina [587294]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001702	Genome-wide genotyping array
2008-06-16	17401366	Gudmundsson J	2007-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17401366	Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.	Prostate cancer	1,453 European ancestry cases, 3,064 European ancestry controls	1,210 European ancestry cases, 2,445 European ancestry controls, 373 African American cases, 372 African American controls	8q24.21	8;8;8;8;8;8;8;8;8;8;8;8;8;8	127081032;127115007;127072294;127063445;127069276;127068178;127125423;127081052;127081233;127075659;127110414;127071852;127080210;127104255	intergenic	CASC19; PCAT1; PRNCR1; CASC19; PCAT1; PCAT1; PCAT1; PCAT1; PCAT1; CASC19; PCAT1; CASC19; PCAT1; PRNCR1; CASC19; PCAT1; PRNCR1; CASC19; PCAT1; CASC19; PCAT1; PCAT1; CASC19; PCAT1; PRNCR1; CASC19; PCAT1						rs1031588-G; rs1456305-T; rs6994316-A; rs1456314-G; rs7825414-G; rs17831626-T; rs7816535-G; rs1016343-T; rs1551510-G; rs6470494-T; rs1378897-G; rs6993569-G; rs1016342-C; rs1456306-C	rs1031588; rs1456305; rs6994316; rs1456314; rs7825414; rs17831626; rs7816535; rs1016343; rs1551510; rs6470494; rs1378897; rs6993569; rs1016342; rs1456306	0		non_coding_transcript_exon_variant; intron_variant; intron_variant; intron_variant; intron_variant; intron_variant; intron_variant; non_coding_transcript_exon_variant; non_coding_transcript_exon_variant; intron_variant; intron_variant; intron_variant; non_coding_transcript_exon_variant; intron_variant		0.022	3E-15	14.522878745280337	(EA)	2.1	[1.75-2.53]	Illumina [316515]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000019	Genome-wide genotyping array
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	10q11.22	10	46046326	MSMB	MSMB - RPL23AP61	ENSG00000263639	ENSG00000280012		57	16924	rs10993994-T	rs10993994	0	10993994	intergenic_variant	1	0.40	9E-29	28.045757490560675		1.25	[1.17-1.34]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000152	Genome-wide genotyping array
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	19q13.33	19	50861367	KLK3	KLK3 - KLK2	ENSG00000142515	ENSG00000167751		603	201	rs2735839-G	rs2735839	0	2735839	intergenic_variant	1	0.85	2E-18	17.69897000433602		1.2	[1.10-1.33]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000152	Genome-wide genotyping array
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	11q13.3	11	69227030	intergenic	AP003071.2 - MYEOV	ENSG00000261070	ENSG00000172927		55466	67108	rs7931342-G	rs7931342	0	7931342	intergenic_variant	1	0.51	2E-12	11.698970004336019		1.19	[1.11-1.27]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000152	Genome-wide genotyping array
2008-06-16	18264098	Gudmundsson J	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264098	Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.	Prostate cancer	1,854 European ancestry cases, 21,372 European ancestry controls	8,239 European ancestry cases, 7,590 European ancestry controls	Xp11.22	X	51486831	LOC340602, NUDT10, NUDT11	AL158055.1 - NUDT11	ENSG00000226530	ENSG00000196368		21170	3180	rs5945572-A	rs5945572	0	5945572	intergenic_variant	1	0.35	4E-13	12.397940008672037		1.23	[1.16-1.30]	Illumina [310520]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000153	Genome-wide genotyping array
2008-06-16	18264098	Gudmundsson J	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264098	Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.	Prostate cancer	1,854 European ancestry cases, 21,372 European ancestry controls	8,239 European ancestry cases, 7,590 European ancestry controls	2p15	2	62904596	EHBP1	EHBP1			ENSG00000115504			rs721048-A	rs721048	0	721048	intron_variant	0	0.19	8E-9	8.096910013008056		1.15	[1.10-1.21]	Illumina [310520]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000153	Genome-wide genotyping array
2008-06-16	17603485	Gudmundsson J	2007-07-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17603485	Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.	Prostate cancer	1,501 European ancestry cases, 11,290 European ancestry controls	1,992 European ancestry cases, 3,058 European ancestry controls	17q12	17	37738049	TCF2	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs4430796-A	rs4430796	0	4430796	intron_variant	0	0.49	1E-11	11.0		1.22	[1.15-1.30]	Illumina [310520]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000050	Genome-wide genotyping array
2008-06-16	17603485	Gudmundsson J	2007-07-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/17603485	Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.	Prostate cancer	1,501 European ancestry cases, 11,290 European ancestry controls	1,992 European ancestry cases, 3,058 European ancestry controls	17q24.3	17	71112612	intergenic	CASC17			ENSG00000260785			rs1859962-G	rs1859962	0	1859962	intron_variant	0	0.46	3E-10	9.522878745280337		1.2	[1.14-1.27]	Illumina [310520]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000050	Genome-wide genotyping array
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	3p12.1	3	87061524	intergenic	PPATP1 - LINC00506	ENSG00000241293	ENSG00000281392		8786	27605	rs2660753-T	rs2660753	0	2660753	intergenic_variant	1	0.11	3E-8	7.522878745280337		1.18	[1.06-1.31]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000152	Genome-wide genotyping array
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	Xp11.22	X	51498820	NUDT10, NUDT11	NUDT11 - LINC01496	ENSG00000196368	ENSG00000234766		2224	3270	rs5945619-C	rs5945619	0	5945619	intergenic_variant	1	0.36	2E-9	8.698970004336019		1.19	[1.07-1.31]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000152	Genome-wide genotyping array
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	8q24.21	8	127401060	intergenic	CCAT2, POU5F1B, PCAT1, CASC8			ENSG00000280997, ENSG00000212993, ENSG00000253438, ENSG00000246228			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	0.49	9E-13	12.045757490560675		1.42	[NR]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000152	Genome-wide genotyping array
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	8q24.21	8	127081052	intergenic	PCAT1, CASC19, PRNCR1			ENSG00000253438, ENSG00000254166, ENSG00000282961			rs1016343-T	rs1016343	0	1016343	non_coding_transcript_exon_variant	0	0.18	1E-7	7.0		1.37	[NR]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000152	Genome-wide genotyping array
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	8q24.21	8	127506309	intergenic	CASC8 - CASC11	ENSG00000246228	ENSG00000249375		24170	180034	rs4242384-C	rs4242384	0	4242384	intergenic_variant	1	0.09	3E-16	15.522878745280337		1.88	[NR]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000152	Genome-wide genotyping array
2008-06-16	18264097	Eeles RA	2008-02-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/18264097	Multiple newly identified loci associated with prostate cancer susceptibility.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	3,268 European ancestry cases, 3,366 European ancestry controls	17q12	17	37741165	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7501939-C	rs7501939	0	7501939	intron_variant	0	0.57	9E-12	11.045757490560675		1.41	[NR]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000152	Genome-wide genotyping array
2011-06-03	21602798	Haiman CA	2011-05-22	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21602798	Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21.	Prostate cancer	3,425 African American cases, 3,290 African American controls	1,500 African American/Afro-Caribbean cases, 1,908 African American/Afro-Caribbean controls, 344 Sub-Saharan African ancestry cases, 1,361 Sub-Saharan African ancestry controls	17q21.33	17	49359387	ZNF652	ZNF652			ENSG00000198740			rs7210100-?	rs7210100	0	7210100	intron_variant	0	0.05	3E-13	12.522878745280337		1.51	[1.35-1.69]	Illumina [10471986]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001078	Genome-wide genotyping array
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	2q37.3	2	237534583	MLPH	MLPH			ENSG00000115648			rs2292884-G	rs2292884	0	2292884	missense_variant	0	0.25	4E-8	7.3979400086720375		1.14	[1.09-1.19]	Illumina [571243]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001147	Genome-wide genotyping array
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	12q13.13	12	52880120	KRT8, EIF4B, TENC1	KRT78 - RPL7P41	ENSG00000170423	ENSG00000241146		31028	5309	rs902774-A	rs902774	0	902774	TF_binding_site_variant	1	0.17	5E-9	8.301029995663981		1.17	[1.11-1.24]	Illumina [571243]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001147	Genome-wide genotyping array
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	3p11.2	3	87192347	intergenic	LINC00506 - MIR4795	ENSG00000281392	ENSG00000264119		35278	33842	rs7629490-T	rs7629490	0	7629490	intergenic_variant	1	NR	1E-7	7.0	(conditioned on rs2660753)	1.06	[1.04-1.09]	Illumina [571243]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001147	Genome-wide genotyping array
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	6q25.3	6	160160342	SLC22A1	SLC22A1 - AL645733.1	ENSG00000175003	ENSG00000216516		1624	3197	rs651164-G	rs651164	0	651164	intergenic_variant	1	NR	2E-10	9.698970004336019	(conditioned on rs9364554)	1.15	[1.10-1.20]	Illumina [571243]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001147	Genome-wide genotyping array
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	8q24.21	8	127082911	intergenic	PCAT1, PRNCR1, CASC19			ENSG00000253438, ENSG00000282961, ENSG00000254166			rs13252298-A	rs13252298	0	13252298	non_coding_transcript_exon_variant	0	NR	4E-6	5.3979400086720375	(conditioned on 5 SNPs)	1.12	[1.05-1.18]	Illumina [571243]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001147	Genome-wide genotyping array
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	22q13.2	22	43122269	BIK	BIK			ENSG00000100290			rs742134-G	rs742134	0	742134	intron_variant	0	NR	6E-6	5.221848749616356	(conditioned on rs5759167)	1.16	[1.01-1.23]	Illumina [571243]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001147	Genome-wide genotyping array
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	8q24.21	8	127310936	intergenic	PCAT1, CASC8			ENSG00000253438, ENSG00000246228			rs445114-T	rs445114	0	445114	intron_variant	0	NR	5E-7	6.301029995663981		1.22	[1.12-1.32]	Illumina [571243]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001147	Genome-wide genotyping array
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	8q24.21	8	127401060	intergenic	CCAT2, POU5F1B, PCAT1, CASC8			ENSG00000280997, ENSG00000212993, ENSG00000253438, ENSG00000246228			rs6983267-G	rs6983267	0	6983267	non_coding_transcript_exon_variant	0	NR	9E-6	5.045757490560675		1.2	[1.11-1.32]	Illumina [571243]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001147	Genome-wide genotyping array
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	8q24.21	8	127506309	intergenic	CASC8 - CASC11	ENSG00000246228	ENSG00000249375		24170	180034	rs4242384-C	rs4242384	0	4242384	intergenic_variant	1	NR	3E-16	15.522878745280337		1.56	[1.40-1.73]	Illumina [571243]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001147	Genome-wide genotyping array
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	10q11.22	10	46046326	MSMB	MSMB - RPL23AP61	ENSG00000263639	ENSG00000280012		57	16924	rs10993994-T	rs10993994	0	10993994	intergenic_variant	1	NR	5E-6	5.301029995663981		1.18	[1.10-1.27]	Illumina [571243]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001147	Genome-wide genotyping array
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	11q13.3	11	69228491	intergenic	AP003071.2 - MYEOV	ENSG00000261070	ENSG00000172927		56927	65647	rs7130881-G	rs7130881	0	7130881	intergenic_variant	1	NR	9E-9	8.045757490560675		1.31	[1.20-1.44]	Illumina [571243]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001147	Genome-wide genotyping array
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	17q12	17	37741165	TCF2	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7501939-C	rs7501939	0	7501939	intron_variant	0	NR	2E-6	5.698970004336019		1.19	[1.11-1.28]	Illumina [571243]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001147	Genome-wide genotyping array
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	17q24.3	17	71112612	intergenic	CASC17			ENSG00000260785			rs1859962-G	rs1859962	0	1859962	intron_variant	0	NR	3E-11	10.522878745280337		1.27	[1.18-1.37]	Illumina [571243]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001147	Genome-wide genotyping array
2011-07-30	21743057	Schumacher FR	2011-07-08	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/21743057	Genome-wide association study identifies new prostate cancer susceptibility loci.	Prostate cancer	2,782 European ancestry cases, 4,458 European ancestry controls	7,358 European ancestry cases, 6,732 European ancestry controls	8q24.21	8	127081052	intergenic	PCAT1, CASC19, PRNCR1			ENSG00000253438, ENSG00000254166, ENSG00000282961			rs1016343-T	rs1016343	0	1016343	non_coding_transcript_exon_variant	0	NR	4E-10	9.397940008672037		1.31	[1.20-1.42]	Illumina [571243]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001147	Genome-wide genotyping array
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	2p21	2	43326810	THADA	THADA			ENSG00000115970			rs1465618-?	rs1465618	0	1465618	intron_variant	0	0.23	2E-8	7.698970004336019		1.08	[1.03-1.12]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000488	Genome-wide genotyping array
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	2q31.1	2	172446825	ITGA6	ITGA6			ENSG00000091409			rs12621278-?	rs12621278	0	12621278	intron_variant	0	0.94	9E-23	22.045757490560675		1.33	[1.25-1.43]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000488	Genome-wide genotyping array
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	4q22.3	4	94641726	PDLIM5	PDLIM5			ENSG00000163110			rs17021918-?	rs17021918	0	17021918	intron_variant	0	0.65	4E-15	14.397940008672037		1.11	[1.08-1.15]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000488	Genome-wide genotyping array
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	4q24	4	105140377	TET2	AC004069.1			ENSG00000251259			rs7679673-?	rs7679673	0	7679673	intron_variant	0	0.55	3E-14	13.522878745280337		1.1	[1.06-1.14]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000488	Genome-wide genotyping array
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	7p15.3	7	20954872	NR	LINC01162			ENSG00000232790			rs12155172-?	rs12155172	0	12155172	intron_variant	0	0.20	9E-6	5.045757490560675		1.05	[1.00-1.10]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000488	Genome-wide genotyping array
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	8p21.2	8	23668950	NKX3.1	SINHCAFP3 - NKX3-1	ENSG00000253488	ENSG00000167034		33443	9743	rs1512268-?	rs1512268	0	1512268	TF_binding_site_variant	1	0.45	3E-30	29.522878745280337		1.18	[1.14-1.22]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000488	Genome-wide genotyping array
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	11p15.5	11	2212344	IGF2, INS, TH, IGF2AS	MIR4686 - ASCL2	ENSG00000265258	ENSG00000183734		39206	56151	rs7127900-?	rs7127900	0	7127900	intergenic_variant	1	0.20	3E-33	32.52287874528034		1.22	[1.17-1.27]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000488	Genome-wide genotyping array
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	22q13.2	22	43104206	NR	AL022237.1 - BIK	ENSG00000234735	ENSG00000100290		11682	6542	rs5759167-?	rs5759167	0	5759167	TF_binding_site_variant	1	0.53	6E-29	28.221848749616356		1.16	[1.14-1.20]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000488	Genome-wide genotyping array
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	4q22.3	4	94593458	PDLIM5	PDLIM5			ENSG00000163110			rs12500426-?	rs12500426	0	12500426	intron_variant	0	0.46	1E-11	11.0		1.08	[1.05-1.12]	Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000488	Genome-wide genotyping array
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	2p15	2	63074029	EHBP1	OTX1 - AC009501.2	ENSG00000115507	ENSG00000270437		16193	8979	rs6545977-?	rs6545977	0	6545977	intergenic_variant	1	NR	5E-7	6.301029995663981				Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000488	Genome-wide genotyping array
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	3p11.2	3	87124174	NR	LINC00506			ENSG00000281392			rs17181170-?	rs17181170	0	17181170	intron_variant	0	NR	3E-8	7.522878745280337				Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000488	Genome-wide genotyping array
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	6q25.3	6	160160342	NR	SLC22A1 - AL645733.1	ENSG00000175003	ENSG00000216516		1624	3197	rs651164-?	rs651164	0	651164	intergenic_variant	1	NR	2E-9	8.698970004336019				Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000488	Genome-wide genotyping array
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	7q21.3	7	98187015	NR	LMTK2			ENSG00000164715			rs6465657-?	rs6465657	0	6465657	intron_variant	0	NR	2E-8	7.698970004336019				Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000488	Genome-wide genotyping array
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	8q24.21	8	127506309	NR	CASC8 - CASC11	ENSG00000246228	ENSG00000249375		24170	180034	rs4242384-?	rs4242384	0	4242384	intergenic_variant	1	NR	2E-24	23.69897000433602				Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000488	Genome-wide genotyping array
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	10q11.22	10	46070851	NR	RPL23AP61 - AGAP7P	ENSG00000280012	ENSG00000264204		7136	38770	rs3123078-?	rs3123078	0	3123078	regulatory_region_variant	1	NR	1E-19	19.0				Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000488	Genome-wide genotyping array
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	11q13.3	11	69228491	NR	AP003071.2 - MYEOV	ENSG00000261070	ENSG00000172927		56927	65647	rs7130881-?	rs7130881	0	7130881	intergenic_variant	1	NR	8E-13	12.096910013008056				Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000488	Genome-wide genotyping array
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	17q12	17	37741165	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs7501939-?	rs7501939	0	7501939	intron_variant	0	NR	3E-18	17.522878745280337				Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000488	Genome-wide genotyping array
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	17q24.3	17	71112612	NR	CASC17			ENSG00000260785			rs1859962-?	rs1859962	0	1859962	intron_variant	0	NR	2E-16	15.698970004336019				Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000488	Genome-wide genotyping array
2009-12-29	19767753	Eeles RA	2009-09-20	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19767753	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	Prostate cancer	1,854 European ancestry cases, 1,894 European ancestry controls	19,879 cases and 18,761 controls of European, East Asian, African American, Latino, and Hawaiian ancestry	Xp11.22	X	51467205	NR	AL158055.1 - NUDT11	ENSG00000226530	ENSG00000196368		1544	22806	rs1327301-?	rs1327301	0	1327301	intergenic_variant	1	NR	2E-10	9.698970004336019				Illumina [541129]	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST000488	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	1q21.3	1	154861707	ADAM15, ADAR, CKS1B, DCST1, DCST2, EFNA3, EFNA4, LOC10050, FLAD1, KCNN3, LENEP, LOC100505666, MIR4258, PBXIP1, DPM3, PYGO2, EFNA1, SHC1, SLC50A1, ZBTB7B, PMVK	KCNN3			ENSG00000143603			rs1218582-G	rs1218582	0	1218582	intron_variant	0	0.45	2E-8	7.698970004336019		1.06	[1.03-1.09]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	1q32.1	1	204549714	LRRN2, PIK3C2B, LOC127841, MDM4, PPP1R15B, PLEKHA6	MDM4			ENSG00000198625			rs4245739-A	rs4245739	0	4245739	3_prime_UTR_variant	0	0.75	2E-11	10.698970004336019		1.1	[1.05-1.14]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	2p25.1	2	9977740	C2orf48, CYS1, GRHL1, KLF11, MIR4261, RRM2, TAF1B	GRHL1			ENSG00000134317			rs11902236-A	rs11902236	0	11902236	intron_variant	0	0.27	3E-8	7.522878745280337		1.07	[1.03-1.10]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	2q37.3	2	241443449	BOK-AS1, DTYMK, FARP2, HDLBP, SEP2, STK25, THAP4, ANO7, ATG4B, BOK	FARP2			ENSG00000006607			rs3771570-A	rs3771570	0	3771570	3_prime_UTR_variant	0	0.15	5E-9	8.301029995663981		1.12	[1.08-1.17]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	3q13.2	3	113556777	WDR52-AS1, ATP6V1A, BOC, KIAA2018, MIR4446, NAA50, SIDT1, SPICE1, WDR52, WDR52-AS	SIDT1			ENSG00000072858			rs7611694-A	rs7611694	0	7611694	intron_variant	0	0.59	4E-13	12.397940008672037		1.1	[1.08-1.14]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	4q13.3	4	73483441	COX18, AFM, RASSF6, ALB, AFP, ANKRD17, LOC72804, LOC728040	AFM			ENSG00000079557			rs1894292-G	rs1894292	0	1894292	intron_variant	0	0.52	5E-13	12.301029995663981		1.1	[1.06-1.12]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	5q35.2	5	173512423	BOD1, FAM44B, LOC285593, STC2	AC008632.1 - AC008663.1	ENSG00000253141	ENSG00000253768		27839	50055	rs6869841-A	rs6869841	0	6869841	regulatory_region_variant	1	0.21	5E-8	7.301029995663981		1.07	[1.04-1.11]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	6p21.32	6	32224554	CYP21A2, DOM3Z, FKBPL, HLA-DRB6, HCG23, LOC10029, ATF6B, LOC100293534, AGER, LOC100507547, MIR1236, PPT2, PPT2-EGF, HLA-DRA, PPT2-EGFL8, RNF5, RNF5P1, CFB, RDBP, TNXA, TNXB, HLA-DQB1, NOTCH4, SKIV2L, STK19, GPSM3, PBX2, LOC10050, EGFL8, AGPAT1, C2, C4A, PRRT1, BTNL2, C4B, HLA-DRB5, C6orf10, HLA-DRB1, CYP21A1P, HLA-DQA1	NOTCH4 - TSBP1-AS1	ENSG00000238196	ENSG00000225914		487	30086	rs3096702-A	rs3096702	0	3096702	intergenic_variant	1	0.4	5E-9	8.301029995663981		1.07	[1.04-1.10]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	6q21	6	108963986	LACE1, LINC0022, LINC00222, ARMC2, SESN1, CEP57L1, FOXO3	ARMC2			ENSG00000118690			rs2273669-G	rs2273669	0	2273669	intron_variant	0	0.15	8E-9	8.096910013008056		1.07	[1.03-1.11]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	6q25.2	6	153119944	RGS17, FBXO5, MTRF1L	RGS17			ENSG00000091844			rs1933488-A	rs1933488	0	1933488	intron_variant	0	0.59	4E-18	17.397940008672037		1.12	[1.09-1.15]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	7p15.3	7	20954872	SP8, ABCB5, RPL23P8	LINC01162			ENSG00000232790			rs12155172-A	rs12155172	0	12155172	intron_variant	0	0.23	5E-13	12.301029995663981		1.11	[1.07-1.15]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	8p21.2	8	26034626	EBF2	EBF2			ENSG00000221818			rs11135910-A	rs11135910	0	11135910	intron_variant	0	0.16	8E-11	10.096910013008056		1.11	[1.07-1.16]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	10q24.32	10	102654464	CNNM2, CUEDC2, CYP17A1, FBXL15, LOC100505761, MIR146B, PSD, SFXN2, SUFU, TMEM180, ARL3, ACTR1A, AS3MT, TRIM8, C10orf32, C10orf32-AS3MT, WBP1L, C10orf95	TRIM8			ENSG00000171206			rs3850699-A	rs3850699	0	3850699	non_coding_transcript_exon_variant	0	0.71	5E-10	9.301029995663981		1.1	[1.06-1.12]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	11q22.2	11	102530930	MMP8, BIRC2, MMP10, MMP20, MMP27, MMP7, YAP1, BIRC3, TMEM123	MMP7 - MMP20	ENSG00000137673	ENSG00000137674		177	45905	rs11568818-A	rs11568818	0	11568818	regulatory_region_variant	1	0.56	2E-11	10.698970004336019		1.1	[1.06-1.14]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	12q24.21	12	114247766	TBX5, LOC255480	LINC02459 - TBX5	ENSG00000257476	ENSG00000089225		5996	106165	rs1270884-A	rs1270884	0	1270884	intergenic_variant	1	0.49	7E-11	10.154901959985743		1.07	[1.04-1.10]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	14q22.1	14	52905612	DDHD1, ERO1L, TXNDC16, FERMT2, GNPNAT1, GPR137C, PSMC6, STYX	AL139317.5, FERMT2			ENSG00000285664, ENSG00000073712			rs8008270-G	rs8008270	0	8008270	intron_variant	0	0.82	2E-14	13.698970004336019		1.12	[1.08-1.16]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	14q24.1	14	68660027	RAD51B, ZFP36L1, ACTN1	RAD51B			ENSG00000182185			rs7141529-G	rs7141529	0	7141529	intron_variant	0	0.5	3E-10	9.522878745280337		1.09	[1.06-1.12]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	17p13.3	17	715725	DBIL5P, FAM57A, GEMIN4, GLOD4, NXN, RNMTL1, VPS53	VPS53			ENSG00000141252			rs684232-G	rs684232	0	684232	intron_variant	0	0.36	5E-15	14.301029995663981		1.1	[1.07-1.14]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	17q21.32	17	49267824	NGFR, PHB, PHOSPHO1, HOXB13, PRAC, SPOP, ZNF652, ABI3, B4GALNT2, FLJ40194, GNGT2, IGF2BP1	FLJ40194 - MIR6129	ENSG00000177369	ENSG00000273500		9162	20522	rs11650494-A	rs11650494	0	11650494	intergenic_variant	1	0.08	2E-9	8.698970004336019		1.15	[1.09-1.22]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	18q23	18	79013973	SALL3, ATP9B	SALL3 - ATP9B	ENSG00000256463	ENSG00000166377		11296	55312	rs7241993-G	rs7241993	0	7241993	intergenic_variant	1	0.7	2E-9	8.698970004336019		1.09	[1.05-1.12]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	20q13.33	20	62440555	GTPBP5, HRH3, MIR1-1, MIR133A2, MIR4758, OSBPL2, RPS21, LAMA5, ADRM1, C20orf15, C20orf151, C20orf166, C20orf166-AS1, CABLES2, GATA5	AL121832.1			ENSG00000233017			rs2427345-G	rs2427345	0	2427345	intron_variant	0	0.63	4E-8	7.3979400086720375		1.06	[1.03-1.1]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	20q13.33	20	63731211	STMN3, ZBTB46, ZGPAT, ABHD16B, ARFRP1, C20orf195, DNAJC5, EEF1A2, GMEB2, LIME1, LOC100505815, MIR1914, MIR647, MIR941-1, MIR941-2, MIR941-3, MIR941-4, PPDPF, PRIC285, PRPF6, PTK6, RTEL1, RTEL1-TN, RTEL1-TNFRSF6B, SAMD10, SRMS, TNFRSF6B, TPD52L2, UCKL1, SLC2A4RG, UCKL1-AS1, ZNF512B	ZGPAT, AL121845.3			ENSG00000197114, ENSG00000273154			rs6062509-A	rs6062509	0	6062509	intron_variant	0	0.7	4E-16	15.397940008672037		1.12	[1.09-1.16]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2013-09-16	23535732	Eeles RA	2013-04-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/23535732	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	Prostate cancer	11,085 European ancestry cases, 11,463 European ancestry controls	19,662 European ancestry cases, 19,715 European ancestry controls	Xp22.2	X	9846095	GPR143, LOC100288814, SHROOM2, TBL1X, WWC3	SHROOM2			ENSG00000146950			rs2405942-A	rs2405942	0	2405942	intron_variant	0	0.79	2E-10	9.698970004336019		1.14	[1.09-1.2]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001942	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	1q21.3	1	150685811	GOLPH3L	GOLPH3L			ENSG00000143457			rs17599629-G	rs17599629	0	17599629	intron_variant	0	0.22	6E-11	10.221848749616356	(EA)	1.1	[1.07-1.13]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	2p25.1	2	10570604	NOL10	AC007249.1 - NOL10	ENSG00000217258	ENSG00000115761		115052	162	rs9287719-C	rs9287719	0	9287719	intergenic_variant	1	0.46	2E-8	7.698970004336019	(EA)	1.07	[1.04-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	4q13.3	4	72989536	COX18	RNU4ATAC9P - RNU6ATAC5P	ENSG00000252955	ENSG00000210839		24233	37212	rs10009409-T	rs10009409	0	10009409	intergenic_variant	1	0.32	2E-10	9.698970004336019	(EA)	1.09	[1.06-1.12]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	6p24.2	6	11218797	NEDD9	NEDD9, AL139807.1			ENSG00000111859, ENSG00000247925			rs4713266-C	rs4713266	0	4713266	intron_variant	0	0.52	4E-8	7.3979400086720375	(EA)	1.07	[1.04-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	6p22.1	6	30105999	TRIM31	TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1			ENSG00000226402, ENSG00000224542, ENSG00000223531, ENSG00000137397, ENSG00000224168, ENSG00000204616, ENSG00000233573, ENSG00000225130, ENSG00000238027, ENSG00000225038, ENSG00000225732, ENSG00000235722, ENSG00000231226, ENSG00000232510, ENSG00000237050, ENSG00000229223			rs115457135-A	rs115457135	1	7767188	intron_variant	0	0.22	2E-8	7.698970004336019	(EA)	1.08	[1.06-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	6p21.32	6	32433162	HLA-DRB6	TSBP1-AS1 - HLA-DRA	ENSG00000225914	ENSG00000234794		25399	6680	rs115306967-G	rs115306967	1	3129859	intron_variant	1	0.65	3E-9	8.522878745280337	(EA)	1.08	[1.06-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	7p12.3	7	47397647	TNS3	TNS3			ENSG00000136205			rs56232506-A	rs56232506	0	56232506	intron_variant	0	0.45	2E-9	8.698970004336019	(EA)	1.07	[1.05-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	9p21.3	9	22041999	CDKN2B-AS1	CDKN2B-AS1			ENSG00000240498			rs17694493-G	rs17694493	0	17694493	intron_variant	0	0.14	4E-8	7.3979400086720375	(EA)	1.1	[1.06-1.13]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	10q11.22	10	45587537	MARCH8	MARCH8			ENSG00000165406			rs76934034-T	rs76934034	0	76934034	intron_variant	0	0.91	5E-9	8.301029995663981	(EA)	1.14	[1.10-1.18]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	11q23.2	11	113936459	HTR3B	HTR3B			ENSG00000149305			rs11214775-G	rs11214775	0	11214775	intron_variant	0	0.71	3E-8	7.522878745280337	(EA)	1.08	[1.05-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	12q13.11	12	48025835	RP1-228P16.4	AC004801.4 - AC004801.6	ENSG00000257985	ENSG00000276814		366	13949	rs80130819-A	rs80130819	0	80130819	intergenic_variant	1	0.91	4E-8	7.3979400086720375	(EA)	1.13	[1.08-1.17]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	14q24.2	14	70625539	TTC9	AL357153.1, AL357153.3			ENSG00000245466, ENSG00000259115			rs8014671-G	rs8014671	0	8014671	intron_variant	0	0.59	1E-8	8.0	(EA)	1.07	[1.05-1.10]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	Xp11.22	X	52867918	XAGE3	XAGE3			ENSG00000171402			rs2807031-C	rs2807031	0	2807031	intron_variant	0	0.18	9E-10	9.045757490560675	(EA)	1.07	[1.04-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	Xq13.1	X	70920000	SLC7A	TEX11 - SLC7A3	ENSG00000120498	ENSG00000165349		11269	5582	rs6625711-A	rs6625711	0	6625711	intergenic_variant	1	0.41	6E-12	11.221848749616356	(EA)	1.07	[1.05-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	Xq13.1	X	71188133	NLGN3, BCYRN1	AL590764.1			ENSG00000228427			rs4844289-G	rs4844289	0	4844289	intron_variant	0	0.39	1E-9	9.0	(EA)	1.05	[1.04-1.07]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	20q13.13	20	50911385	ADNP	ADNP			ENSG00000101126			rs12480328-T	rs12480328	0	12480328	intron_variant	0	0.93	2E-7	6.698970004336019	(EA)	1.13	[1.08-1.17]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	21q22.3	21	41529494	TMPRSS2	TMPRSS2			ENSG00000184012			rs1041449-G	rs1041449	0	1041449	intron_variant	0	0.44	3E-7	6.522878745280337	(EA)	1.06	[1.04-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	22q11.21	22	19770369	TBX1	TBX1			ENSG00000184058			rs2238776-G	rs2238776	0	2238776	intron_variant	0	0.8	2E-7	6.698970004336019	(EA)	1.09	[1.06-1.12]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	1p36.22	1	10496040	PEX14	PEX14			ENSG00000142655			rs636291-A	rs636291	0	636291	intron_variant	0	0.16	2E-8	7.698970004336019	(EA, early-onset)	1.18	[1.12-1.24]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2013-01-10	23065704	Amin Al Olama A	2012-10-12	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23065704	A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.	Prostate cancer	5,132 European ancestry non-aggressive cases, 5,953 European ancestry aggressive cases, 11,463 European ancestry controls	22,387 European ancestry non-aggressive cases, 2,008 European ancestry aggressive cases, up to 24,726 European ancestry controls	19q13.2	19	41479679	ATP5SL, CEACAM21	PCAT19			ENSG00000267107			rs11672691-G	rs11672691	0	11672691	intron_variant	0	NR	1E-8	8.0	(Aggressive)	1.11	[1.02-1.20]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001714	Genome-wide genotyping array
2013-01-10	23065704	Amin Al Olama A	2012-10-12	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23065704	A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.	Prostate cancer	5,132 European ancestry non-aggressive cases, 5,953 European ancestry aggressive cases, 11,463 European ancestry controls	22,387 European ancestry non-aggressive cases, 2,008 European ancestry aggressive cases, up to 24,726 European ancestry controls	19q13.2	19	41479679	ATP5SL, CEACAM21	PCAT19			ENSG00000267107			rs11672691-G	rs11672691	0	11672691	intron_variant	0	NR	2E-12	11.698970004336019	(All)	1.08	[1.04-1.12]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001714	Genome-wide genotyping array
2013-01-10	23065704	Amin Al Olama A	2012-10-12	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23065704	A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.	Prostate cancer	5,132 European ancestry non-aggressive cases, 5,953 European ancestry aggressive cases, 11,463 European ancestry controls	22,387 European ancestry non-aggressive cases, 2,008 European ancestry aggressive cases, up to 24,726 European ancestry controls	22q13.1	22	40040969	TNRC6B	FAM83F			ENSG00000133477			rs11704416-C	rs11704416	0	11704416	3_prime_UTR_variant	0	NR	4E-6	5.3979400086720375	(Aggressive)	1.05	[0.96-1.15]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001714	Genome-wide genotyping array
2013-01-10	23065704	Amin Al Olama A	2012-10-12	Hum Mol Genet	www.ncbi.nlm.nih.gov/pubmed/23065704	A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.	Prostate cancer	5,132 European ancestry non-aggressive cases, 5,953 European ancestry aggressive cases, 11,463 European ancestry controls	22,387 European ancestry non-aggressive cases, 2,008 European ancestry aggressive cases, up to 24,726 European ancestry controls	22q13.1	22	40040969	TNRC6B	FAM83F			ENSG00000133477			rs11704416-C	rs11704416	0	11704416	3_prime_UTR_variant	0	NR	4E-7	6.3979400086720375	(All)	1.06	[1.02-1.10]	Illumina [~ 2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001714	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q22	1	155212052	MTX1	MTX1, AC234582.2			ENSG00000173171, ENSG00000236263			rs2974935-T	rs2974935	0	2974935	non_coding_transcript_exon_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q22	1	155216951	GBAP1	GBAP1			ENSG00000160766			rs1057941-A	rs1057941	0	1057941	non_coding_transcript_exon_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q32.2	1	210816167	KCNH1	KCNH1			ENSG00000143473			rs11119608-T	rs11119608	0	11119608	intron_variant	0	NR	1E-7	7.0		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	3q26.2	3	169043635	Intergenic	LINC01997 - MECOM	ENSG00000241383	ENSG00000085276		38169	39864	rs75316749-G	rs75316749	0	75316749	intergenic_variant	1	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p22.1	6	30374976	Intergenic	UBQLN1P1 - MICC	ENSG00000236122	ENSG00000229651		10696	39739	rs115707823-A	rs115707823	1	3129817	intergenic_variant	1	NR	2E-6	5.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.33	6	31347004	HLA-C	HLA-B, HLA-B, HLA-B			ENSG00000228964, ENSG00000234745, ENSG00000206450			rs115392158-G	rs115392158	1	2507997	intron_variant	0	NR	9E-6	5.045757490560675		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.32	6	32699696	Intergenic	HLA-DQB1 - MTCO3P1	ENSG00000231286	ENSG00000237145		31313	6428	rs147527678-C	rs147527678	1	1794514	intergenic_variant	1	NR	5E-7	6.301029995663981		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6q14.1	6	80398959	Intergenic	RPL17P25 - AL359715.4	ENSG00000219547	ENSG00000279022		24390	41771	rs4604234-C	rs4604234	0	4604234	intergenic_variant	1	NR	6E-6	5.221848749616356		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	9p21.3	9	21951903	Intergenic	AL359922.1			ENSG00000264545			rs12349081-A	rs12349081	0	12349081	intron_variant	0	NR	6E-6	5.221848749616356		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	9p21.3	9	22062135	CDKN2B, AS1	CDKN2B-AS1			ENSG00000240498			rs1011970-T	rs1011970	0	1011970	intron_variant	0	NR	2E-7	6.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q24.12	12	111446804	SH2B3	SH2B3, ATXN2			ENSG00000111252, ENSG00000204842			rs3184504-C	rs3184504	0	3184504	missense_variant	0	NR	2E-6	5.698970004336019		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32398489	BRCA2	BRCA2			ENSG00000139618			rs11571833-T	rs11571833	0	11571833	stop_gained	0	NR	8E-12	11.096910013008056		1.6	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	17q12	17	37741642	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs12601991-T	rs12601991	0	12601991	intron_variant	0	NR	1E-9	9.0		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	19p13.11	19	17279482	BABAM1	USHBP1, BABAM1, AC010463.1			ENSG00000130307, ENSG00000105393, ENSG00000269307			rs4808075-C	rs4808075	0	4808075	intron_variant	0	NR	4E-7	6.3979400086720375		1.1	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34131991	Intergenic	RPS2P1 - ASIP	ENSG00000225246	ENSG00000101440		8701	62578	rs11907546-C	rs11907546	0	11907546	intergenic_variant	1	NR	3E-9	8.522878745280337		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32265853	FRY	FRY			ENSG00000073910			rs56404467-A	rs56404467	0	56404467	intron_variant	0	NR	1E-7	7.0		1.2	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34002002	RALY	RALY			ENSG00000125970			rs2300206-G	rs2300206	0	2300206	intron_variant	0	NR	2E-8	7.698970004336019		1.1111112	[NR]	Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003587	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1p36.33	1	1351675	Intergenic	DVL1 - MXRA8	ENSG00000107404	ENSG00000162576		2325	1014	rs186507655-A	rs186507655	0	186507655	regulatory_region_variant	1	NR	5E-10	9.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	1q22	1	155212373	MTX1	MTX1, AC234582.2			ENSG00000173171, ENSG00000236263			rs2075570-T	rs2075570	0	2075570	intron_variant	0	NR	5E-6	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	3p24.1	3	27285723	NEK10	NEK10			ENSG00000163491			rs481519-T	rs481519	0	481519	intron_variant	0	NR	2E-9	8.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	4q24	4	105140377	Intergenic	AC004069.1			ENSG00000251259			rs7679673-A	rs7679673	0	7679673	intron_variant	0	NR	1E-10	10.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	5p15.33	5	1282299	TERT	TERT			ENSG00000164362			rs7725218-A	rs7725218	0	7725218	intron_variant	0	NR	2E-10	9.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	5q11.2	5	56737113	Intergenic	C5orf67 - AC008940.1	ENSG00000225940	ENSG00000228650		130881	33686	rs1862626-T	rs1862626	0	1862626	intergenic_variant	1	NR	4E-12	11.397940008672037	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p22.1	6	29785031	Intergenic	AL645939.3 - HLA-V	ENSG00000270896	ENSG00000206507		21639	5923	rs147680653-G	rs147680653	1	9258375	regulatory_region_variant	1	NR	1E-6	6.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p22.1	6	30374976	Intergenic	UBQLN1P1 - MICC	ENSG00000236122	ENSG00000229651		10696	39739	rs115707823-A	rs115707823	1	3129817	intergenic_variant	1	NR	5E-7	6.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.33	6	31347004	HLA-C	HLA-B, HLA-B, HLA-B			ENSG00000228964, ENSG00000234745, ENSG00000206450			rs115392158-G	rs115392158	1	2507997	intron_variant	0	NR	3E-7	6.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	6p21.32	6	32699696	Intergenic	HLA-DQB1 - MTCO3P1	ENSG00000231286	ENSG00000237145		31313	6428	rs147527678-C	rs147527678	1	1794514	intergenic_variant	1	NR	6E-8	7.221848749616356	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	9p21.3	9	22062135	CDKN2B, AS1	CDKN2B-AS1			ENSG00000240498			rs1011970-T	rs1011970	0	1011970	intron_variant	0	NR	5E-6	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	10q26.13	10	121575416	FGFR2	FGFR2			ENSG00000066468			rs11200014-A	rs11200014	0	11200014	intron_variant	0	NR	8E-35	34.096910013008056	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	11q13.3	11	69227030	Intergenic	AP003071.2 - MYEOV	ENSG00000261070	ENSG00000172927		55466	67108	rs7931342-G	rs7931342	0	7931342	intergenic_variant	1	NR	4E-14	13.397940008672037	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	11q22.3	11	103813371	Intergenic	AP002989.1			ENSG00000254987			rs148883465-G	rs148883465	0	148883465	intron_variant	0	NR	3E-8	7.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q13.12	12	49251457	TUBA1C	AC010173.1, TUBA1C			ENSG00000258101, ENSG00000167553			rs11168936-C	rs11168936	0	11168936	intron_variant	0	NR	9E-7	6.045757490560675	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q13.13	12	52918828	KRT8	KRT8			ENSG00000170421			rs73110464-T	rs73110464	0	73110464	intron_variant	0	NR	2E-15	14.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q24.12	12	111446804	SH2B3	SH2B3, ATXN2			ENSG00000111252, ENSG00000204842			rs3184504-C	rs3184504	0	3184504	missense_variant	0	NR	1E-6	6.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, squamous cell lung carcinoma, lung adenocarcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000708, http://www.ebi.ac.uk/efo/EFO_0000571	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32394673	BRCA2	BRCA2			ENSG00000139618			rs11571818-C	rs11571818	0	11571818	intron_variant	0	NR	5E-10	9.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	14q24.1	14	68559662	RAD51B	RAD51B			ENSG00000182185			rs11844632-A	rs11844632	0	11844632	intron_variant	0	NR	3E-10	9.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	17q12	17	37741642	HNF1B	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs12601991-T	rs12601991	0	12601991	intron_variant	0	NR	7E-28	27.154901959985743	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	19p13.11	19	17279482	BABAM1	USHBP1, BABAM1, AC010463.1			ENSG00000130307, ENSG00000105393, ENSG00000269307			rs4808075-C	rs4808075	0	4808075	intron_variant	0	NR	2E-9	8.698970004336019	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34131991	Intergenic	RPS2P1 - ASIP	ENSG00000225246	ENSG00000101440		8701	62578	rs11907546-T	rs11907546	0	11907546	intergenic_variant	1	NR	3E-6	5.522878745280337	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	11q22.3	11	103745837	Intergenic	AP002989.1			ENSG00000254987			rs141752671-G	rs141752671	0	141752671	intron_variant	0	NR	1E-7	7.0	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	12q24.12	12	111621753	Intergenic	ATXN2-AS - BRAP	ENSG00000258099	ENSG00000089234		21497	20393	rs11065979-T	rs11065979	0	11065979	intergenic_variant	1	NR	5E-6	5.301029995663981	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	20q11.22	20	34002002	RALY	RALY			ENSG00000125970			rs2300206-C	rs2300206	0	2300206	intron_variant	0	NR	6E-6	5.221848749616356	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2017-02-03	27197191	Fehringer G	2016-04-20	Cancer Res	www.ncbi.nlm.nih.gov/pubmed/27197191	Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.	Cancer (pleiotropy)	5,020 European ancestry lung cancer cases, 3,718 European ancestry lung adenocarcinoma cases, 3,422 European ancestry lung squamous cell carcinoma cases, 15,414 European ancestry colorectal cancer cases, 10,809 European ancestry breast cancer cases, 4,939 European ancestry estrogen receptor negative breast cancer cases, 1,098 European ancestry ovarian cancer cases, 2,556 European ancestry serous ovarian cancer cases, 715 European ancestry ovarian endometrioid carcinoma cases, 9,710 European ancestry prostate cancer cases, 4,450 European ancestry aggressive prostate cancer cases,  61,820 European ancestry controls	NA	13q13.1	13	32295727	FRY	FRY			ENSG00000073910			rs56084662-A	rs56084662	0	56084662	3_prime_UTR_variant	0	NR	4E-9	8.397940008672037	(subset analysis)			Affymetrix, Illumina [9916564] (imputed)	N	lung carcinoma, estrogen-receptor negative breast cancer, colorectal cancer, ovarian endometrioid carcinoma, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0001071, http://www.ebi.ac.uk/efo/EFO_1000650, http://www.ebi.ac.uk/efo/EFO_0005842, http://www.ebi.ac.uk/efo/EFO_1001515, http://www.ebi.ac.uk/efo/EFO_0001663, http://www.ebi.ac.uk/efo/EFO_1001516, http://www.ebi.ac.uk/efo/EFO_0000305, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0000571, http://www.ebi.ac.uk/efo/EFO_0000708	GCST003588	Genome-wide genotyping array
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	2p11.2	2	85567174	GGCX, VAMP8, VAMP5, RNF181	VAMP8			ENSG00000118640			rs10187424-A	rs10187424	0	10187424	intron_variant	0	0.59	3E-15	14.522878745280337		1.09	[1.06-1.12]	NR [2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001148	Genome-wide genotyping array
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	2q37.3	2	237478585	intergenic	AC112721.2 - MLPH	ENSG00000222032	ENSG00000115648		43763	6843	rs7584330-C	rs7584330	0	7584330	intergenic_variant	1	0.22	3E-9	8.522878745280337		1.06	[1.02-1.09]	NR [2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001148	Genome-wide genotyping array
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	3q23	3	141383991	ZBTB38	ZBTB38			ENSG00000177311			rs6763931-T	rs6763931	0	6763931	intron_variant	0	0.45	2E-8	7.698970004336019		1.04	[1.01-1.07]	NR [2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001148	Genome-wide genotyping array
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	3q26.2	3	170412314	CLDN11, SKIL	AC073288.2			ENSG00000242578			rs10936632-A	rs10936632	0	10936632	intron_variant	0	0.52	7E-22	21.154901959985743		1.11	[1.08-1.14]	NR [2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001148	Genome-wide genotyping array
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	5p15.33	5	1279913	TERT	TERT			ENSG00000164362			rs2242652-G	rs2242652	0	2242652	intron_variant	0	0.81	3E-24	23.522878745280337		1.15	[1.11-1.19]	NR [2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001148	Genome-wide genotyping array
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	5p12	5	44365443	FGF10	FGF10			ENSG00000070193			rs2121875-G	rs2121875	0	2121875	intron_variant	0	0.34	4E-8	7.3979400086720375		1.05	[1.02-1.08]	NR [2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001148	Genome-wide genotyping array
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	6p21.33	6	31150734	CCHCR1	CCHCR1, CCHCR1, CCHCR1, CCHCR1, CCHCR1			ENSG00000204536, ENSG00000206457, ENSG00000206355, ENSG00000224180, ENSG00000234114			rs130067-G	rs130067	0	130067	missense_variant	0	0.21	3E-8	7.522878745280337		1.05	[1.02-1.09]	NR [2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001148	Genome-wide genotyping array
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	12q13.12	12	49282227	PRPH	TUBA1C - AC125611.4	ENSG00000167553	ENSG00000258334		7624	10404	rs10875943-C	rs10875943	0	10875943	regulatory_region_variant	1	0.31	7E-12	11.154901959985743		1.07	[1.04-1.10]	NR [2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001148	Genome-wide genotyping array
2011-08-22	21743467	Kote-Jarai Z	2011-07-10	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/21743467	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	Prostate cancer	6,621 European ancestry cases, 6,939 European ancestry controls	22,957 European ancestry cases, 23,234 European ancestry controls, 420 East Asian ancestry cases, 433 East Asian ancestry controls, 112 African American cases, 298 African American controls, 7,140 cases, 5,455 controls	Xq12	X	67801708	AR	BMI1P1 - AL157700.1	ENSG00000234201	ENSG00000260118		8813	211762	rs5919432-A	rs5919432	0	5919432	intergenic_variant	1	0.81	1E-8	8.0		1.06	[1.02-1.12]	NR [2600000] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST001148	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	1q21.3	1	150685811	GOLPH3L	GOLPH3L			ENSG00000143457			rs17599629-G	rs17599629	0	17599629	intron_variant	0	0.22	3E-9	8.522878745280337		1.08	[1.06-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	2p25.1	2	10570604	NOL10	AC007249.1 - NOL10	ENSG00000217258	ENSG00000115761		115052	162	rs9287719-C	rs9287719	0	9287719	intergenic_variant	1	0.46	3E-8	7.522878745280337		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	4q13.3	4	72989536	COX18	RNU4ATAC9P - RNU6ATAC5P	ENSG00000252955	ENSG00000210839		24233	37212	rs10009409-T	rs10009409	0	10009409	intergenic_variant	1	0.32	2E-10	9.698970004336019		1.08	[1.05-1.10]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	6p24.2	6	11218797	NEDD9	NEDD9, AL139807.1			ENSG00000111859, ENSG00000247925			rs4713266-C	rs4713266	0	4713266	intron_variant	0	0.52	3E-9	8.522878745280337		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	6p22.1	6	30105999	TRIM31	TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1			ENSG00000226402, ENSG00000224542, ENSG00000223531, ENSG00000137397, ENSG00000224168, ENSG00000204616, ENSG00000233573, ENSG00000225130, ENSG00000238027, ENSG00000225038, ENSG00000225732, ENSG00000235722, ENSG00000231226, ENSG00000232510, ENSG00000237050, ENSG00000229223			rs115457135-A	rs115457135	1	7767188	intron_variant	0	0.22	1E-7	7.0		1.07	[1.05-1.10]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	6p21.32	6	32433162	HLA-DRB6	TSBP1-AS1 - HLA-DRA	ENSG00000225914	ENSG00000234794		25399	6680	rs115306967-G	rs115306967	1	3129859	intron_variant	1	0.65	9E-7	6.045757490560675		1.06	[1.05-1.10]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	7p12.3	7	47397647	TNS3	TNS3			ENSG00000136205			rs56232506-A	rs56232506	0	56232506	intron_variant	0	0.45	9E-9	8.045757490560675		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	9p21.3	9	22041999	CDKN2B-AS1	CDKN2B-AS1			ENSG00000240498			rs17694493-G	rs17694493	0	17694493	intron_variant	0	0.14	1E-6	6.0		1.08	[1.05-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	10q11.22	10	45587537	MARCH8	MARCH8			ENSG00000165406			rs76934034-T	rs76934034	0	76934034	intron_variant	0	0.91	1E-8	8.0		1.13	[1.09-1.17]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	11q23.2	11	113936459	HTR3B	HTR3B			ENSG00000149305			rs11214775-G	rs11214775	0	11214775	intron_variant	0	0.71	5E-8	7.301029995663981		1.07	[1.04-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	12q13.11	12	48025835	RP1-228P16.4	AC004801.4 - AC004801.6	ENSG00000257985	ENSG00000276814		366	13949	rs80130819-A	rs80130819	0	80130819	intergenic_variant	1	0.91	2E-9	8.698970004336019		1.14	[1.09-1.18]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	14q24.2	14	70625539	TTC9	AL357153.1, AL357153.3			ENSG00000245466, ENSG00000259115			rs8014671-G	rs8014671	0	8014671	intron_variant	0	0.59	3E-7	6.522878745280337		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	Xp11.22	X	52867918	XAGE3	XAGE3			ENSG00000171402			rs2807031-C	rs2807031	0	2807031	intron_variant	0	0.18	3E-11	10.522878745280337		1.07	[1.05-1.09]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	Xq13.1	X	70920000	SLC7A	TEX11 - SLC7A3	ENSG00000120498	ENSG00000165349		11269	5582	rs6625711-A	rs6625711	0	6625711	intergenic_variant	1	0.41	6E-7	6.221848749616356		1.04	[1.03-1.06]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	Xq13.1	X	71188133	NLGN3, BCYRN1	AL590764.1			ENSG00000228427			rs4844289-G	rs4844289	0	4844289	intron_variant	0	0.39	9E-8	7.045757490560675		1.04	[1.03-1.06]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	1q32.1	1	205788696	SLC41A1	AC119673.1 - SLC41A1	ENSG00000285521	ENSG00000133065		5073	397	rs1775148-C	rs1775148	0	1775148	intergenic_variant	1	0.27	4E-8	7.3979400086720375		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	6q14.1	6	75786165	MYO6	MYO6			ENSG00000196586			rs9443189-G	rs9443189	0	9443189	intron_variant	0	0.14	4E-8	7.3979400086720375		1.08	[1.05-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	14q23.1	14	60655808	SIX1	SIX1			ENSG00000126778			rs7153648-C	rs7153648	0	7153648	intron_variant	0	0.06	2E-9	8.698970004336019		1.11	[1.07-1.14]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	16q22.2	16	71657426	PHLPP2	PHLPP2, AC009097.1			ENSG00000040199, ENSG00000260185			rs12051443-A	rs12051443	0	12051443	intron_variant	0	0.34	3E-8	7.522878745280337		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	20q13.13	20	50911385	ADNP	ADNP			ENSG00000101126			rs12480328-T	rs12480328	0	12480328	intron_variant	0	0.93	5E-11	10.301029995663981		1.13	[1.10-1.17]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	21q22.3	21	41529494	TMPRSS2	TMPRSS2			ENSG00000184012			rs1041449-G	rs1041449	0	1041449	intron_variant	0	0.44	3E-8	7.522878745280337		1.06	[1.04-1.08]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2015-05-07	25217961	Al Olama AA	2014-09-14	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/25217961	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	Prostate cancer	34,379 European ancestry cases, 33,164 European ancestry controls, 5,327 African ancestry cases, 5,136 African ancestry controls, 2,563 Japanese ancestry cases, 4,391 Japanese ancestry controls, 1,034 Latino cases, 1,046 Latino controls	NA	22q11.21	22	19770369	TBX1	TBX1			ENSG00000184058			rs2238776-G	rs2238776	0	2238776	intron_variant	0	0.8	2E-8	7.698970004336019		1.08	[1.05-1.11]	Affymetrix, Illumina [up to 16852405] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST002606	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls	NA	12p13.1	12	14263984	RNU6-491P	GNAI2P1 - RPL30P11	ENSG00000255749	ENSG00000244573		8758	92858	rs10845938-G	rs10845938	0	10845938	intergenic_variant	1	1.11	7E-8	7.154901959985743		1.11	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006089	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls	NA	19p13.11	19	17103263	MYO9B	MYO9B			ENSG00000099331			rs11666569-C	rs11666569	0	11666569	non_coding_transcript_exon_variant	0	1.11	3E-6	5.522878745280337		1.11	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006089	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls	NA	9p22.1	9	19055967	HAUS6	HAUS6			ENSG00000147874			rs1048169-C	rs1048169	0	1048169	3_prime_UTR_variant	0	1.1	8E-7	6.096910013008056		1.1	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006089	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls	NA	20q13.2	20	53838666	BCAS1	AC006076.1 - SUMO1P1	ENSG00000225563	ENSG00000241721		37348	36586	rs6091758-G	rs6091758	0	6091758	intergenic_variant	1	1.1	6E-6	5.221848749616356		1.1	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006089	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls	NA	16q23.3	16	82145289	RP11-510J16.5	AC092142.1 - MPHOSPH6	ENSG00000261235	ENSG00000135698		5658	2509	rs201158093-TAA	rs201158093	0	201158093	intergenic_variant	1	1.11	6E-7	6.221848749616356		1.11	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006089	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls	NA	9q34.11	9	129813781	TOR1A	TOR1A			ENSG00000136827			rs1182-A	rs1182	0	1182	3_prime_UTR_variant	0	1.13	1E-7	7.0		1.13	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006089	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls	NA	12q24.33	12	132491403	FBRSL1	FBRSL1			ENSG00000112787			rs7295014-G	rs7295014	0	7295014	intron_variant	0	1.12	6E-8	7.221848749616356		1.12	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006089	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls	NA	10p15.3	10	808752	LARP4B	LARP4B			ENSG00000107929			rs141536087-GCGCA	rs141536087	0	141536087	3_prime_UTR_variant	0	NR	5E-6	5.301029995663981		1.09	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006083	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls	NA	7p22.3	7	1904901	MAD1L1	MAD1L1			ENSG00000002822			rs527510716-C	rs527510716	0	527510716	intron_variant	0	NR	3E-7	6.522878745280337		1.1	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006083	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls	NA	11p15.4	11	7526356	PPFIBP2	PPFIBP2			ENSG00000166387			rs61890184-A	rs61890184	0	61890184	intron_variant	0	NR	1E-7	7.0		1.11	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006083	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls	NA	Xp22.2	X	11464514	ARHGAP6	ARHGAP6			ENSG00000047648			rs17321482-C	rs17321482	0	17321482	intron_variant	0	NR	1E-8	8.0		1.1	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006083	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls	NA	12p13.1	12	14263984	RNU6-491P	GNAI2P1 - RPL30P11	ENSG00000255749	ENSG00000244573		8758	92858	rs10845938-G	rs10845938	0	10845938	intergenic_variant	1	NR	9E-7	6.045757490560675		1.07	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006083	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls	NA	6p21.31	6	34825347	UHRF1BP1	UHRF1BP1			ENSG00000065060			rs9469899-A	rs9469899	0	9469899	intron_variant	0	NR	2E-6	5.698970004336019		1.07	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006083	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls	NA	19q13.2	19	42196795	POU2F2	POU2F2 - DEDD2	ENSG00000028277	ENSG00000160570		210	1803	rs61088131-T	rs61088131	0	61088131	intergenic_variant	1	NR	4E-6	5.3979400086720375		1.09	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006083	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls	NA	20q13.2	20	53838666	BCAS1	AC006076.1 - SUMO1P1	ENSG00000225563	ENSG00000241721		37348	36586	rs6091758-G	rs6091758	0	6091758	intergenic_variant	1	NR	2E-7	6.698970004336019		1.08	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006083	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls	NA	18q21.2	18	55563628	TCF4	TCF4			ENSG00000196628			rs28607662-C	rs28607662	0	28607662	intron_variant	0	NR	5E-6	5.301029995663981		1.11	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006083	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls	NA	16q21	16	57620664	GPR56	ADGRG1			ENSG00000205336			rs11863709-C	rs11863709	0	11863709	intron_variant	0	NR	7E-7	6.154901959985743		1.21	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006083	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls	NA	12q21.33	12	89766754	RNU6-148P	AC084200.1	ENSG00000252823			12602		rs5799921-GA	rs5799921	0	5799921	regulatory_region_variant	0	NR	1E-6	6.0		1.08	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006083	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls	NA	2q13	2	111135519	BCL2L11	BCL2L11, MIR4435-2HG			ENSG00000153094, ENSG00000172965			rs11691517-T	rs11691517	0	11691517	intron_variant	0	NR	7E-7	6.154901959985743		1.08	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006083	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls	NA	9q34.11	9	129813781	TOR1A	TOR1A			ENSG00000136827			rs1182-A	rs1182	0	1182	3_prime_UTR_variant	0	NR	1E-7	7.0		1.09	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006083	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls	NA	5q31.1	5	134500518	RNU6-456P	RNU6-456P - LINC01843	ENSG00000207222	ENSG00000251169		234	6034	rs10793821-T	rs10793821	0	10793821	intergenic_variant	1	NR	9E-7	6.045757490560675		1.07	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006083	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls	NA	1q21.3	1	153927425	DENND4B	AL358472.5			ENSG00000284738			rs34579442-C	rs34579442	0	34579442	intron_variant	0	NR	8E-7	6.096910013008056		1.08	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006083	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls	NA	16q21	16	57619621	intergenic	ADGRG1			ENSG00000205336			rs11859370-T	rs11859370	0	11859370	intron_variant	0	NR	2E-8	7.698970004336019		1.21	[1.13-1.29]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006083	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls	NA	Xp22.2	X	11321091	intergenic	ARHGAP6			ENSG00000047648			rs2788524-G	rs2788524	0	2788524	intron_variant	0	NR	4E-10	9.397940008672037		1.1	[1.07-1.13]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006083	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (advanced)	15,167 European ancestry cases, 58,308 European ancestry controls	NA	2q13	2	111146954	intergenic	BCL2L11, MIR4435-2HG			ENSG00000153094, ENSG00000172965			rs56366063-C	rs56366063	0	56366063	intron_variant	0	NR	1E-8	8.0		1.14	[1.09-1.19]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006083	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls	NA	6q27	6	170160655	LOC154449	AL049612.1 - AL596442.1	ENSG00000236173	ENSG00000232197		350553	1862	rs138004030-G	rs138004030	0	138004030	regulatory_region_variant	1	0.91	3E-8	7.522878745280337		1.27	[1.17-1.38]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006089	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls	NA	12q24.33	12	132563775	Intergenic	FBRSL1			ENSG00000112787			rs111599055-C	rs111599055	0	111599055	intron_variant	0	0.69	1E-8	8.0		1.13	[1.08-1.18]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006089	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls	NA	6p22.3	6	19628196	Intergenic	AL022068.1			ENSG00000228412			rs77777548-G	rs77777548	0	77777548	intron_variant	0	0.02	3E-8	7.522878745280337		2.94	[2.01-4.29]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006089	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer (early onset)	6,988 European ancestry cases, 44,256 European ancestry controls	NA	10p15.3	10	808752	LARP4B	LARP4B			ENSG00000107929			rs141536087-GCGCA	rs141536087	0	141536087	3_prime_UTR_variant	0	1.13	4E-6	5.3979400086720375		1.13	[NR]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006089	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	Xq12	X	67801708	NR	BMI1P1 - AL157700.1	ENSG00000234201	ENSG00000260118		8813	211762	rs5919432-T	rs5919432	0	5919432	intergenic_variant	1	0.8	1E-9	9.0		1.04	[1.03-1.06]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	Xq13.1	X	71188133	NR	AL590764.1			ENSG00000228427			rs4844289-G	rs4844289	0	4844289	intron_variant	0	0.38	3E-12	11.522878745280337		1.04	[1.03-1.05]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	12q24.33	12	132563775	NR	FBRSL1			ENSG00000112787			rs111599055-C	rs111599055	0	111599055	intron_variant	0	0.69	8E-8	7.096910013008056		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	16q21	16	57619621	NR	ADGRG1			ENSG00000205336			rs11859370-T	rs11859370	0	11859370	intron_variant	0	0.95	2E-10	9.698970004336019		1.13	[1.09-1.17]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	Xp22.2	X	11321091	NR	ARHGAP6			ENSG00000047648			rs2788524-G	rs2788524	0	2788524	intron_variant	0	0.15	9E-11	10.045757490560675		1.06	[1.04-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	2q13	2	111146954	NR	BCL2L11, MIR4435-2HG			ENSG00000153094, ENSG00000172965			rs56366063-C	rs56366063	0	56366063	intron_variant	0	0.11	2E-8	7.698970004336019		1.08	[1.05-1.11]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	1q21.3	1	154861707	NR	KCNN3			ENSG00000143603			rs1218582-G	rs1218582	0	1218582	intron_variant	0	0.45	1E-8	8.0		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	12q13.13	12	52880120	NR	KRT78 - RPL7P41	ENSG00000170423	ENSG00000241146		31028	5309	rs902774-A	rs902774	0	902774	TF_binding_site_variant	1	0.15	2E-31	30.69897000433602		1.13	[1.11-1.16]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	14q24.1	14	68660027	NR	RAD51B			ENSG00000182185			rs7141529-C	rs7141529	0	7141529	intron_variant	0	0.5	2E-10	9.698970004336019		1.05	[1.04-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	17q12	17	37738049	NR	HNF1B, HNF1B			ENSG00000276194, ENSG00000275410			rs4430796-A	rs4430796	0	4430796	intron_variant	0	0.53	1E-132	132.0		1.22	[1.20-1.24]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	17q24.3	17	71112612	NR	CASC17			ENSG00000260785			rs1859962-G	rs1859962	0	1859962	intron_variant	0	0.48	1E-91	91.0		1.17	[1.16-1.19]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	19q13.2	19	41479679	NR	PCAT19			ENSG00000267107			rs11672691-G	rs11672691	0	11672691	intron_variant	0	0.74	2E-23	22.69897000433602		1.1	[1.08-1.12]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	20q13.33	20	63731211	NR	ZGPAT, AL121845.3			ENSG00000197114, ENSG00000273154			rs6062509-T	rs6062509	0	6062509	intron_variant	0	0.7	3E-18	17.522878745280337		1.08	[1.06-1.10]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	Xp22.2	X	9846095	NR	SHROOM2			ENSG00000146950			rs2405942-A	rs2405942	0	2405942	intron_variant	0	0.78	2E-12	11.698970004336019		1.05	[1.04-1.06]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	1p36.22	1	10496040	NR	PEX14			ENSG00000142655			rs636291-A	rs636291	0	636291	intron_variant	0	0.68	6E-7	6.221848749616356		1.04	[1.03-1.06]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	1q21.3	1	150685811	NR	GOLPH3L			ENSG00000143457			rs17599629-G	rs17599629	0	17599629	intron_variant	0	0.22	1E-11	11.0		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	1q32.1	1	204549714	NR	MDM4			ENSG00000198625			rs4245739-A	rs4245739	0	4245739	3_prime_UTR_variant	0	0.74	3E-24	23.522878745280337		1.1	[1.08-1.12]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	2p25.1	2	9977740	NR	GRHL1			ENSG00000134317			rs11902236-T	rs11902236	0	11902236	intron_variant	0	0.27	5E-7	6.301029995663981		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	2p25.1	2	10570604	NR	AC007249.1 - NOL10	ENSG00000217258	ENSG00000115761		115052	162	rs9287719-C	rs9287719	0	9287719	intergenic_variant	1	0.47	6E-17	16.221848749616356		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	2p24.1	2	20678393	NR	GDF7, AC012065.4			ENSG00000143869, ENSG00000270100			rs9306895-C	rs9306895	0	9306895	3_prime_UTR_variant	0	0.36	3E-21	20.522878745280337		1.08	[1.06-1.10]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	2p21	2	43326810	NR	THADA			ENSG00000115970			rs1465618-T	rs1465618	0	1465618	intron_variant	0	0.21	2E-18	17.69897000433602		1.09	[1.07-1.11]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	2p15	2	62904596	NR	EHBP1			ENSG00000115504			rs721048-A	rs721048	0	721048	intron_variant	0	0.18	5E-22	21.30102999566398		1.1	[1.08-1.12]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	2p11.2	2	85567174	NR	VAMP8			ENSG00000118640			rs10187424-T	rs10187424	0	10187424	intron_variant	0	0.57	1E-20	20.0		1.08	[1.06-1.09]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	2q31.1	2	172446825	NR	ITGA6			ENSG00000091409			rs12621278-A	rs12621278	0	12621278	intron_variant	0	0.94	2E-42	41.69897000433602		1.27	[1.23-1.32]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	2q37.3	2	237534583	NR	MLPH			ENSG00000115648			rs2292884-G	rs2292884	0	2292884	missense_variant	0	0.24	4E-11	10.397940008672037		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	2q37.3	2	241443449	NR	FARP2			ENSG00000006607			rs3771570-T	rs3771570	0	3771570	3_prime_UTR_variant	0	0.15	1E-14	14.0		1.09	[1.06-1.11]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	3p12.1	3	87061524	NR	PPATP1 - LINC00506	ENSG00000241293	ENSG00000281392		8786	27605	rs2660753-T	rs2660753	0	2660753	intergenic_variant	1	0.1	6E-21	20.221848749616356		1.13	[1.10-1.16]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	3q13.2	3	113556777	NR	SIDT1			ENSG00000072858			rs7611694-A	rs7611694	0	7611694	intron_variant	0	0.58	5E-25	24.30102999566398		1.09	[1.07-1.10]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	3q21.3	3	128319530	NR	EEFSEC			ENSG00000132394			rs10934853-A	rs10934853	0	10934853	intron_variant	0	0.28	1E-29	29.0		1.1	[1.09-1.12]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	3q23	3	141383991	NR	ZBTB38			ENSG00000177311			rs6763931-A	rs6763931	0	6763931	intron_variant	0	0.44	7E-8	7.154901959985743		1.04	[1.03-1.06]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	3q26.2	3	170412314	NR	AC073288.2			ENSG00000242578			rs10936632-A	rs10936632	0	10936632	intron_variant	0	0.51	3E-34	33.52287874528034		1.1	[1.08-1.12]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	4q13.3	4	72989536	NR	RNU4ATAC9P - RNU6ATAC5P	ENSG00000252955	ENSG00000210839		24233	37212	rs10009409-T	rs10009409	0	10009409	intergenic_variant	1	0.31	4E-10	9.397940008672037		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	4q13.3	4	73483441	NR	AFM			ENSG00000079557			rs1894292-G	rs1894292	0	1894292	intron_variant	0	0.52	5E-15	14.301029995663981		1.06	[1.05-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	4q22.3	4	94641726	NR	PDLIM5			ENSG00000163110			rs17021918-C	rs17021918	0	17021918	intron_variant	0	0.65	1E-24	24.0		1.09	[1.07-1.11]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	4q24	4	105140377	NR	AC004069.1			ENSG00000251259			rs7679673-C	rs7679673	0	7679673	intron_variant	0	0.59	1E-49	49.0		1.13	[1.11-1.15]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	5p15.33	5	1279913	NR	TERT			ENSG00000164362			rs2242652-G	rs2242652	0	2242652	intron_variant	0	0.79	4E-52	51.39794000867204		1.17	[1.15-1.20]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	5p12	5	44365443	NR	FGF10			ENSG00000070193			rs2121875-C	rs2121875	0	2121875	intron_variant	0	0.33	1E-8	8.0		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	6p24.2	6	11218797	NR	NEDD9, AL139807.1			ENSG00000111859, ENSG00000247925			rs4713266-C	rs4713266	0	4713266	intron_variant	0	0.52	1E-10	10.0		1.05	[1.04-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	6p22.1	6	30105999	NR	TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1, TRIM31-AS1			ENSG00000226402, ENSG00000224542, ENSG00000223531, ENSG00000137397, ENSG00000224168, ENSG00000204616, ENSG00000233573, ENSG00000225130, ENSG00000238027, ENSG00000225038, ENSG00000225732, ENSG00000235722, ENSG00000231226, ENSG00000232510, ENSG00000237050, ENSG00000229223			rs7767188-A	rs7767188	0	7767188	intron_variant	0	0.21	2E-8	7.698970004336019		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	6p21.33	6	31150734	NR	CCHCR1, CCHCR1, CCHCR1, CCHCR1, CCHCR1			ENSG00000204536, ENSG00000206457, ENSG00000206355, ENSG00000224180, ENSG00000234114			rs130067-G	rs130067	0	130067	missense_variant	0	0.2	2E-7	6.698970004336019		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	6p21.32	6	32224554	NR	NOTCH4 - TSBP1-AS1	ENSG00000238196	ENSG00000225914		487	30086	rs3096702-A	rs3096702	0	3096702	intergenic_variant	1	0.38	1E-11	11.0		1.06	[1.04-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	6p21.32	6	32433162	NR	TSBP1-AS1 - HLA-DRA	ENSG00000225914	ENSG00000234794		25399	6680	rs3129859-G	rs3129859	0	3129859	intron_variant	1	0.67	1E-12	12.0		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	6q21	6	108963986	NR	ARMC2			ENSG00000118690			rs2273669-G	rs2273669	0	2273669	intron_variant	0	0.15	3E-10	9.522878745280337		1.07	[1.05-1.10]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	6q25.2	6	153119944	NR	RGS17			ENSG00000091844			rs1933488-A	rs1933488	0	1933488	intron_variant	0	0.58	4E-21	20.397940008672037		1.08	[1.06-1.10]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	6q25.3	6	160412632	NR	SLC22A3			ENSG00000146477			rs9364554-T	rs9364554	0	9364554	intron_variant	0	0.28	5E-33	32.30102999566398		1.11	[1.09-1.13]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	7p15.3	7	20954872	NR	LINC01162			ENSG00000232790			rs12155172-A	rs12155172	0	12155172	intron_variant	0	0.22	9E-23	22.045757490560675		1.1	[1.08-1.12]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	7p15.1	7	27936944	NR	JAZF1			ENSG00000153814			rs10486567-G	rs10486567	0	10486567	intron_variant	0	0.76	2E-45	44.69897000433602		1.14	[1.12-1.16]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	7p12.3	7	47397647	NR	TNS3			ENSG00000136205			rs56232506-A	rs56232506	0	56232506	intron_variant	0	0.45	1E-11	11.0		1.06	[1.04-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	7q21.3	7	98187015	NR	LMTK2			ENSG00000164715			rs6465657-C	rs6465657	0	6465657	intron_variant	0	0.46	7E-37	36.15490195998574		1.11	[1.09-1.12]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	8p21.2	8	23581462	NR	SLC25A37 - RNU4-71P	ENSG00000147454	ENSG00000252067		5999	18564	rs2928679-A	rs2928679	0	2928679	intergenic_variant	1	0.44	2E-11	10.698970004336019		1.05	[1.04-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	8p21.2	8	26034626	NR	EBF2			ENSG00000221818			rs11135910-T	rs11135910	0	11135910	intron_variant	0	0.15	9E-13	12.045757490560675		1.08	[1.06-1.10]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	8q24.21	8	127091872	NR	PCAT1, CASC19, PRNCR1			ENSG00000253438, ENSG00000254166, ENSG00000282961			rs183373024-G	rs183373024	0	183373024	non_coding_transcript_exon_variant	0	0.01	4E-160	159.39794000867204		2.91	[2.69-3.14]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	8q24.21	8	127472793	NR	CASC8			ENSG00000246228			rs1447295-A	rs1447295	0	1447295	intron_variant	0	0.11	1E-179	179.0		1.41	[1.38-1.45]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	9p21.3	9	22041999	NR	CDKN2B-AS1			ENSG00000240498			rs17694493-G	rs17694493	0	17694493	intron_variant	0	0.14	2E-10	9.698970004336019		1.08	[1.05-1.10]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	10q11.22	10	45587537	NR	MARCH8			ENSG00000165406			rs76934034-T	rs76934034	0	76934034	intron_variant	0	0.92	2E-14	13.698970004336019		1.12	[1.09-1.16]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	10q11.22	10	46046326	NR	MSMB - RPL23AP61	ENSG00000263639	ENSG00000280012		57	16924	rs10993994-T	rs10993994	0	10993994	intergenic_variant	1	0.38	2E-147	146.69897000433602		1.23	[1.21-1.25]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	10q24.32	10	102654464	NR	TRIM8			ENSG00000171206			rs3850699-A	rs3850699	0	3850699	non_coding_transcript_exon_variant	0	0.7	6E-16	15.221848749616356		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	10q26.13	10	125008303	NR	CTBP2			ENSG00000175029			rs4962416-C	rs4962416	0	4962416	intron_variant	0	0.27	2E-11	10.698970004336019		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	11p15.5	11	2212344	NR	MIR4686 - ASCL2	ENSG00000265258	ENSG00000183734		39206	56151	rs7127900-A	rs7127900	0	7127900	intergenic_variant	1	0.2	5E-68	67.30102999566398		1.19	[1.16-1.21]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	11q13.3	11	69227030	NR	AP003071.2 - MYEOV	ENSG00000261070	ENSG00000172927		55466	67108	rs7931342-G	rs7931342	0	7931342	intergenic_variant	1	0.5	1E-86	86.0		1.17	[1.15-1.19]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	11q22.2	11	102530930	NR	MMP7 - MMP20	ENSG00000137673	ENSG00000137674		177	45905	rs11568818-T	rs11568818	0	11568818	regulatory_region_variant	1	0.55	2E-19	18.69897000433602		1.08	[1.06-1.09]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	11q23.2	11	113936459	NR	HTR3B			ENSG00000149305			rs11214775-G	rs11214775	0	11214775	intron_variant	0	0.71	4E-15	14.397940008672037		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	12q13.11	12	48025835	NR	AC004801.4 - AC004801.6	ENSG00000257985	ENSG00000276814		366	13949	rs80130819-A	rs80130819	0	80130819	intergenic_variant	1	0.91	2E-11	10.698970004336019		1.1	[1.07-1.13]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	12q13.12	12	49282227	NR	TUBA1C - AC125611.4	ENSG00000167553	ENSG00000258334		7624	10404	rs10875943-C	rs10875943	0	10875943	regulatory_region_variant	1	0.29	2E-15	14.698970004336019		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	12q24.21	12	114247766	NR	LINC02459 - TBX5	ENSG00000257476	ENSG00000089225		5996	106165	rs1270884-A	rs1270884	0	1270884	intergenic_variant	1	0.48	1E-18	18.0		1.07	[1.06-1.09]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	14q22.1	14	52905612	NR	AL139317.5, FERMT2			ENSG00000285664, ENSG00000073712			rs8008270-C	rs8008270	0	8008270	intron_variant	0	0.81	6E-16	15.221848749616356		1.09	[1.07-1.11]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	14q24.2	14	70625539	NR	AL357153.1, AL357153.3			ENSG00000245466, ENSG00000259115			rs8014671-G	rs8014671	0	8014671	intron_variant	0	0.58	2E-8	7.698970004336019		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	17p13.3	17	715725	NR	VPS53			ENSG00000141252			rs684232-C	rs684232	0	684232	intron_variant	0	0.35	4E-24	23.397940008672037		1.09	[1.07-1.10]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	17q21.32	17	48728343	NR	HOXB13			ENSG00000159184			rs138213197-T	rs138213197	0	138213197	missense_variant	0	0.002	9E-63	62.045757490560675		3.85	[3.29-4.51]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	17q21.32	17	49267824	NR	FLJ40194 - MIR6129	ENSG00000177369	ENSG00000273500		9162	20522	rs11650494-A	rs11650494	0	11650494	intergenic_variant	1	0.08	9E-12	11.045757490560675		1.1	[1.07-1.14]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	18q23	18	79013973	NR	SALL3 - ATP9B	ENSG00000256463	ENSG00000166377		11296	55312	rs7241993-C	rs7241993	0	7241993	intergenic_variant	1	0.69	2E-18	17.69897000433602		1.08	[1.06-1.10]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	19q13.2	19	38244973	NR	SPINT2			ENSG00000167642			rs8102476-C	rs8102476	0	8102476	intron_variant	0	0.54	9E-30	29.045757490560675		1.09	[1.08-1.11]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	19q13.33	19	50861367	NR	KLK3 - KLK2	ENSG00000142515	ENSG00000167751		603	201	rs2735839-G	rs2735839	0	2735839	intergenic_variant	1	0.85	3E-47	46.52287874528034		1.18	[1.15-1.21]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	20q13.33	20	62440555	NR	AL121832.1			ENSG00000233017			rs2427345-C	rs2427345	0	2427345	intron_variant	0	0.62	3E-8	7.522878745280337		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	22q13.1	22	40075184	NR	TNRC6B			ENSG00000100354			rs58133635-T	rs58133635	0	58133635	intron_variant	0	0.2	5E-12	11.301029995663981		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	22q13.2	22	43104206	NR	AL022237.1 - BIK	ENSG00000234735	ENSG00000100290		11682	6542	rs5759167-G	rs5759167	0	5759167	TF_binding_site_variant	1	0.5	6E-71	70.22184874961636		1.15	[1.14-1.17]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	Xp11.22	X	51498820	NR	NUDT11 - LINC01496	ENSG00000196368	ENSG00000234766		2224	3270	rs5945619-C	rs5945619	0	5945619	intergenic_variant	1	0.36	1E-73	73.0		1.11	[1.10-1.12]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	Xp11.22	X	52867918	NR	XAGE3			ENSG00000171402			rs2807031-C	rs2807031	0	2807031	intron_variant	0	0.18	8E-16	15.096910013008056		1.06	[1.04-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	1p22.3	1	87745033	RP11-60A14.1	PKN2-AS1			ENSG00000237505			rs56391074-AT	rs56391074	0	56391074	intron_variant	0	0.38	2E-8	7.698970004336019		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	1q21.3	1	153927425	DENND4B	AL358472.5			ENSG00000284738			rs34579442-C	rs34579442	0	34579442	intron_variant	0	0.34	5E-14	13.301029995663981		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	2p25.1	2	8456993	AC011747.3	LINC00299 - AC092617.1	ENSG00000236790	ENSG00000285591		73372	31427	rs62106670-T	rs62106670	0	62106670	intergenic_variant	1	0.38	7E-9	8.154901959985743		1.05	[1.04-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	2p14	2	66425753	MEIS1-AS3	LINC01873 - MEIS1-AS3	ENSG00000232164	ENSG00000226819		33303	982	rs74702681-T	rs74702681	0	74702681	regulatory_region_variant	1	0.02	2E-9	8.698970004336019		1.17	[1.11-1.23]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	2q13	2	111135519	BCL2L11	BCL2L11, MIR4435-2HG			ENSG00000153094, ENSG00000172965			rs11691517-T	rs11691517	0	11691517	intron_variant	0	0.74	4E-12	11.397940008672037		1.07	[1.05-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	2q31.1	2	173369819	CDCA7	CDCA7 - AC073465.1	ENSG00000144354	ENSG00000213148		822	61530	rs34925593-C	rs34925593	0	34925593	intergenic_variant	1	0.48	3E-8	7.522878745280337		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	2q33.1	2	201258757	CASP8	CASP8			ENSG00000064012			rs59308963-T	rs59308963	0	59308963	intron_variant	0	0.73	2E-8	7.698970004336019		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	3q13.12	3	107243674	DUBR	DUBR			ENSG00000243701			rs1283104-G	rs1283104	0	1283104	intron_variant	0	0.38	9E-9	8.045757490560675		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	3q25.1	3	152286413	MBNL1	MBNL1			ENSG00000152601			rs182314334-T	rs182314334	0	182314334	intron_variant	0	0.9	4E-11	10.397940008672037		1.09	[1.06-1.12]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	3q26.2	3	169375312	MECOM	MECOM			ENSG00000085276			rs142436749-G	rs142436749	0	142436749	intron_variant	0	0.01	5E-9	8.301029995663981		1.25	[1.16-1.34]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	5q31.1	5	134500518	RNU6-456P	RNU6-456P - LINC01843	ENSG00000207222	ENSG00000251169		234	6034	rs10793821-T	rs10793821	0	10793821	intergenic_variant	1	0.57	5E-11	10.301029995663981		1.05	[1.04-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	5q35.3	5	178541914	COL23A1	COL23A1			ENSG00000050767			rs4976790-T	rs4976790	0	4976790	intron_variant	0	0.11	7E-9	8.154901959985743		1.08	[1.05-1.10]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	6p21.33	6	30633455	ATAT1	ATAT1, ATAT1, ATAT1, ATAT1, ATAT1, ATAT1, ATAT1			ENSG00000223752, ENSG00000234549, ENSG00000229061, ENSG00000235658, ENSG00000231257, ENSG00000206488, ENSG00000137343			rs12665339-G	rs12665339	0	12665339	intron_variant	0	0.17	6E-9	8.221848749616356		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	6p21.32	6	33020918	HLA-DOA	HLA-DOA - HLA-DPA1	ENSG00000230141	ENSG00000236177		11306	43651	rs9296068-T	rs9296068	0	9296068	intergenic_variant	1	0.65	1E-8	8.0		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	6p21.31	6	34825347	UHRF1BP1	UHRF1BP1			ENSG00000065060			rs9469899-A	rs9469899	0	9469899	intron_variant	0	0.36	5E-9	8.301029995663981		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	6p21.1	6	43726861	RP1-261G23.5	AL136131.2			ENSG00000236961			rs4711748-T	rs4711748	0	4711748	intron_variant	0	0.23	3E-8	7.522878745280337		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	7p22.3	7	1904901	MAD1L1	MAD1L1			ENSG00000002822			rs527510716-C	rs527510716	0	527510716	intron_variant	0	0.24	5E-8	7.301029995663981		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	7p21.1	7	20374488	ITGB8	ITGB8			ENSG00000105855			rs11452686-T	rs11452686	0	11452686	intron_variant	0	0.56	8E-9	8.096910013008056		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	7p14.1	7	40835593	SUGCT	SUGCT			ENSG00000175600			rs17621345-A	rs17621345	0	17621345	intron_variant	0	0.74	7E-14	13.154901959985743		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	9p22.1	9	19055967	HAUS6	HAUS6			ENSG00000147874			rs1048169-C	rs1048169	0	1048169	3_prime_UTR_variant	0	0.38	7E-14	13.154901959985743		1.06	[1.05-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	9p13.3	9	34049781	RN7SKP114	UBAP2 - RN7SKP114	ENSG00000137073	ENSG00000222259		832	185	rs10122495-T	rs10122495	0	10122495	regulatory_region_variant	1	0.31	1E-8	8.0		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	9q34.11	9	129813781	TOR1A	TOR1A			ENSG00000136827			rs1182-A	rs1182	0	1182	3_prime_UTR_variant	0	0.22	1E-9	9.0		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	10p15.3	10	808752	LARP4B	LARP4B			ENSG00000107929			rs141536087-GCGCA	rs141536087	0	141536087	3_prime_UTR_variant	0	0.15	9E-13	12.045757490560675		1.08	[1.06-1.11]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	10q23.31	10	88435392	RNLS	RNLS			ENSG00000184719			rs1935581-C	rs1935581	0	1935581	intron_variant	0	0.63	7E-9	8.154901959985743		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	10q25.2	10	112952395	TCF7L2	TCF7L2			ENSG00000148737			rs7094871-G	rs7094871	0	7094871	intron_variant	0	0.54	5E-8	7.301029995663981		1.04	[1.03-1.06]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	11p15.5	11	1486282	MOB2	MOB2			ENSG00000182208			rs1881502-T	rs1881502	0	1881502	intron_variant	0	0.19	7E-9	8.154901959985743		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA				PPFIBP2							rs61890184-A	rs61890184d	0	61890184d		1	0.12	7E-9	8.154901959985743		1.07	[1.05-1.10]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	11p11.2	11	47400412	RP11-750H9.5	AC090559.1			ENSG00000255197			rs547171081-CGG	rs547171081	0	547171081	intron_variant	0	0.47	3E-8	7.522878745280337		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	11q12.3	11	62140968	INCENP	INCENP			ENSG00000149503			rs2277283-C	rs2277283	0	2277283	missense_variant	0	0.31	3E-10	9.522878745280337		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	11q13.2	11	67184494	KDM2A	KDM2A			ENSG00000173120			rs12785905-C	rs12785905	0	12785905	intron_variant	0	0.05	8E-9	8.096910013008056		1.12	[1.08-1.17]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	11q13.5	11	76549500	C11orf30	EMSY			ENSG00000158636			rs11290954-AC	rs11290954	0	11290954	intron_variant	0	0.68	7E-13	12.154901959985743		1.06	[1.05-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	11q22.3	11	108272729	ATM	ATM			ENSG00000149311			rs1800057-G	rs1800057	0	1800057	missense_variant	0	0.02	8E-9	8.096910013008056		1.16	[1.10-1.22]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	11q24.2	11	125184897	PKNOX2	PKNOX2			ENSG00000165495			rs138466039-T	rs138466039	0	138466039	intron_variant	0	0.01	2E-11	10.698970004336019		1.32	[1.22-1.44]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	11q25	11	134396478	B3GAT1	B3GAT1			ENSG00000109956			rs878987-G	rs878987	0	878987	intron_variant	0	0.15	5E-8	7.301029995663981		1.07	[1.04-1.09]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	12p13.1	12	12718165	CDKN1B	CDKN1B			ENSG00000111276			rs2066827-T	rs2066827	0	2066827	missense_variant	0	0.76	2E-9	8.698970004336019		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	12p13.1	12	14263984	RNU6-491P	GNAI2P1 - RPL30P11	ENSG00000255749	ENSG00000244573		8758	92858	rs10845938-G	rs10845938	0	10845938	intergenic_variant	1	0.55	1E-12	12.0		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	12q14.2	12	64619044	RASSF3	RASSF3			ENSG00000153179			rs7968403-T	rs7968403	0	7968403	intron_variant	0	0.64	3E-12	11.522878745280337		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	12q21.33	12	89766754	RNU6-148P	AC084200.1	ENSG00000252823			12602		rs5799921-GA	rs5799921	0	5799921	regulatory_region_variant	0	0.68	7E-12	11.154901959985743		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	12q24.33	12	132491403	FBRSL1	FBRSL1			ENSG00000112787			rs7295014-G	rs7295014	0	7295014	intron_variant	0	0.35	1E-9	9.0		1.05	[1.04-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	14q11.2	14	22836440	MMP14	MRPL52 - MMP14	ENSG00000172590	ENSG00000157227		1403	117	rs1004030-T	rs1004030	0	1004030	TF_binding_site_variant	1	0.58	2E-8	7.698970004336019		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	14q13.3	14	36669089	PAX9	PAX9			ENSG00000198807			rs11629412-C	rs11629412	0	11629412	intron_variant	0	0.58	2E-12	11.698970004336019		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	15q15.1	15	40630717	CASC5	KNL1			ENSG00000137812			rs4924487-C	rs4924487	0	4924487	intron_variant	0	0.81	1E-8	8.0		1.06	[1.04-1.09]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	15q21.3	15	56093670	RFX7	RFX7			ENSG00000181827			rs33984059-A	rs33984059	0	33984059	missense_variant	0	0.98	1E-8	8.0		1.19	[1.12-1.27]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	15q22.31	15	66472304	MAP2K1	MAP2K1			ENSG00000169032			rs112293876-C	rs112293876	0	112293876	intron_variant	0	0.29	4E-10	9.397940008672037		1.06	[1.04-1.08]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	16q21	16	57620664	GPR56	ADGRG1			ENSG00000205336			rs11863709-C	rs11863709	0	11863709	intron_variant	0	0.96	2E-11	10.698970004336019		1.16	[1.11-1.21]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	16q23.3	16	82145289	RP11-510J16.5	AC092142.1 - MPHOSPH6	ENSG00000261235	ENSG00000135698		5658	2509	rs201158093-TAA	rs201158093	0	201158093	intergenic_variant	1	0.44	9E-9	8.045757490560675		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	17p13.1	17	7899800	CHD3	CHD3			ENSG00000170004			rs28441558-C	rs28441558	0	28441558	intron_variant	0	0.05	1E-16	16.0		1.16	[1.12-1.20]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	17q11.2	17	31771730	RP11-805L22.3	AC007923.1 - AC004253.2	ENSG00000263567	ENSG00000265046		2682	59001	rs142444269-C	rs142444269	0	142444269	intergenic_variant	1	0.78	3E-10	9.522878745280337		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	17q22	17	58378759	RNF43	RNF43, AC004687.2, TSPOAP1-AS1			ENSG00000108375, ENSG00000285897, ENSG00000265148			rs2680708-G	rs2680708	0	2680708	intron_variant	0	0.61	2E-8	7.698970004336019		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	18q21.2	18	54246103	MBD2	MBD2 - AC093462.1	ENSG00000134046	ENSG00000277324		21315	22243	rs8093601-C	rs8093601	0	8093601	intergenic_variant	1	0.44	2E-8	7.698970004336019		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	18q21.2	18	55563628	TCF4	TCF4			ENSG00000196628			rs28607662-C	rs28607662	0	28607662	intron_variant	0	0.1	3E-8	7.522878745280337		1.08	[1.05-1.11]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	18q21.32	18	59079083	OACYLP	OACYLP - AC040963.1	ENSG00000224367	ENSG00000267215		9745	2841	rs12956892-T	rs12956892	0	12956892	intergenic_variant	1	0.3	8E-9	8.096910013008056		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	18q21.33	18	63293961	BCL2	BCL2			ENSG00000171791			rs533722308-CT	rs533722308	0	533722308	intron_variant	0	0.42	1E-8	8.0		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	18q22.3	18	75324210	TSHZ1	TSHZ1 - AC116003.3	ENSG00000179981	ENSG00000276993		34260	62846	rs10460109-T	rs10460109	0	10460109	intergenic_variant	1	0.42	4E-8	7.3979400086720375		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	19p13.11	19	17103263	MYO9B	MYO9B			ENSG00000099331			rs11666569-C	rs11666569	0	11666569	non_coding_transcript_exon_variant	0	0.71	8E-9	8.096910013008056		1.05	[1.03-1.07]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	19q12	19	31676897	THEG5	RNA5SP471 - RNU6-967P	ENSG00000252780	ENSG00000201894		21436	110251	rs118005503-G	rs118005503	0	118005503	intergenic_variant	1	0.91	7E-9	8.154901959985743		1.09	[1.06-1.13]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	19q13.2	19	42196795	POU2F2	POU2F2 - DEDD2	ENSG00000028277	ENSG00000160570		210	1803	rs61088131-T	rs61088131	0	61088131	intergenic_variant	1	0.82	9E-9	8.045757490560675		1.06	[1.04-1.09]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	20q11.21	20	32759707	DNMT3B	COMMD7 - DNMT3B	ENSG00000149600	ENSG00000088305		15710	2678	rs11480453-C	rs11480453	0	11480453	intergenic_variant	1	0.6	3E-8	7.522878745280337		1.05	[1.03-1.06]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	20q13.2	20	53838666	BCAS1	AC006076.1 - SUMO1P1	ENSG00000225563	ENSG00000241721		37348	36586	rs6091758-G	rs6091758	0	6091758	intergenic_variant	1	0.47	6E-18	17.221848749616356		1.07	[1.06-1.09]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	22q12.1	22	28492951	TTC28	TTC28			ENSG00000100154			rs9625483-A	rs9625483	0	9625483	intron_variant	0	0.03	2E-8	7.698970004336019		1.14	[1.09-1.20]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	Xp22.2	X	11464514	ARHGAP6	ARHGAP6			ENSG00000047648			rs17321482-C	rs17321482	0	17321482	intron_variant	0	0.87	2E-13	12.698970004336019		1.07	[1.05-1.09]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
2018-08-14	29892016	Schumacher FR	2018-06-11	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/29892016	Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.	Prostate cancer	79,148 European ancestry cases, 61,106 European ancestry controls	NA	5q35.1	5	169745129	DOCK2	DOCK2			ENSG00000134516			rs76551843-A	rs76551843	0	76551843	intron_variant	0	0.99	2E-8	7.698970004336019		1.31	[1.19-1.44]	Illumina [20370935] (imputed)	N	prostate carcinoma	http://www.ebi.ac.uk/efo/EFO_0001663	GCST006085	Genome-wide genotyping array
